[{
  "_id": {
    "$oid": "676543ed8a3f82637a73c6fa"
  },
  "id": "1",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0114,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "15;43",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.083 (0 - 0.646)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c6fb"
  },
  "id": "1",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0114,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "15;43",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.083 (0 - 0.646)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c6fc"
  },
  "id": "1",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0114,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "15;43",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.083 (0 - 0.646)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c6fd"
  },
  "id": "1",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0114,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "15;43",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.083 (0 - 0.646)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c6fe"
  },
  "id": "1",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0114,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "15;43",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.083 (0 - 0.646)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c6ff"
  },
  "id": "1",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0114,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "15;43",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.083 (0 - 0.646)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c700"
  },
  "id": "2",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:02",
  "GeTH_AlleleCount": 10,
  "GeTH_AlleleFreq": 0.001336184,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.3233,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.377 (0.053 - 2.797)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c701"
  },
  "id": "2",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:02",
  "GeTH_AlleleCount": 10,
  "GeTH_AlleleFreq": 0.001336184,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.3233,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.377 (0.053 - 2.797)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c702"
  },
  "id": "2",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:02",
  "GeTH_AlleleCount": 10,
  "GeTH_AlleleFreq": 0.001336184,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.3233,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.377 (0.053 - 2.797)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c703"
  },
  "id": "3",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.9869,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.013 (0.241 - 4.849)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c704"
  },
  "id": "3",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.9869,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.013 (0.241 - 4.849)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c705"
  },
  "id": "3",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.9869,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.013 (0.241 - 4.849)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c706"
  },
  "id": "4",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.1229,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;20",
  "hla_adr_exposed_frequency": "2;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.714 (0.591 - 30.132)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c707"
  },
  "id": "4",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.1229,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;20",
  "hla_adr_exposed_frequency": "2;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.714 (0.591 - 30.132)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c708"
  },
  "id": "4",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.1229,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;20",
  "hla_adr_exposed_frequency": "2;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.714 (0.591 - 30.132)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c709"
  },
  "id": "5",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.4161,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_exposed_frequency": "4;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.264 (0.278 - 14.569)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c70a"
  },
  "id": "5",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.4161,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_exposed_frequency": "4;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.264 (0.278 - 14.569)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c70b"
  },
  "id": "5",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.4161,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_exposed_frequency": "4;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.264 (0.278 - 14.569)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c70c"
  },
  "id": "6",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.7656,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.768 (0.121 - 3.95)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c70d"
  },
  "id": "6",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.7656,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.768 (0.121 - 3.95)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c70e"
  },
  "id": "6",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.7656,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.768 (0.121 - 3.95)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c70f"
  },
  "id": "7",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:05",
  "GeTH_AlleleCount": 24,
  "GeTH_AlleleFreq": 0.003206841,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.6807,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.664 (0.086 - 4.318)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c710"
  },
  "id": "7",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:05",
  "GeTH_AlleleCount": 24,
  "GeTH_AlleleFreq": 0.003206841,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.6807,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.664 (0.086 - 4.318)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c711"
  },
  "id": "7",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16981842",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:05",
  "GeTH_AlleleCount": 24,
  "GeTH_AlleleFreq": 0.003206841,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.6807,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_exposed_frequency": "6;43",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.664 (0.086 - 4.318)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c712"
  },
  "id": "8",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18505179",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_pvalue_exposed": 0.0005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "11;11",
  "hla_adr_exposed_frequency": "2;9",
  "hla_adr_population_frequency": "4;8",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Australia",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "General Population is comprised of HIV patients who were abacavir naive",
  "hla_adr_region_id": "Oceania",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c713"
  },
  "id": "647",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11266078",
  "hla_adr_drug_id": "clozapine",
  "db_id": "DB00363",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01",
  "GeTH_AlleleCount": 3049,
  "GeTH_AlleleFreq": 0.407293615,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;31",
  "hla_adr_exposed_frequency": "17;77",
  "hla_adr_adr": "agranulocytosis",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "schizophrenia",
  "hla_adr_region_id": "Europe",
  "c_id": "C2063865"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c714"
  },
  "id": "647",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11266078",
  "hla_adr_drug_id": "clozapine",
  "db_id": "DB00363",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01",
  "GeTH_AlleleCount": 3049,
  "GeTH_AlleleFreq": 0.407293615,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;31",
  "hla_adr_exposed_frequency": "17;77",
  "hla_adr_adr": "agranulocytosis",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "schizophrenia",
  "hla_adr_region_id": "Europe",
  "c_id": "C2063865"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c715"
  },
  "id": "495",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "6;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c716"
  },
  "id": "495",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "6;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c717"
  },
  "id": "495",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "6;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c718"
  },
  "id": "495",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "6;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c719"
  },
  "id": "495",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "6;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c71a"
  },
  "id": "495",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "6;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c71b"
  },
  "id": "564",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.21",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_exposed_frequency": "0;64",
  "hla_adr_population_frequency": "3;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.14 (0.24 - 155.12)",
  "hla_adr_odds_population": "5.65 (0.57 - 55.86)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c71c"
  },
  "id": "564",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.21",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_exposed_frequency": "0;64",
  "hla_adr_population_frequency": "3;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.14 (0.24 - 155.12)",
  "hla_adr_odds_population": "5.65 (0.57 - 55.86)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c71d"
  },
  "id": "564",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.21",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_exposed_frequency": "0;64",
  "hla_adr_population_frequency": "3;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.14 (0.24 - 155.12)",
  "hla_adr_odds_population": "5.65 (0.57 - 55.86)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c71e"
  },
  "id": "12",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0022,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.09 (0.04 - 27.51)",
  "hla_adr_region_id": "North America",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c71f"
  },
  "id": "12",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0022,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.09 (0.04 - 27.51)",
  "hla_adr_region_id": "North America",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c720"
  },
  "id": "12",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0022,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.09 (0.04 - 27.51)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c721"
  },
  "id": "13",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.09 (0.04 - 27.51)",
  "hla_adr_region_id": "North America",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c722"
  },
  "id": "13",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.09 (0.04 - 27.51)",
  "hla_adr_region_id": "North America",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c723"
  },
  "id": "13",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.09 (0.04 - 27.51)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c724"
  },
  "id": "14",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.44 (0.16 - 120.08)",
  "hla_adr_region_id": "North America",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c725"
  },
  "id": "14",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.44 (0.16 - 120.08)",
  "hla_adr_region_id": "North America",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c726"
  },
  "id": "14",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23588310",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;6",
  "hla_adr_exposed_frequency": "1;87",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.44 (0.16 - 120.08)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c727"
  },
  "id": "15",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.239,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10 (0.44 - 228.7)",
  "hla_adr_odds_population": "5.42 (0.43 - 68.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c728"
  },
  "id": "15",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.239,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10 (0.44 - 228.7)",
  "hla_adr_odds_population": "5.42 (0.43 - 68.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c729"
  },
  "id": "15",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.239,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10 (0.44 - 228.7)",
  "hla_adr_odds_population": "5.42 (0.43 - 68.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c72a"
  },
  "id": "15",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.239,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10 (0.44 - 228.7)",
  "hla_adr_odds_population": "5.42 (0.43 - 68.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c72b"
  },
  "id": "15",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.239,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10 (0.44 - 228.7)",
  "hla_adr_odds_population": "5.42 (0.43 - 68.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c72c"
  },
  "id": "15",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.239,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10 (0.44 - 228.7)",
  "hla_adr_odds_population": "5.42 (0.43 - 68.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c72d"
  },
  "id": "16",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;22",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.17 - 23.9)",
  "hla_adr_odds_population": "1.08 (0.2 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c72e"
  },
  "id": "16",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;22",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.17 - 23.9)",
  "hla_adr_odds_population": "1.08 (0.2 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c72f"
  },
  "id": "16",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;22",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.17 - 23.9)",
  "hla_adr_odds_population": "1.08 (0.2 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c730"
  },
  "id": "16",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;22",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.17 - 23.9)",
  "hla_adr_odds_population": "1.08 (0.2 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c731"
  },
  "id": "16",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;22",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.17 - 23.9)",
  "hla_adr_odds_population": "1.08 (0.2 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c732"
  },
  "id": "16",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21071176",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;22",
  "hla_adr_exposed_frequency": "1;21",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.17 - 23.9)",
  "hla_adr_odds_population": "1.08 (0.2 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c733"
  },
  "id": "17",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22197535",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "18;18",
  "hla_adr_exposed_frequency": "2;470",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Canada",
  "hla_adr_disease_id": "HIV",
  "hla_adr_odds_exposed": "6934 (321 - 149735)",
  "hla_adr_region_id": "North America",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c734"
  },
  "id": "18",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.24e-10,
  "hla_adr_pvalue_population": "2.10E-15",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "203.4 (10.93 - 3785.04)",
  "hla_adr_odds_population": "165.19 (9.72 - 2806.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c735"
  },
  "id": "18",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.24e-10,
  "hla_adr_pvalue_population": "2.10E-15",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "203.4 (10.93 - 3785.04)",
  "hla_adr_odds_population": "165.19 (9.72 - 2806.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c736"
  },
  "id": "18",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.24e-10,
  "hla_adr_pvalue_population": "2.10E-15",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "203.4 (10.93 - 3785.04)",
  "hla_adr_odds_population": "165.19 (9.72 - 2806.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c737"
  },
  "id": "18",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.24e-10,
  "hla_adr_pvalue_population": "2.10E-15",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "203.4 (10.93 - 3785.04)",
  "hla_adr_odds_population": "165.19 (9.72 - 2806.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c738"
  },
  "id": "18",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.24e-10,
  "hla_adr_pvalue_population": "2.10E-15",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "203.4 (10.93 - 3785.04)",
  "hla_adr_odds_population": "165.19 (9.72 - 2806.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c739"
  },
  "id": "18",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.24e-10,
  "hla_adr_pvalue_population": "2.10E-15",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "203.4 (10.93 - 3785.04)",
  "hla_adr_odds_population": "165.19 (9.72 - 2806.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c73a"
  },
  "id": "18",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.24e-10,
  "hla_adr_pvalue_population": "2.10E-15",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "203.4 (10.93 - 3785.04)",
  "hla_adr_odds_population": "165.19 (9.72 - 2806.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c73b"
  },
  "id": "19",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 9.21e-14,
  "hla_adr_pvalue_population": "3.74E-24",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "22;22",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "339 (18.58 - 6186.39)",
  "hla_adr_odds_population": "275.31 (16.54 - 4583.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c73c"
  },
  "id": "19",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 9.21e-14,
  "hla_adr_pvalue_population": "3.74E-24",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "22;22",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "339 (18.58 - 6186.39)",
  "hla_adr_odds_population": "275.31 (16.54 - 4583.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c73d"
  },
  "id": "19",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 9.21e-14,
  "hla_adr_pvalue_population": "3.74E-24",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "22;22",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "339 (18.58 - 6186.39)",
  "hla_adr_odds_population": "275.31 (16.54 - 4583.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c73e"
  },
  "id": "19",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 9.21e-14,
  "hla_adr_pvalue_population": "3.74E-24",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "22;22",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "339 (18.58 - 6186.39)",
  "hla_adr_odds_population": "275.31 (16.54 - 4583.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c73f"
  },
  "id": "19",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 9.21e-14,
  "hla_adr_pvalue_population": "3.74E-24",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "22;22",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "339 (18.58 - 6186.39)",
  "hla_adr_odds_population": "275.31 (16.54 - 4583.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c740"
  },
  "id": "19",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 9.21e-14,
  "hla_adr_pvalue_population": "3.74E-24",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "22;22",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "339 (18.58 - 6186.39)",
  "hla_adr_odds_population": "275.31 (16.54 - 4583.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c741"
  },
  "id": "19",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 9.21e-14,
  "hla_adr_pvalue_population": "3.74E-24",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "22;22",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "339 (18.58 - 6186.39)",
  "hla_adr_odds_population": "275.31 (16.54 - 4583.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c742"
  },
  "id": "20",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.002,
  "hla_adr_pvalue_population": "0.002",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;3",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "52.73 (2.47 - 1124.13)",
  "hla_adr_odds_population": "42.83 (2.19 - 836.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c743"
  },
  "id": "20",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.002,
  "hla_adr_pvalue_population": "0.002",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;3",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "52.73 (2.47 - 1124.13)",
  "hla_adr_odds_population": "42.83 (2.19 - 836.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c744"
  },
  "id": "20",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.002,
  "hla_adr_pvalue_population": "0.002",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;3",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "52.73 (2.47 - 1124.13)",
  "hla_adr_odds_population": "42.83 (2.19 - 836.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c745"
  },
  "id": "20",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.002,
  "hla_adr_pvalue_population": "0.002",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;3",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "52.73 (2.47 - 1124.13)",
  "hla_adr_odds_population": "42.83 (2.19 - 836.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c746"
  },
  "id": "20",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.002,
  "hla_adr_pvalue_population": "0.002",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;3",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "52.73 (2.47 - 1124.13)",
  "hla_adr_odds_population": "42.83 (2.19 - 836.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c747"
  },
  "id": "20",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.002,
  "hla_adr_pvalue_population": "0.002",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;3",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "52.73 (2.47 - 1124.13)",
  "hla_adr_odds_population": "42.83 (2.19 - 836.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c748"
  },
  "id": "20",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22909208",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.002,
  "hla_adr_pvalue_population": "0.002",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;3",
  "hla_adr_exposed_frequency": "7;63",
  "hla_adr_population_frequency": "80;572",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "52.73 (2.47 - 1124.13)",
  "hla_adr_odds_population": "42.83 (2.19 - 836.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c749"
  },
  "id": "21",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23362284",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:01",
  "GeTH_AlleleCount": 392,
  "GeTH_AlleleFreq": 0.052378407,
  "hla_adr_cohort_ethnicity_id": "Black",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;36",
  "hla_adr_exposed_frequency": "39;153",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as < 0.001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Malawi",
  "hla_adr_disease_id": "HIV",
  "hla_adr_odds_exposed": "5.17 (2.39 - 11.18)",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c74a"
  },
  "id": "22",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_pvalue_population": "0.00000787",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "12;16",
  "hla_adr_population_frequency": "47;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "16.15 (4.57 - 62.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c74b"
  },
  "id": "22",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_pvalue_population": "0.00000787",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "12;16",
  "hla_adr_population_frequency": "47;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "16.15 (4.57 - 62.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c74c"
  },
  "id": "22",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_pvalue_population": "0.00000787",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "12;16",
  "hla_adr_population_frequency": "47;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "16.15 (4.57 - 62.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c74d"
  },
  "id": "23",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;16",
  "hla_adr_population_frequency": "15;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c74e"
  },
  "id": "23",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;16",
  "hla_adr_population_frequency": "15;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c74f"
  },
  "id": "23",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;16",
  "hla_adr_population_frequency": "15;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c750"
  },
  "id": "24",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;16",
  "hla_adr_population_frequency": "8;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c751"
  },
  "id": "24",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;16",
  "hla_adr_population_frequency": "8;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c752"
  },
  "id": "24",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21244392",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Malay",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;16",
  "hla_adr_population_frequency": "8;300",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Malaysia",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c753"
  },
  "id": "585",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "0;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "3.13 (0.12 - 80.69)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c754"
  },
  "id": "585",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "0;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "3.13 (0.12 - 80.69)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c755"
  },
  "id": "585",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "0;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "3.13 (0.12 - 80.69)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c756"
  },
  "id": "26",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19104471",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:01",
  "GeTH_AlleleCount": 392,
  "GeTH_AlleleFreq": 0.052378407,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;128",
  "hla_adr_exposed_frequency": "4;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.36 (1.83 - 15.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2363741",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c757"
  },
  "id": "27",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19104471",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:02",
  "GeTH_AlleleCount": 1226,
  "GeTH_AlleleFreq": 0.163816141,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;128",
  "hla_adr_exposed_frequency": "34;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.4 (0.2 - 0.78)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2363741",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c758"
  },
  "id": "28",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19104471",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:05",
  "GeTH_AlleleCount": 173,
  "GeTH_AlleleFreq": 0.023115981,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.035,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;152",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "16.53 (2.74 - 98.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2363741",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c759"
  },
  "id": "29",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19104471",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;152",
  "hla_adr_exposed_frequency": "13;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.22 (0.07 - 0.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2363741",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c75a"
  },
  "id": "30",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19104471",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "41;160",
  "hla_adr_exposed_frequency": "19;160",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.56 (1.41 - 4.61)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2363741",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c75b"
  },
  "id": "31",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 3.51e-18,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "24;26",
  "hla_adr_exposed_frequency": "16;135",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "89.25 (19.25 - 413.83)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c75c"
  },
  "id": "31",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 3.51e-18,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "24;26",
  "hla_adr_exposed_frequency": "16;135",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "89.25 (19.25 - 413.83)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c75d"
  },
  "id": "31",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 3.51e-18,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "24;26",
  "hla_adr_exposed_frequency": "16;135",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "89.25 (19.25 - 413.83)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c75e"
  },
  "id": "32",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.045,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;15",
  "hla_adr_exposed_frequency": "15;75",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.5 (1.1 - 11.18)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c75f"
  },
  "id": "32",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.045,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;15",
  "hla_adr_exposed_frequency": "15;75",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.5 (1.1 - 11.18)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c760"
  },
  "id": "32",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.045,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;15",
  "hla_adr_exposed_frequency": "15;75",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.5 (1.1 - 11.18)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c761"
  },
  "id": "32",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.045,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;15",
  "hla_adr_exposed_frequency": "15;75",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.5 (1.1 - 11.18)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c762"
  },
  "id": "33",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.256,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.25 (0.44 - 23.95)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c763"
  },
  "id": "33",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.256,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.25 (0.44 - 23.95)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c764"
  },
  "id": "33",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.256,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.25 (0.44 - 23.95)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c765"
  },
  "id": "33",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.256,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.25 (0.44 - 23.95)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c766"
  },
  "id": "33",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.256,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.25 (0.44 - 23.95)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c767"
  },
  "id": "33",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.256,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.25 (0.44 - 23.95)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c768"
  },
  "id": "34",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "valproic acid",
  "db_id": "DB00313",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "4;15",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.38 (0.1 - 19.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c769"
  },
  "id": "34",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "valproic acid",
  "db_id": "DB00313",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "4;15",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.38 (0.1 - 19.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014553",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c76a"
  },
  "id": "35",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23692434",
  "hla_adr_drug_id": "phenobarbital",
  "db_id": "DB01174",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;2",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c76b"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c76c"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c76d"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c76e"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c76f"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c770"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c771"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c772"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c773"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c774"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c775"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c776"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c777"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c778"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c779"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c77a"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c77b"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c77c"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c77d"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c77e"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c77f"
  },
  "id": "36",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348415",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "4;30",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS),Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Hong Kong",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "123.5 (12.8 - 1195.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c780"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c781"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c782"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c783"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c784"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c785"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c786"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c787"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c788"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c789"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c78a"
  },
  "id": "37",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;76",
  "hla_adr_exposed_frequency": "8;73",
  "hla_adr_population_frequency": "12;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c78b"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c78c"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c78d"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c78e"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c78f"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c790"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c791"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c792"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c793"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c794"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c795"
  },
  "id": "38",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;76",
  "hla_adr_exposed_frequency": "2;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "9.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c796"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c797"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c798"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c799"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c79a"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c79b"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c79c"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c79d"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c79e"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c79f"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a0"
  },
  "id": "39",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "28;76",
  "hla_adr_exposed_frequency": "14;73",
  "hla_adr_population_frequency": "19;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.3",
  "hla_adr_odds_population": "2.2",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a1"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a2"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a3"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a4"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a5"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a6"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a7"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a8"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7a9"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7aa"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ab"
  },
  "id": "40",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;76",
  "hla_adr_exposed_frequency": "10;73",
  "hla_adr_population_frequency": "16;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ac"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ad"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ae"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7af"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b0"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b1"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b2"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b3"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b4"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b5"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b6"
  },
  "id": "41",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15007363",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;76",
  "hla_adr_exposed_frequency": "6;73",
  "hla_adr_population_frequency": "4;91",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.2 (1.8 - 14.7)",
  "hla_adr_odds_population": "8.3 (2.7 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b7"
  },
  "id": "42",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15057820",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 3.13e-27,
  "hla_adr_pvalue_population": "1.38E-21",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "44;44",
  "hla_adr_exposed_frequency": "3;101",
  "hla_adr_population_frequency": "8;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2504 (126 - 49522)",
  "hla_adr_odds_population": "895 (50 - 15869)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b8"
  },
  "id": "42",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15057820",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 3.13e-27,
  "hla_adr_pvalue_population": "1.38E-21",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "44;44",
  "hla_adr_exposed_frequency": "3;101",
  "hla_adr_population_frequency": "8;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2504 (126 - 49522)",
  "hla_adr_odds_population": "895 (50 - 15869)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7b9"
  },
  "id": "42",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15057820",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 3.13e-27,
  "hla_adr_pvalue_population": "1.38E-21",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "44;44",
  "hla_adr_exposed_frequency": "3;101",
  "hla_adr_population_frequency": "8;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2504 (126 - 49522)",
  "hla_adr_odds_population": "895 (50 - 15869)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ba"
  },
  "id": "671",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23057547",
  "hla_adr_drug_id": "EGF receptor inhibitors",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_pvalue_exposed": 0.4008,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;38",
  "hla_adr_exposed_frequency": "25;172",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "the odds ratio for this entry represents the Hazard Ratio",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "cancer",
  "hla_adr_odds_exposed": "1.446 (0.472 - 4.428)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7bb"
  },
  "id": "44",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.12",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7bc"
  },
  "id": "44",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.12",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7bd"
  },
  "id": "44",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.12",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7be"
  },
  "id": "45",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.999",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7bf"
  },
  "id": "45",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.999",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c0"
  },
  "id": "45",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.999",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c1"
  },
  "id": "46",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c2"
  },
  "id": "46",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c3"
  },
  "id": "46",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c4"
  },
  "id": "47",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c5"
  },
  "id": "47",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c6"
  },
  "id": "47",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c7"
  },
  "id": "48",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c8"
  },
  "id": "48",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7c9"
  },
  "id": "48",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ca"
  },
  "id": "49",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7cb"
  },
  "id": "49",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7cc"
  },
  "id": "49",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7cd"
  },
  "id": "50",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ce"
  },
  "id": "50",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7cf"
  },
  "id": "50",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d0"
  },
  "id": "51",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d1"
  },
  "id": "51",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d2"
  },
  "id": "51",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d3"
  },
  "id": "52",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;10",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0015967",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d4"
  },
  "id": "52",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;10",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d5"
  },
  "id": "52",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "Acetaminophen",
  "db_id": "DB00316",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;10",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234238",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d6"
  },
  "id": "827",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24856347",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.308,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;10",
  "hla_adr_exposed_frequency": "1;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.444 (0.311 - 95.21)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d7"
  },
  "id": "54",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d8"
  },
  "id": "54",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7d9"
  },
  "id": "54",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7da"
  },
  "id": "54",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7db"
  },
  "id": "54",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7dc"
  },
  "id": "54",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7dd"
  },
  "id": "54",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7de"
  },
  "id": "55",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.248",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7df"
  },
  "id": "55",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.248",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e0"
  },
  "id": "55",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.248",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e1"
  },
  "id": "55",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.248",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e2"
  },
  "id": "55",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.248",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e3"
  },
  "id": "55",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.248",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e4"
  },
  "id": "55",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.248",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "6;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e5"
  },
  "id": "56",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e6"
  },
  "id": "56",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e7"
  },
  "id": "56",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e8"
  },
  "id": "56",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7e9"
  },
  "id": "56",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ea"
  },
  "id": "56",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7eb"
  },
  "id": "56",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ec"
  },
  "id": "57",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ed"
  },
  "id": "57",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ee"
  },
  "id": "57",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ef"
  },
  "id": "57",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f0"
  },
  "id": "57",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f1"
  },
  "id": "57",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f2"
  },
  "id": "57",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "0;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f3"
  },
  "id": "58",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f4"
  },
  "id": "58",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f5"
  },
  "id": "58",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f6"
  },
  "id": "58",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f7"
  },
  "id": "58",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f8"
  },
  "id": "58",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7f9"
  },
  "id": "58",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7fa"
  },
  "id": "59",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7fb"
  },
  "id": "59",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7fc"
  },
  "id": "59",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7fd"
  },
  "id": "59",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7fe"
  },
  "id": "59",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c7ff"
  },
  "id": "59",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c800"
  },
  "id": "59",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.575",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_population_frequency": "2;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c801"
  },
  "id": "60",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c802"
  },
  "id": "60",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c803"
  },
  "id": "60",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c804"
  },
  "id": "60",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c805"
  },
  "id": "60",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c806"
  },
  "id": "60",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c807"
  },
  "id": "60",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.366",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_population_frequency": "33;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c808"
  },
  "id": "61",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c809"
  },
  "id": "61",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c80a"
  },
  "id": "61",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c80b"
  },
  "id": "61",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c80c"
  },
  "id": "61",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c80d"
  },
  "id": "61",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c80e"
  },
  "id": "61",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;7",
  "hla_adr_population_frequency": "4;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c80f"
  },
  "id": "62",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c810"
  },
  "id": "62",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c811"
  },
  "id": "62",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c812"
  },
  "id": "62",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c813"
  },
  "id": "62",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c814"
  },
  "id": "62",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c815"
  },
  "id": "62",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21545408",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.672",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_population_frequency": "25;115",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "Italy",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c816"
  },
  "id": "63",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 8.97e-19,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;51",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "80.6 (22.8 - 284.9)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c817"
  },
  "id": "63",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 8.97e-19,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;51",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "80.6 (22.8 - 284.9)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c818"
  },
  "id": "64",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.000019,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "36;51",
  "hla_adr_exposed_frequency": "16;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "7.2 (3.15 - 16.45)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c819"
  },
  "id": "64",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.000019,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "36;51",
  "hla_adr_exposed_frequency": "16;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "7.2 (3.15 - 16.45)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c81a"
  },
  "id": "65",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01",
  "GeTH_AlleleCount": 3082,
  "GeTH_AlleleFreq": 0.411811865,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.459,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;51",
  "hla_adr_exposed_frequency": "13;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c81b"
  },
  "id": "65",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01",
  "GeTH_AlleleCount": 3082,
  "GeTH_AlleleFreq": 0.411811865,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.459,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;51",
  "hla_adr_exposed_frequency": "13;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c81c"
  },
  "id": "66",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03",
  "GeTH_AlleleCount": 708,
  "GeTH_AlleleFreq": 0.094601817,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.557,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;51",
  "hla_adr_exposed_frequency": "24;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c81d"
  },
  "id": "66",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03",
  "GeTH_AlleleCount": 708,
  "GeTH_AlleleFreq": 0.094601817,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.557,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;51",
  "hla_adr_exposed_frequency": "24;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c81e"
  },
  "id": "67",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04",
  "GeTH_AlleleCount": 944,
  "GeTH_AlleleFreq": 0.126135756,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.096,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;51",
  "hla_adr_exposed_frequency": "22;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c81f"
  },
  "id": "67",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04",
  "GeTH_AlleleCount": 944,
  "GeTH_AlleleFreq": 0.126135756,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.096,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;51",
  "hla_adr_exposed_frequency": "22;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c820"
  },
  "id": "68",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08",
  "GeTH_AlleleCount": 196,
  "GeTH_AlleleFreq": 0.026189204,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.086,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;51",
  "hla_adr_exposed_frequency": "1;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c821"
  },
  "id": "68",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08",
  "GeTH_AlleleCount": 196,
  "GeTH_AlleleFreq": 0.026189204,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.086,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;51",
  "hla_adr_exposed_frequency": "1;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c822"
  },
  "id": "69",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09",
  "GeTH_AlleleCount": 743,
  "GeTH_AlleleFreq": 0.099278461,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;51",
  "hla_adr_exposed_frequency": "2;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c823"
  },
  "id": "69",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09",
  "GeTH_AlleleCount": 743,
  "GeTH_AlleleFreq": 0.099278461,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;51",
  "hla_adr_exposed_frequency": "2;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c824"
  },
  "id": "70",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*10",
  "GeTH_AlleleCount": 183,
  "GeTH_AlleleFreq": 0.024452165,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;51",
  "hla_adr_exposed_frequency": "1;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c825"
  },
  "id": "70",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*10",
  "GeTH_AlleleCount": 183,
  "GeTH_AlleleFreq": 0.024452165,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;51",
  "hla_adr_exposed_frequency": "1;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c826"
  },
  "id": "71",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11",
  "GeTH_AlleleCount": 369,
  "GeTH_AlleleFreq": 0.049305184,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c827"
  },
  "id": "71",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11",
  "GeTH_AlleleCount": 369,
  "GeTH_AlleleFreq": 0.049305184,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c828"
  },
  "id": "72",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13",
  "GeTH_AlleleCount": 389,
  "GeTH_AlleleFreq": 0.051977552,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.643,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;51",
  "hla_adr_exposed_frequency": "14;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c829"
  },
  "id": "72",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13",
  "GeTH_AlleleCount": 389,
  "GeTH_AlleleFreq": 0.051977552,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.643,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;51",
  "hla_adr_exposed_frequency": "14;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c82a"
  },
  "id": "73",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14",
  "GeTH_AlleleCount": 629,
  "GeTH_AlleleFreq": 0.084045965,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.38,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;51",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c82b"
  },
  "id": "73",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14",
  "GeTH_AlleleCount": 629,
  "GeTH_AlleleFreq": 0.084045965,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.38,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;51",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c82c"
  },
  "id": "74",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15",
  "GeTH_AlleleCount": 1699,
  "GeTH_AlleleFreq": 0.227017638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.21,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;51",
  "hla_adr_exposed_frequency": "18;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.27 (0.09 - 0.81)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c82d"
  },
  "id": "74",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15",
  "GeTH_AlleleCount": 1699,
  "GeTH_AlleleFreq": 0.227017638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.21,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;51",
  "hla_adr_exposed_frequency": "18;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.27 (0.09 - 0.81)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c82e"
  },
  "id": "75",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16",
  "GeTH_AlleleCount": 399,
  "GeTH_AlleleFreq": 0.053313736,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;51",
  "hla_adr_exposed_frequency": "1;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c82f"
  },
  "id": "75",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19483685",
  "hla_adr_drug_id": "flucloxacillin",
  "db_id": "DB00301",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16",
  "GeTH_AlleleCount": 399,
  "GeTH_AlleleFreq": 0.053313736,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;51",
  "hla_adr_exposed_frequency": "1;64",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_region_id": "Europe",
  "c_id": "C0427965",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c830"
  },
  "id": "76",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "65;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.83",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c831"
  },
  "id": "76",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "65;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.83",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c832"
  },
  "id": "77",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:01",
  "GeTH_AlleleCount": 13,
  "GeTH_AlleleFreq": 0.001737039,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "30;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.95",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c833"
  },
  "id": "77",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:01",
  "GeTH_AlleleCount": 13,
  "GeTH_AlleleFreq": 0.001737039,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "30;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.95",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c834"
  },
  "id": "78",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:03",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "9;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "2.09",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c835"
  },
  "id": "78",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:03",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "9;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "2.09",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c836"
  },
  "id": "79",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;25",
  "hla_adr_exposed_frequency": "236;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.63",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c837"
  },
  "id": "79",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;25",
  "hla_adr_exposed_frequency": "236;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.63",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c838"
  },
  "id": "80",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:06",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "19;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.44",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c839"
  },
  "id": "80",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:06",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "19;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.44",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c83a"
  },
  "id": "81",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:10",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068947,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "20;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.91",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c83b"
  },
  "id": "81",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:10",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068947,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "20;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.91",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c83c"
  },
  "id": "82",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:02",
  "GeTH_AlleleCount": 14,
  "GeTH_AlleleFreq": 0.001870657,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.0000196,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;25",
  "hla_adr_exposed_frequency": "7;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "25.17 (7.98 - 79.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c83d"
  },
  "id": "82",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:02",
  "GeTH_AlleleCount": 14,
  "GeTH_AlleleFreq": 0.001870657,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.0000196,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;25",
  "hla_adr_exposed_frequency": "7;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "25.17 (7.98 - 79.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c83e"
  },
  "id": "83",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "45;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.38",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c83f"
  },
  "id": "83",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "45;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.38",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c840"
  },
  "id": "84",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;25",
  "hla_adr_exposed_frequency": "125;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.79",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c841"
  },
  "id": "84",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;25",
  "hla_adr_exposed_frequency": "125;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.79",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c842"
  },
  "id": "85",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "15;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.56",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c843"
  },
  "id": "85",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "15;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.56",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c844"
  },
  "id": "86",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "35;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.06",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c845"
  },
  "id": "86",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "35;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.06",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c846"
  },
  "id": "87",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "9;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.93",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c847"
  },
  "id": "87",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "9;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.93",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c848"
  },
  "id": "88",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "41;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.89",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c849"
  },
  "id": "88",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "41;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.89",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c84a"
  },
  "id": "89",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "7;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "2.7",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c84b"
  },
  "id": "89",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "7;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "2.7",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c84c"
  },
  "id": "90",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:06",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "13;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.43",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c84d"
  },
  "id": "90",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:06",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "13;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.43",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c84e"
  },
  "id": "91",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:54",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "28;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c84f"
  },
  "id": "91",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:54",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "28;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.3",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c850"
  },
  "id": "92",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "51;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.33",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c851"
  },
  "id": "92",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "51;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.33",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c852"
  },
  "id": "93",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "80;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.41",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c853"
  },
  "id": "93",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "80;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.41",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c854"
  },
  "id": "94",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;25",
  "hla_adr_exposed_frequency": "89;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.62",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c855"
  },
  "id": "94",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;25",
  "hla_adr_exposed_frequency": "89;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.62",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c856"
  },
  "id": "95",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "40;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.91",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c857"
  },
  "id": "95",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "40;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.91",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c858"
  },
  "id": "96",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;25",
  "hla_adr_exposed_frequency": "129;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.44",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c859"
  },
  "id": "96",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;25",
  "hla_adr_exposed_frequency": "129;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.44",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c85a"
  },
  "id": "97",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;25",
  "hla_adr_exposed_frequency": "243;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.6",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c85b"
  },
  "id": "97",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;25",
  "hla_adr_exposed_frequency": "243;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.6",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c85c"
  },
  "id": "98",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:02",
  "GeTH_AlleleCount": 82,
  "GeTH_AlleleFreq": 0.010956708,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000269,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;25",
  "hla_adr_exposed_frequency": "20;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "10.35 (3.99 - 26.83)",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c85d"
  },
  "id": "98",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:02",
  "GeTH_AlleleCount": 82,
  "GeTH_AlleleFreq": 0.010956708,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000269,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;25",
  "hla_adr_exposed_frequency": "20;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "10.35 (3.99 - 26.83)",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c85e"
  },
  "id": "99",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "69;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.77",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c85f"
  },
  "id": "99",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "69;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.77",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c860"
  },
  "id": "100",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:02",
  "GeTH_AlleleCount": 1325,
  "GeTH_AlleleFreq": 0.177044361,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "25;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.73",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c861"
  },
  "id": "100",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:02",
  "GeTH_AlleleCount": 1325,
  "GeTH_AlleleFreq": 0.177044361,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "25;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.73",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c862"
  },
  "id": "101",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "17;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.5",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c863"
  },
  "id": "101",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "17;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.5",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c864"
  },
  "id": "102",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "124;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.37",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c865"
  },
  "id": "102",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "124;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.37",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c866"
  },
  "id": "103",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:02",
  "GeTH_AlleleCount": 105,
  "GeTH_AlleleFreq": 0.014029931,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "49;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.35",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c867"
  },
  "id": "103",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:02",
  "GeTH_AlleleCount": 105,
  "GeTH_AlleleFreq": 0.014029931,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_exposed_frequency": "49;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.35",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c868"
  },
  "id": "104",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "37;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.99",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c869"
  },
  "id": "104",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "37;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.99",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c86a"
  },
  "id": "105",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;25",
  "hla_adr_exposed_frequency": "209;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.3",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c86b"
  },
  "id": "105",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;25",
  "hla_adr_exposed_frequency": "209;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.3",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c86c"
  },
  "id": "106",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "46;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.23",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c86d"
  },
  "id": "106",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "46;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.23",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c86e"
  },
  "id": "107",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "32;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.82",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c86f"
  },
  "id": "107",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;25",
  "hla_adr_exposed_frequency": "32;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.82",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c870"
  },
  "id": "108",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "36;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.02",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c871"
  },
  "id": "108",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "36;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "1.02",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c872"
  },
  "id": "109",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;25",
  "hla_adr_exposed_frequency": "100;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "2.03",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c873"
  },
  "id": "109",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;25",
  "hla_adr_exposed_frequency": "100;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "2.03",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c874"
  },
  "id": "110",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;25",
  "hla_adr_exposed_frequency": "275;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.62",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c875"
  },
  "id": "110",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;25",
  "hla_adr_exposed_frequency": "275;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.62",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c876"
  },
  "id": "111",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "62;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.56",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c877"
  },
  "id": "111",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;25",
  "hla_adr_exposed_frequency": "62;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.56",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c878"
  },
  "id": "112",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "13;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.65",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c879"
  },
  "id": "112",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "13;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.65",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c87a"
  },
  "id": "113",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "17;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.5",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c87b"
  },
  "id": "113",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24899791",
  "hla_adr_drug_id": "bucillamine",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;25",
  "hla_adr_exposed_frequency": "17;460",
  "hla_adr_adr": "bucillamine-induced proteinuria",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "rheumatoid arthritis",
  "hla_adr_odds_exposed": "0.5",
  "hla_adr_region_id": "Asia",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c87c"
  },
  "id": "872",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "35;134",
  "hla_adr_population_frequency": "37;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "0.76",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c87d"
  },
  "id": "115",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "0;257",
  "hla_adr_population_frequency": "4;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c87e"
  },
  "id": "115",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "0;257",
  "hla_adr_population_frequency": "4;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c87f"
  },
  "id": "115",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "0;257",
  "hla_adr_population_frequency": "4;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c880"
  },
  "id": "986",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;134",
  "hla_adr_population_frequency": "21;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "0.38",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c881"
  },
  "id": "117",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "0;257",
  "hla_adr_population_frequency": "4;8862",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c882"
  },
  "id": "117",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "0;257",
  "hla_adr_population_frequency": "4;8862",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c883"
  },
  "id": "117",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "0;257",
  "hla_adr_population_frequency": "4;8862",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c884"
  },
  "id": "1146",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;34",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c885"
  },
  "id": "1146",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;34",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c886"
  },
  "id": "1146",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;34",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c887"
  },
  "id": "119",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "41;53",
  "hla_adr_exposed_frequency": "4;72",
  "hla_adr_population_frequency": "60;710",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "58.1 (17.6 - 192)",
  "hla_adr_odds_population": "37 (18.5 - 74.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c888"
  },
  "id": "119",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "41;53",
  "hla_adr_exposed_frequency": "4;72",
  "hla_adr_population_frequency": "60;710",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "58.1 (17.6 - 192)",
  "hla_adr_odds_population": "37 (18.5 - 74.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c889"
  },
  "id": "119",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "41;53",
  "hla_adr_exposed_frequency": "4;72",
  "hla_adr_population_frequency": "60;710",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "58.1 (17.6 - 192)",
  "hla_adr_odds_population": "37 (18.5 - 74.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c88a"
  },
  "id": "1220",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;24",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c88b"
  },
  "id": "1220",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;24",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c88c"
  },
  "id": "1220",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;24",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c88d"
  },
  "id": "121",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "4;72",
  "hla_adr_population_frequency": "60;710",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c88e"
  },
  "id": "121",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "4;72",
  "hla_adr_population_frequency": "60;710",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c88f"
  },
  "id": "121",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24322785",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "4;72",
  "hla_adr_population_frequency": "60;710",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c890"
  },
  "id": "122",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;19",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "37.71 (4.13 - 343.87)",
  "hla_adr_odds_population": "85.36 (32.52 - 224.04)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c891"
  },
  "id": "122",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;19",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "37.71 (4.13 - 343.87)",
  "hla_adr_odds_population": "85.36 (32.52 - 224.04)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c892"
  },
  "id": "122",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;19",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "37.71 (4.13 - 343.87)",
  "hla_adr_odds_population": "85.36 (32.52 - 224.04)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c893"
  },
  "id": "122",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;19",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "37.71 (4.13 - 343.87)",
  "hla_adr_odds_population": "85.36 (32.52 - 224.04)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c894"
  },
  "id": "122",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;19",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "37.71 (4.13 - 343.87)",
  "hla_adr_odds_population": "85.36 (32.52 - 224.04)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c895"
  },
  "id": "122",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;19",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "37.71 (4.13 - 343.87)",
  "hla_adr_odds_population": "85.36 (32.52 - 224.04)",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c896"
  },
  "id": "122",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;19",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "37.71 (4.13 - 343.87)",
  "hla_adr_odds_population": "85.36 (32.52 - 224.04)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c897"
  },
  "id": "123",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "44 (3.18 - 608.19)",
  "hla_adr_odds_population": "99.59 (17.91 - 553.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c898"
  },
  "id": "123",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "44 (3.18 - 608.19)",
  "hla_adr_odds_population": "99.59 (17.91 - 553.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c899"
  },
  "id": "123",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "44 (3.18 - 608.19)",
  "hla_adr_odds_population": "99.59 (17.91 - 553.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c89a"
  },
  "id": "123",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "44 (3.18 - 608.19)",
  "hla_adr_odds_population": "99.59 (17.91 - 553.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c89b"
  },
  "id": "123",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "44 (3.18 - 608.19)",
  "hla_adr_odds_population": "99.59 (17.91 - 553.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c89c"
  },
  "id": "123",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "44 (3.18 - 608.19)",
  "hla_adr_odds_population": "99.59 (17.91 - 553.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c89d"
  },
  "id": "123",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as significant (using P < 0.05 as the threshold)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "44 (3.18 - 608.19)",
  "hla_adr_odds_population": "99.59 (17.91 - 553.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c89e"
  },
  "id": "124",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as not significant (using P < 0.05 as the threshold)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c89f"
  },
  "id": "124",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as not significant (using P < 0.05 as the threshold)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a0"
  },
  "id": "124",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as not significant (using P < 0.05 as the threshold)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a1"
  },
  "id": "124",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as not significant (using P < 0.05 as the threshold)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a2"
  },
  "id": "124",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as not significant (using P < 0.05 as the threshold)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a3"
  },
  "id": "124",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as not significant (using P < 0.05 as the threshold)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a4"
  },
  "id": "124",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23600531",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "1;23",
  "hla_adr_population_frequency": "63;3200",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was not reported but the study declared this as not significant (using P < 0.05 as the threshold)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Portugal",
  "hla_adr_disease_id": "gout",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a5"
  },
  "id": "125",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;28",
  "hla_adr_exposed_frequency": "4;70",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.75 (0.64 - 11.87)",
  "hla_adr_odds_population": "7.83 (2.32 - 26.41)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a6"
  },
  "id": "125",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;28",
  "hla_adr_exposed_frequency": "4;70",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.75 (0.64 - 11.87)",
  "hla_adr_odds_population": "7.83 (2.32 - 26.41)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a7"
  },
  "id": "126",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "3;70",
  "hla_adr_population_frequency": "24;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.83 (0.08 - 8.31)",
  "hla_adr_odds_population": "0.78 (0.1 - 5.97)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a8"
  },
  "id": "126",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "3;70",
  "hla_adr_population_frequency": "24;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.83 (0.08 - 8.31)",
  "hla_adr_odds_population": "0.78 (0.1 - 5.97)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8a9"
  },
  "id": "127",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.699",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "1;70",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.47)",
  "hla_adr_odds_population": "0.46 (0.06 - 3.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8aa"
  },
  "id": "127",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.699",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "1;70",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.47)",
  "hla_adr_odds_population": "0.46 (0.06 - 3.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ab"
  },
  "id": "128",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_pvalue_population": "0.007",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "13.3 (0.62 - 286.29)",
  "hla_adr_odds_population": "40.54 (3.56 - 461.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ac"
  },
  "id": "128",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_pvalue_population": "0.007",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "13.3 (0.62 - 286.29)",
  "hla_adr_odds_population": "40.54 (3.56 - 461.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ad"
  },
  "id": "129",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_pvalue_population": "0.071",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "13.3 (0.62 - 286.29)",
  "hla_adr_odds_population": "5.73 (1.13 - 28.93)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ae"
  },
  "id": "129",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_pvalue_population": "0.071",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "13.3 (0.62 - 286.29)",
  "hla_adr_odds_population": "5.73 (1.13 - 28.93)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8af"
  },
  "id": "130",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.69,
  "hla_adr_pvalue_population": "0.817",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;28",
  "hla_adr_exposed_frequency": "15;70",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.26 - 2.45)",
  "hla_adr_odds_population": "1.29 (0.48 - 3.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b0"
  },
  "id": "130",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.69,
  "hla_adr_pvalue_population": "0.817",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;28",
  "hla_adr_exposed_frequency": "15;70",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.26 - 2.45)",
  "hla_adr_odds_population": "1.29 (0.48 - 3.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b1"
  },
  "id": "131",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.51,
  "hla_adr_pvalue_population": "0.94",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;28",
  "hla_adr_exposed_frequency": "14;70",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.67 (0.2 - 2.24)",
  "hla_adr_odds_population": "1.23 (0.41 - 3.66)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b2"
  },
  "id": "131",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.51,
  "hla_adr_pvalue_population": "0.94",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;28",
  "hla_adr_exposed_frequency": "14;70",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.67 (0.2 - 2.24)",
  "hla_adr_odds_population": "1.23 (0.41 - 3.66)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b3"
  },
  "id": "132",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.936",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;28",
  "hla_adr_exposed_frequency": "4;70",
  "hla_adr_population_frequency": "26;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.27 (0.22 - 7.36)",
  "hla_adr_odds_population": "1.49 (0.33 - 6.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b4"
  },
  "id": "132",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.936",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;28",
  "hla_adr_exposed_frequency": "4;70",
  "hla_adr_population_frequency": "26;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.27 (0.22 - 7.36)",
  "hla_adr_odds_population": "1.49 (0.33 - 6.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b5"
  },
  "id": "133",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.519",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "1.47 (0.19 - 11.63)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b6"
  },
  "id": "133",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.519",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "1.47 (0.19 - 11.63)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b7"
  },
  "id": "134",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:04",
  "GeTH_AlleleCount": 44,
  "GeTH_AlleleFreq": 0.005879209,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.098",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "19.52 (1.19 - 320.54)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b8"
  },
  "id": "134",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:04",
  "GeTH_AlleleCount": 44,
  "GeTH_AlleleFreq": 0.005879209,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.098",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "19.52 (1.19 - 320.54)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8b9"
  },
  "id": "135",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.024",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "0;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "124.2 (4.94 - 3117.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ba"
  },
  "id": "135",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.024",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "0;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "124.2 (4.94 - 3117.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8bb"
  },
  "id": "136",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:09",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.024",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "0;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "124.2 (4.94 - 3117.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8bc"
  },
  "id": "136",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:09",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.024",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "0;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "124.2 (4.94 - 3117.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8bd"
  },
  "id": "137",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:05",
  "GeTH_AlleleCount": 6,
  "GeTH_AlleleFreq": 0.00080171,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.093",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "3;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "14.01 (1.41 - 139.08)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8be"
  },
  "id": "137",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:05",
  "GeTH_AlleleCount": 6,
  "GeTH_AlleleFreq": 0.00080171,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.093",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "3;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "14.01 (1.41 - 139.08)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8bf"
  },
  "id": "138",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:04",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.024",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "0;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "124.2 (4.94 - 3117.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c0"
  },
  "id": "138",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:04",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.024",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "0;1138",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "124.2 (4.94 - 3117.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c1"
  },
  "id": "139",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*49:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.22",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "1;212",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "7.82 (0.48 - 128.59)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c2"
  },
  "id": "139",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22818943",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*49:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.29,
  "hla_adr_pvalue_population": "0.22",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;28",
  "hla_adr_exposed_frequency": "0;70",
  "hla_adr_population_frequency": "1;212",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "7.69 (0.3 - 194.59)",
  "hla_adr_odds_population": "7.82 (0.48 - 128.59)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c3"
  },
  "id": "1294",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c4"
  },
  "id": "1294",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c5"
  },
  "id": "1294",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_population_frequency": "7;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c6"
  },
  "id": "141",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000535,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "13;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "13.85 (3.77 - 50.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0265114",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c7"
  },
  "id": "141",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000535,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "13;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "13.85 (3.77 - 50.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0242129",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c8"
  },
  "id": "141",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000535,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "13;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "13.85 (3.77 - 50.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038454",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8c9"
  },
  "id": "142",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:03",
  "GeTH_AlleleCount": 2,
  "GeTH_AlleleFreq": 0.000267237,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000158,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "12;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "15.21 (4.1 - 56.39)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0265114",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ca"
  },
  "id": "142",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:03",
  "GeTH_AlleleCount": 2,
  "GeTH_AlleleFreq": 0.000267237,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000158,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "12;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "15.21 (4.1 - 56.39)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0242129",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8cb"
  },
  "id": "142",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:03",
  "GeTH_AlleleCount": 2,
  "GeTH_AlleleFreq": 0.000267237,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000158,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "12;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "15.21 (4.1 - 56.39)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038454",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8cc"
  },
  "id": "143",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.0000395,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "10;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "18.75 (4.94 - 71.19)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0265114",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8cd"
  },
  "id": "143",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.0000395,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "10;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "18.75 (4.94 - 71.19)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0242129",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ce"
  },
  "id": "143",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.0000395,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "10;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "18.75 (4.94 - 71.19)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038454",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8cf"
  },
  "id": "144",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.00000905,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "9;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "21.11 (5.47 - 81.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0265114",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d0"
  },
  "id": "144",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.00000905,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "9;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "21.11 (5.47 - 81.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0242129",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d1"
  },
  "id": "144",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/17339877",
  "hla_adr_drug_id": "ticlopidine",
  "db_id": "DB00208",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.00000905,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;14",
  "hla_adr_exposed_frequency": "9;85",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "21.11 (5.47 - 81.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038454",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d2"
  },
  "id": "145",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;112",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.11 (0.01 - 0.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d3"
  },
  "id": "145",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;112",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.11 (0.01 - 0.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d4"
  },
  "id": "145",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;112",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.11 (0.01 - 0.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d5"
  },
  "id": "146",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 5.8e-43,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "99;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "97.62 (42 - 226.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d6"
  },
  "id": "146",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 5.8e-43,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "99;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "97.62 (42 - 226.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d7"
  },
  "id": "146",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 5.8e-43,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "99;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "97.62 (42 - 226.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d8"
  },
  "id": "147",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;112",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.67 (0.1 - 3.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8d9"
  },
  "id": "147",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;112",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.67 (0.1 - 3.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8da"
  },
  "id": "147",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;112",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.67 (0.1 - 3.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8db"
  },
  "id": "148",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.000083,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;112",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.22 (0.1 - 0.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8dc"
  },
  "id": "148",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.000083,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;112",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.22 (0.1 - 0.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8dd"
  },
  "id": "148",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.000083,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;112",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.22 (0.1 - 0.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8de"
  },
  "id": "149",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;112",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.45 (0.02 - 11.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8df"
  },
  "id": "149",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;112",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.45 (0.02 - 11.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e0"
  },
  "id": "149",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;112",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.45 (0.02 - 11.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e1"
  },
  "id": "150",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;112",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.39 (0.1 - 1.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e2"
  },
  "id": "150",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;112",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.39 (0.1 - 1.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e3"
  },
  "id": "150",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;112",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.39 (0.1 - 1.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e4"
  },
  "id": "151",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0.05 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e5"
  },
  "id": "151",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0.05 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e6"
  },
  "id": "151",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0.05 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e7"
  },
  "id": "152",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;112",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.14 (0.02 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e8"
  },
  "id": "152",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;112",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.14 (0.02 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8e9"
  },
  "id": "152",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;112",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.14 (0.02 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ea"
  },
  "id": "1412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28101480",
  "hla_adr_drug_id": "levetiracetam",
  "db_id": "DB01202",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "3;50",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.58 (0.02 - 13.05)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8eb"
  },
  "id": "1412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28101480",
  "hla_adr_drug_id": "levetiracetam",
  "db_id": "DB01202",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "3;50",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.58 (0.02 - 13.05)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ec"
  },
  "id": "1460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.976",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ed"
  },
  "id": "1460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.976",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ee"
  },
  "id": "1460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.976",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ef"
  },
  "id": "1460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.976",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f0"
  },
  "id": "1460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.976",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f1"
  },
  "id": "1460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.976",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f2"
  },
  "id": "1509",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f3"
  },
  "id": "1509",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234533",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f4"
  },
  "id": "1509",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0238111",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f5"
  },
  "id": "1509",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0011570",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f6"
  },
  "id": "1509",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0751495",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f7"
  },
  "id": "1509",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "2;10",
  "hla_adr_population_frequency": "50;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.04 - 78.77)",
  "hla_adr_odds_population": "2.03 (0.07 - 29.33)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0853193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f8"
  },
  "id": "1679",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28278336",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.17",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;39",
  "hla_adr_population_frequency": "20;133",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe occular complicatoins",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Brazil",
  "hla_adr_disease_id": "common cold",
  "hla_adr_region_id": "South America",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8f9"
  },
  "id": "1789",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.503",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;28",
  "hla_adr_population_frequency": "2731;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "2.2 (1.1 - 4.7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8fa"
  },
  "id": "1789",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.503",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;28",
  "hla_adr_population_frequency": "2731;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "2.2 (1.1 - 4.7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8fb"
  },
  "id": "1789",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.503",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;28",
  "hla_adr_population_frequency": "2731;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "2.2 (1.1 - 4.7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8fc"
  },
  "id": "1802",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;28",
  "hla_adr_population_frequency": "124;529",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Null",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "3.3 (1.5 - 7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8fd"
  },
  "id": "1802",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;28",
  "hla_adr_population_frequency": "124;529",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Null",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "3.3 (1.5 - 7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8fe"
  },
  "id": "1802",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:01",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02484638,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;28",
  "hla_adr_population_frequency": "124;529",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Null",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "3.3 (1.5 - 7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c8ff"
  },
  "id": "873",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;134",
  "hla_adr_population_frequency": "1;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "0.26",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c900"
  },
  "id": "1147",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c901"
  },
  "id": "1147",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c902"
  },
  "id": "1147",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c903"
  },
  "id": "1221",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c904"
  },
  "id": "1221",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c905"
  },
  "id": "1221",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c906"
  },
  "id": "1295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c907"
  },
  "id": "1295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c908"
  },
  "id": "1295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*01:03",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000667913,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c909"
  },
  "id": "163",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "53 (0.07 - 4.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c90a"
  },
  "id": "163",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "53 (0.07 - 4.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c90b"
  },
  "id": "163",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "53 (0.07 - 4.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c90c"
  },
  "id": "164",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.26 (0.01 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c90d"
  },
  "id": "164",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.26 (0.01 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c90e"
  },
  "id": "164",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.26 (0.01 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c90f"
  },
  "id": "165",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;23",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10.28 (2.5 - 41.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c910"
  },
  "id": "165",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;23",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10.28 (2.5 - 41.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c911"
  },
  "id": "165",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;23",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "10.28 (2.5 - 41.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c912"
  },
  "id": "166",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;23",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.16 (0.04 - 0.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c913"
  },
  "id": "166",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;23",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.16 (0.04 - 0.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c914"
  },
  "id": "166",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;23",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.16 (0.04 - 0.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c915"
  },
  "id": "167",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;23",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "14.38 (1.2 - 165.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c916"
  },
  "id": "167",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;23",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "14.38 (1.2 - 165.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c917"
  },
  "id": "167",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;23",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "14.38 (1.2 - 165.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c918"
  },
  "id": "168",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;23",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.94 (1.2 - 12.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c919"
  },
  "id": "168",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;23",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.94 (1.2 - 12.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c91a"
  },
  "id": "168",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;23",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.94 (1.2 - 12.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c91b"
  },
  "id": "169",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.92 (0.5 - 7.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c91c"
  },
  "id": "169",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.92 (0.5 - 7.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c91d"
  },
  "id": "169",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.92 (0.5 - 7.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c91e"
  },
  "id": "170",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.72 (0.1 - 6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c91f"
  },
  "id": "170",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.72 (0.1 - 6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c920"
  },
  "id": "170",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.72 (0.1 - 6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c921"
  },
  "id": "648",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11266078",
  "hla_adr_drug_id": "clozapine",
  "db_id": "DB00363",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02",
  "GeTH_AlleleCount": 2970,
  "GeTH_AlleleFreq": 0.396740582,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;31",
  "hla_adr_exposed_frequency": "40;77",
  "hla_adr_adr": "agranulocytosis",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "schizophrenia",
  "hla_adr_region_id": "Europe",
  "c_id": "C2063865"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c922"
  },
  "id": "648",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11266078",
  "hla_adr_drug_id": "clozapine",
  "db_id": "DB00363",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02",
  "GeTH_AlleleCount": 2970,
  "GeTH_AlleleFreq": 0.396740582,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;31",
  "hla_adr_exposed_frequency": "40;77",
  "hla_adr_adr": "agranulocytosis",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "schizophrenia",
  "hla_adr_region_id": "Europe",
  "c_id": "C2063865"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c923"
  },
  "id": "153",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "36;112",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.84 (0.5 - 1.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c924"
  },
  "id": "153",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "36;112",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.84 (0.5 - 1.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c925"
  },
  "id": "153",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "36;112",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.84 (0.5 - 1.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c926"
  },
  "id": "171",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;23",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.13 (46 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c927"
  },
  "id": "171",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;23",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.13 (46 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c928"
  },
  "id": "171",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;23",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.13 (46 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c929"
  },
  "id": "189",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;51",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.04 (0.4 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c92a"
  },
  "id": "189",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;51",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.04 (0.4 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c92b"
  },
  "id": "189",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;51",
  "hla_adr_exposed_frequency": "55;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.04 (0.4 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c92c"
  },
  "id": "232",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7662,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c92d"
  },
  "id": "232",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7662,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c92e"
  },
  "id": "232",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7662,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c92f"
  },
  "id": "232",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7662,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c930"
  },
  "id": "329",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.9 (0.4 - 9.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c931"
  },
  "id": "329",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.9 (0.4 - 9.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c932"
  },
  "id": "329",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.9 (0.4 - 9.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c933"
  },
  "id": "342",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.1 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c934"
  },
  "id": "342",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.1 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c935"
  },
  "id": "342",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.1 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c936"
  },
  "id": "355",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.9 (0.3 - 2.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c937"
  },
  "id": "355",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.9 (0.3 - 2.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c938"
  },
  "id": "355",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "14;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.9 (0.3 - 2.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c939"
  },
  "id": "375",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.033,
  "hla_adr_pvalue_population": "0.094",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "11;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c93a"
  },
  "id": "375",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.033,
  "hla_adr_pvalue_population": "0.094",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "11;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c93b"
  },
  "id": "375",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.033,
  "hla_adr_pvalue_population": "0.094",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "11;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c93c"
  },
  "id": "400",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.993",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c93d"
  },
  "id": "400",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.993",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c93e"
  },
  "id": "400",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.993",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c93f"
  },
  "id": "400",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.993",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c940"
  },
  "id": "400",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.993",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c941"
  },
  "id": "400",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.993",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c942"
  },
  "id": "181",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.99 (0.3 - 3.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c943"
  },
  "id": "181",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.99 (0.3 - 3.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c944"
  },
  "id": "181",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "12;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.99 (0.3 - 3.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c945"
  },
  "id": "182",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.3 - 3.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c946"
  },
  "id": "182",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.3 - 3.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c947"
  },
  "id": "182",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.3 - 3.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c948"
  },
  "id": "183",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;51",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.51 (0.3 - 8.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c949"
  },
  "id": "183",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;51",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.51 (0.3 - 8.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c94a"
  },
  "id": "183",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;51",
  "hla_adr_exposed_frequency": "4;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.51 (0.3 - 8.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c94b"
  },
  "id": "184",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;51",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.51 (0.2 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c94c"
  },
  "id": "184",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;51",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.51 (0.2 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c94d"
  },
  "id": "184",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;51",
  "hla_adr_exposed_frequency": "57;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.51 (0.2 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c94e"
  },
  "id": "185",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;51",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.02 (0.2 - 49.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c94f"
  },
  "id": "185",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;51",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.02 (0.2 - 49.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c950"
  },
  "id": "185",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;51",
  "hla_adr_exposed_frequency": "1;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.02 (0.2 - 49.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c951"
  },
  "id": "186",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.02,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;51",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.86 (2 - 11.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c952"
  },
  "id": "186",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.02,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;51",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.86 (2 - 11.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c953"
  },
  "id": "186",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.02,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;51",
  "hla_adr_exposed_frequency": "10;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.86 (2 - 11.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c954"
  },
  "id": "187",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.39 (0.5 - 4.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c955"
  },
  "id": "187",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.39 (0.5 - 4.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c956"
  },
  "id": "187",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.39 (0.5 - 4.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c957"
  },
  "id": "188",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.35 (0.4 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c958"
  },
  "id": "188",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.35 (0.4 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c959"
  },
  "id": "188",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "9;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.35 (0.4 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c95a"
  },
  "id": "496",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;61",
  "hla_adr_exposed_frequency": "93;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c95b"
  },
  "id": "496",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;61",
  "hla_adr_exposed_frequency": "93;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c95c"
  },
  "id": "496",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;61",
  "hla_adr_exposed_frequency": "93;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c95d"
  },
  "id": "496",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;61",
  "hla_adr_exposed_frequency": "93;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c95e"
  },
  "id": "496",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;61",
  "hla_adr_exposed_frequency": "93;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c95f"
  },
  "id": "496",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;61",
  "hla_adr_exposed_frequency": "93;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c960"
  },
  "id": "565",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_population_frequency": "31;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.17 - 5.77)",
  "hla_adr_odds_population": "1.07 (0.24 - 4.68)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c961"
  },
  "id": "565",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_population_frequency": "31;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.17 - 5.77)",
  "hla_adr_odds_population": "1.07 (0.24 - 4.68)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c962"
  },
  "id": "565",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_population_frequency": "31;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.17 - 5.77)",
  "hla_adr_odds_population": "1.07 (0.24 - 4.68)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c963"
  },
  "id": "586",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "0;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.44 (0.25 - 119.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c964"
  },
  "id": "586",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "0;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.44 (0.25 - 119.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c965"
  },
  "id": "586",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "0;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.44 (0.25 - 119.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c966"
  },
  "id": "672",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23057547",
  "hla_adr_drug_id": "EGF receptor inhibitors",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_pvalue_exposed": 0.0145,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;38",
  "hla_adr_exposed_frequency": "31;172",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "cancer",
  "hla_adr_odds_exposed": "0.377 (0.175 - 0.81)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c967"
  },
  "id": "874",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "0.000006395",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "128;134",
  "hla_adr_population_frequency": "51;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "4",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c968"
  },
  "id": "987",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "34;134",
  "hla_adr_population_frequency": "60;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "1.87",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c969"
  },
  "id": "1148",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;34",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c96a"
  },
  "id": "1148",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;34",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c96b"
  },
  "id": "1148",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;34",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c96c"
  },
  "id": "1222",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c96d"
  },
  "id": "1222",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c96e"
  },
  "id": "1222",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c96f"
  },
  "id": "1296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c970"
  },
  "id": "1296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c971"
  },
  "id": "1296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;20",
  "hla_adr_population_frequency": "6;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c972"
  },
  "id": "1413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28101480",
  "hla_adr_drug_id": "levetiracetam",
  "db_id": "DB01202",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.43 (0.02 - 9.34)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c973"
  },
  "id": "1413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28101480",
  "hla_adr_drug_id": "levetiracetam",
  "db_id": "DB01202",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;10",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.43 (0.02 - 9.34)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c974"
  },
  "id": "199",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21169036",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.294,
  "hla_adr_pvalue_population": "0.011",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;9",
  "hla_adr_exposed_frequency": "1;9",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.4 (0.5471 - 74.891)",
  "hla_adr_odds_population": "8.8 (1.853 - 41.79)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c975"
  },
  "id": "199",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21169036",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.294,
  "hla_adr_pvalue_population": "0.011",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;9",
  "hla_adr_exposed_frequency": "1;9",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.4 (0.5471 - 74.891)",
  "hla_adr_odds_population": "8.8 (1.853 - 41.79)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c976"
  },
  "id": "200",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15247625",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.006,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;13",
  "hla_adr_exposed_frequency": "5;51",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "England",
  "hla_adr_disease_id": "HIV",
  "hla_adr_odds_exposed": "7.9 (1.5 - 41.4)",
  "hla_adr_region_id": "Europe",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c977"
  },
  "id": "1429",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.123,
  "hla_adr_pvalue_population": "0.136",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;2",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.93 (0.69 - 168.29)",
  "hla_adr_odds_population": "3.16 (0.59 - 22.46)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c978"
  },
  "id": "1429",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.123,
  "hla_adr_pvalue_population": "0.136",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;2",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.93 (0.69 - 168.29)",
  "hla_adr_odds_population": "3.16 (0.59 - 22.46)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c979"
  },
  "id": "1429",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.123,
  "hla_adr_pvalue_population": "0.136",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;2",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.93 (0.69 - 168.29)",
  "hla_adr_odds_population": "3.16 (0.59 - 22.46)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c97a"
  },
  "id": "1429",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.123,
  "hla_adr_pvalue_population": "0.136",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;2",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.93 (0.69 - 168.29)",
  "hla_adr_odds_population": "3.16 (0.59 - 22.46)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c97b"
  },
  "id": "1461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c97c"
  },
  "id": "1461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c97d"
  },
  "id": "1461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c97e"
  },
  "id": "1461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c97f"
  },
  "id": "1461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c980"
  },
  "id": "1461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c981"
  },
  "id": "1474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.113,
  "hla_adr_pvalue_population": "0.294",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;2",
  "hla_adr_exposed_frequency": "8;23",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9.12 (0.37 - 62610000)",
  "hla_adr_odds_population": "4.51 (0.23 - 286.11)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c982"
  },
  "id": "1474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.113,
  "hla_adr_pvalue_population": "0.294",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;2",
  "hla_adr_exposed_frequency": "8;23",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9.12 (0.37 - 62610000)",
  "hla_adr_odds_population": "4.51 (0.23 - 286.11)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c983"
  },
  "id": "1474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.113,
  "hla_adr_pvalue_population": "0.294",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;2",
  "hla_adr_exposed_frequency": "8;23",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9.12 (0.37 - 62610000)",
  "hla_adr_odds_population": "4.51 (0.23 - 286.11)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c984"
  },
  "id": "204",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.6e-41,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "59;60",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1357 (193.4 - 8838.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c985"
  },
  "id": "204",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.6e-41,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "59;60",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1357 (193.4 - 8838.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c986"
  },
  "id": "204",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.6e-41,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "59;60",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1357 (193.4 - 8838.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c987"
  },
  "id": "205",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.00026,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;60",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.16 (0.1 - 0.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c988"
  },
  "id": "205",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.00026,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;60",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.16 (0.1 - 0.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c989"
  },
  "id": "205",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.00026,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;60",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.16 (0.1 - 0.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c98a"
  },
  "id": "206",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0086,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;60",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.26 (0.1 - 0.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c98b"
  },
  "id": "206",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0086,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;60",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.26 (0.1 - 0.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c98c"
  },
  "id": "206",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0086,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;60",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.26 (0.1 - 0.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c98d"
  },
  "id": "207",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 7.8e-27,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "56;60",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "86.8 (29.3 - 254.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c98e"
  },
  "id": "207",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 7.8e-27,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "56;60",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "86.8 (29.3 - 254.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c98f"
  },
  "id": "207",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 7.8e-27,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "56;60",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "86.8 (29.3 - 254.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c990"
  },
  "id": "208",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;60",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.08 (0.01 - 0.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c991"
  },
  "id": "208",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;60",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.08 (0.01 - 0.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c992"
  },
  "id": "208",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;60",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.08 (0.01 - 0.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c993"
  },
  "id": "209",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 2.3e-11,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "41;60",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "11.4 (5.6 - 22.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c994"
  },
  "id": "209",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 2.3e-11,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "41;60",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "11.4 (5.6 - 22.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c995"
  },
  "id": "209",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 2.3e-11,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "41;60",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "11.4 (5.6 - 22.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c996"
  },
  "id": "1484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;5",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.82)",
  "hla_adr_odds_population": "1.35 (0.18 - 11.79)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c997"
  },
  "id": "1484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;5",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.82)",
  "hla_adr_odds_population": "1.35 (0.18 - 11.79)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014549",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c998"
  },
  "id": "1484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;5",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.82)",
  "hla_adr_odds_population": "1.35 (0.18 - 11.79)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0036572",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c999"
  },
  "id": "1484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;5",
  "hla_adr_exposed_frequency": "15;28",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.82)",
  "hla_adr_odds_population": "1.35 (0.18 - 11.79)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0149958",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c99a"
  },
  "id": "1510",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c99b"
  },
  "id": "1510",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234533",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c99c"
  },
  "id": "1510",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0238111",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c99d"
  },
  "id": "1510",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0011570",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c99e"
  },
  "id": "1510",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0751495",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c99f"
  },
  "id": "1510",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.874,
  "hla_adr_pvalue_population": "0.929",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "6;10",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.01 - 8.01)",
  "hla_adr_odds_population": "0.45 (0.02 - 6.44)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0853193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a0"
  },
  "id": "1522",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.559",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;4",
  "hla_adr_exposed_frequency": "8;23",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.63 (0.02 - 9.16)",
  "hla_adr_odds_population": "0.3 (0.01 - 3.29)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a1"
  },
  "id": "1522",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.559",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;4",
  "hla_adr_exposed_frequency": "8;23",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.63 (0.02 - 9.16)",
  "hla_adr_odds_population": "0.3 (0.01 - 3.29)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a2"
  },
  "id": "1522",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.559",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;4",
  "hla_adr_exposed_frequency": "8;23",
  "hla_adr_population_frequency": "133;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.63 (0.02 - 9.16)",
  "hla_adr_odds_population": "0.3 (0.01 - 3.29)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a3"
  },
  "id": "213",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.79 (0.1 - 8.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a4"
  },
  "id": "213",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.79 (0.1 - 8.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a5"
  },
  "id": "213",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.79 (0.1 - 8.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a6"
  },
  "id": "214",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.43 (0.1 - 1.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a7"
  },
  "id": "214",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.43 (0.1 - 1.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a8"
  },
  "id": "214",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.43 (0.1 - 1.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9a9"
  },
  "id": "215",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;13",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.04 (0.3 - 3.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9aa"
  },
  "id": "215",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;13",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.04 (0.3 - 3.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ab"
  },
  "id": "215",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;13",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.04 (0.3 - 3.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ac"
  },
  "id": "216",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ad"
  },
  "id": "216",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ae"
  },
  "id": "216",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9af"
  },
  "id": "217",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0 - 2.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b0"
  },
  "id": "217",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0 - 2.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b1"
  },
  "id": "217",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0 - 2.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b2"
  },
  "id": "218",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.58 (0.4 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b3"
  },
  "id": "218",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.58 (0.4 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b4"
  },
  "id": "218",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.58 (0.4 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b5"
  },
  "id": "1590",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;39",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.05 (1.06 - 15.08)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b6"
  },
  "id": "1590",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;39",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.05 (1.06 - 15.08)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b7"
  },
  "id": "1590",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;39",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.05 (1.06 - 15.08)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b8"
  },
  "id": "1590",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;39",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.05 (1.06 - 15.08)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9b9"
  },
  "id": "1600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;21",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.67 (0.76 - 17.81)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ba"
  },
  "id": "1600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;21",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.67 (0.76 - 17.81)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9bb"
  },
  "id": "1600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;21",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.67 (0.76 - 17.81)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9bc"
  },
  "id": "1600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/26928377",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;21",
  "hla_adr_exposed_frequency": "4;92",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.67 (0.76 - 17.81)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9bd"
  },
  "id": "1635",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28476759",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.042,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "1;40",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "11.7 (1.1 - 124.84)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9be"
  },
  "id": "1635",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28476759",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.042,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "1;40",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "11.7 (1.1 - 124.84)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9bf"
  },
  "id": "1635",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28476759",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.042,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "1;40",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "11.7 (1.1 - 124.84)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c0"
  },
  "id": "1635",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28476759",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.042,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;13",
  "hla_adr_exposed_frequency": "1;40",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "11.7 (1.1 - 124.84)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c1"
  },
  "id": "222",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;18",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.35 (0.2 - 9.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c2"
  },
  "id": "222",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;18",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.35 (0.2 - 9.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c3"
  },
  "id": "222",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;18",
  "hla_adr_exposed_frequency": "6;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.35 (0.2 - 9.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c4"
  },
  "id": "223",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;18",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.92 (0.4 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c5"
  },
  "id": "223",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;18",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.92 (0.4 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c6"
  },
  "id": "223",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;18",
  "hla_adr_exposed_frequency": "59;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.92 (0.4 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c7"
  },
  "id": "224",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;18",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.67 (0.6 - 4.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c8"
  },
  "id": "224",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;18",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.67 (0.6 - 4.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9c9"
  },
  "id": "224",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;18",
  "hla_adr_exposed_frequency": "54;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.67 (0.6 - 4.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ca"
  },
  "id": "225",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;18",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.78 (0.2 - 3.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9cb"
  },
  "id": "225",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;18",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.78 (0.2 - 3.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9cc"
  },
  "id": "225",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;18",
  "hla_adr_exposed_frequency": "20;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.78 (0.2 - 3.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9cd"
  },
  "id": "226",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;18",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.03 (1.1 - 8.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ce"
  },
  "id": "226",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;18",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.03 (1.1 - 8.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9cf"
  },
  "id": "226",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;18",
  "hla_adr_exposed_frequency": "25;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.03 (1.1 - 8.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d0"
  },
  "id": "227",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;18",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.66 (0.2 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d1"
  },
  "id": "227",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;18",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.66 (0.2 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d2"
  },
  "id": "227",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16538176",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;18",
  "hla_adr_exposed_frequency": "23;144",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.66 (0.2 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d3"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d4"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d5"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d6"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d7"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d8"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9d9"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9da"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9db"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9dc"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9dd"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9de"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9df"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e0"
  },
  "id": "228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 4.7e-24,
  "hla_adr_pvalue_population": "8.10E-18",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "51;51",
  "hla_adr_exposed_frequency": "20;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "580.3 (34.4 - 9780.9)",
  "hla_adr_odds_population": "393.5 (23.2 - 6665.26)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e1"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e2"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e3"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e4"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e5"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e6"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e7"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e8"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9e9"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ea"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9eb"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ec"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ed"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ee"
  },
  "id": "229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1.4e-19,
  "hla_adr_pvalue_population": "2.50E-13",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "48;51",
  "hla_adr_exposed_frequency": "19;135",
  "hla_adr_population_frequency": "19;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.7",
  "hla_adr_odds_population": "62.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ef"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0746693",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f0"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0155804",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f1"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0043167",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f2"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0271429",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f3"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0031350",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f4"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0679246",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f5"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0032269",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f6"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030824",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f7"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0035243",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f8"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0427965",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9f9"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0037278",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9fa"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0004771",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9fb"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C1396580",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9fc"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0694549",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9fd"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0554628",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9fe"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0010418",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73c9ff"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0013295",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca00"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2367228",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca01"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014038",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca02"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0948279",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca03"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0850666",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca04"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0348321",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca05"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0455590",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca06"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0019693",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca07"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0020523",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca08"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0023241",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca09"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040425",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca0a"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040558",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca0b"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C1096746",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca0c"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0746690",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca0d"
  },
  "id": "1658",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 6.45,
  "hla_adr_pvalue_population": "4.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "11;34",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "0.42 (0.08 - 2.24)",
  "hla_adr_odds_population": "1.82 (0.38 - 8.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0856695",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca0e"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca0f"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca10"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca11"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca12"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca13"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca14"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca15"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca16"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca17"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca18"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca19"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca1a"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca1b"
  },
  "id": "231",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15743917",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0000028,
  "hla_adr_pvalue_population": "0.00085",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "33;51",
  "hla_adr_exposed_frequency": "17;135",
  "hla_adr_population_frequency": "14;93",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "12.7",
  "hla_adr_odds_population": "10.3",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca1c"
  },
  "id": "1680",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28278336",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;39",
  "hla_adr_population_frequency": "61;133",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe occular complicatoins",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Brazil",
  "hla_adr_disease_id": "common cold",
  "hla_adr_region_id": "South America",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca1d"
  },
  "id": "1790",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.724",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;28",
  "hla_adr_population_frequency": "5118;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "0.5 (0.2 - 1)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca1e"
  },
  "id": "1790",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.724",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;28",
  "hla_adr_population_frequency": "5118;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "0.5 (0.2 - 1)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca1f"
  },
  "id": "1790",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.724",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;28",
  "hla_adr_population_frequency": "5118;8862",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "0.5 (0.2 - 1)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca20"
  },
  "id": "1803",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.245",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;28",
  "hla_adr_population_frequency": "274;529",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Null",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "0.6 (0.3 - 1.3)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca21"
  },
  "id": "1803",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.245",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;28",
  "hla_adr_population_frequency": "274;529",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Null",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "0.6 (0.3 - 1.3)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca22"
  },
  "id": "1803",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30972788",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "European",
  "hla_adr_pvalue_population": "0.245",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;28",
  "hla_adr_population_frequency": "274;529",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Null",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "0.6 (0.3 - 1.3)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca23"
  },
  "id": "1818",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27749688",
  "hla_adr_drug_id": "tetanus antitoxin",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:01",
  "GeTH_AlleleCount": 308,
  "GeTH_AlleleFreq": 0.041143468,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.2",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "/ 118",
  "hla_adr_population_frequency": "28;283",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "tetanus",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca24"
  },
  "id": "875",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;134",
  "hla_adr_population_frequency": "0;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "2.42",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca25"
  },
  "id": "1681",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28278336",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;39",
  "hla_adr_population_frequency": "5;133",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe occular complicatoins",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Brazil",
  "hla_adr_disease_id": "common cold",
  "hla_adr_region_id": "South America",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca26"
  },
  "id": "154",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;112",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.58 (0.26 - 1.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca27"
  },
  "id": "154",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;112",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.58 (0.26 - 1.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca28"
  },
  "id": "154",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;112",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.58 (0.26 - 1.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca29"
  },
  "id": "172",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.27 (0.03 - 2.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca2a"
  },
  "id": "172",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.27 (0.03 - 2.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca2b"
  },
  "id": "172",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;23",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.27 (0.03 - 2.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca2c"
  },
  "id": "240",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0154,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "14;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.7 (1.4 - 10)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca2d"
  },
  "id": "240",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0154,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "14;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.7 (1.4 - 10)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca2e"
  },
  "id": "240",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0154,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "14;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.7 (1.4 - 10)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca2f"
  },
  "id": "240",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0154,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "14;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.7 (1.4 - 10)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca30"
  },
  "id": "241",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0041,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.1 (1.8 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca31"
  },
  "id": "241",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0041,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.1 (1.8 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca32"
  },
  "id": "241",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0041,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.1 (1.8 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca33"
  },
  "id": "241",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0041,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.1 (1.8 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca34"
  },
  "id": "242",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:25",
  "GeTH_AlleleCount": 160,
  "GeTH_AlleleFreq": 0.021378942,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca35"
  },
  "id": "242",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:25",
  "GeTH_AlleleCount": 160,
  "GeTH_AlleleFreq": 0.021378942,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca36"
  },
  "id": "242",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:25",
  "GeTH_AlleleCount": 160,
  "GeTH_AlleleFreq": 0.021378942,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca37"
  },
  "id": "242",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:25",
  "GeTH_AlleleCount": 160,
  "GeTH_AlleleFreq": 0.021378942,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca38"
  },
  "id": "243",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6753,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "7;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.2 - 6.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca39"
  },
  "id": "243",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6753,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "7;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.2 - 6.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca3a"
  },
  "id": "243",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6753,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "7;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.2 - 6.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca3b"
  },
  "id": "243",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6753,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "7;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.2 - 6.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca3c"
  },
  "id": "244",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.315,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.6 - 6.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca3d"
  },
  "id": "244",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.315,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.6 - 6.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca3e"
  },
  "id": "244",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.315,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.6 - 6.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca3f"
  },
  "id": "244",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.315,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2 (0.6 - 6.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca40"
  },
  "id": "245",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1907,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "52;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.2 - 1.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca41"
  },
  "id": "245",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1907,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "52;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.2 - 1.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca42"
  },
  "id": "245",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1907,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "52;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.2 - 1.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca43"
  },
  "id": "245",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1907,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "52;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.2 - 1.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca44"
  },
  "id": "246",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0898,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9.3 (0.8 - 107.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca45"
  },
  "id": "246",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0898,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9.3 (0.8 - 107.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca46"
  },
  "id": "246",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0898,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9.3 (0.8 - 107.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca47"
  },
  "id": "246",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0898,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9.3 (0.8 - 107.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca48"
  },
  "id": "247",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4091,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca49"
  },
  "id": "247",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4091,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca4a"
  },
  "id": "247",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4091,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca4b"
  },
  "id": "247",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4091,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca4c"
  },
  "id": "248",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca4d"
  },
  "id": "248",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca4e"
  },
  "id": "248",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca4f"
  },
  "id": "248",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca50"
  },
  "id": "249",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1698,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.8 (0.6 - 12.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca51"
  },
  "id": "249",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1698,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.8 (0.6 - 12.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca52"
  },
  "id": "249",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1698,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.8 (0.6 - 12.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca53"
  },
  "id": "249",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1698,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.8 (0.6 - 12.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca54"
  },
  "id": "250",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca55"
  },
  "id": "250",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca56"
  },
  "id": "250",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca57"
  },
  "id": "250",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca58"
  },
  "id": "251",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca59"
  },
  "id": "251",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca5a"
  },
  "id": "251",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca5b"
  },
  "id": "251",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca5c"
  },
  "id": "252",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca5d"
  },
  "id": "252",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca5e"
  },
  "id": "252",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca5f"
  },
  "id": "252",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca60"
  },
  "id": "253",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca61"
  },
  "id": "253",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca62"
  },
  "id": "253",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca63"
  },
  "id": "253",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca64"
  },
  "id": "254",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1963,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca65"
  },
  "id": "254",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1963,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca66"
  },
  "id": "254",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1963,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca67"
  },
  "id": "254",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1963,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca68"
  },
  "id": "255",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca69"
  },
  "id": "255",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca6a"
  },
  "id": "255",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca6b"
  },
  "id": "255",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca6c"
  },
  "id": "256",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1103,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "41;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca6d"
  },
  "id": "256",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1103,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "41;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca6e"
  },
  "id": "256",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1103,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "41;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca6f"
  },
  "id": "256",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1103,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "41;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca70"
  },
  "id": "257",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca71"
  },
  "id": "257",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca72"
  },
  "id": "257",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca73"
  },
  "id": "257",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca74"
  },
  "id": "258",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca75"
  },
  "id": "258",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca76"
  },
  "id": "258",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca77"
  },
  "id": "258",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5254,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "16;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.1 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca78"
  },
  "id": "259",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4261,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.6 - 4.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca79"
  },
  "id": "259",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4261,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.6 - 4.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca7a"
  },
  "id": "259",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4261,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.6 - 4.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca7b"
  },
  "id": "259",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4261,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.6 - 4.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca7c"
  },
  "id": "260",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:01",
  "GeTH_AlleleCount": 392,
  "GeTH_AlleleFreq": 0.052378407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1951,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca7d"
  },
  "id": "260",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:01",
  "GeTH_AlleleCount": 392,
  "GeTH_AlleleFreq": 0.052378407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1951,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca7e"
  },
  "id": "260",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:01",
  "GeTH_AlleleCount": 392,
  "GeTH_AlleleFreq": 0.052378407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1951,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca7f"
  },
  "id": "260",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:01",
  "GeTH_AlleleCount": 392,
  "GeTH_AlleleFreq": 0.052378407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1951,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.2 (0 - 1.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca80"
  },
  "id": "261",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:03",
  "GeTH_AlleleCount": 291,
  "GeTH_AlleleFreq": 0.03888295,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca81"
  },
  "id": "261",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:03",
  "GeTH_AlleleCount": 291,
  "GeTH_AlleleFreq": 0.03888295,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca82"
  },
  "id": "261",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:03",
  "GeTH_AlleleCount": 291,
  "GeTH_AlleleFreq": 0.03888295,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca83"
  },
  "id": "261",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:03",
  "GeTH_AlleleCount": 291,
  "GeTH_AlleleFreq": 0.03888295,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca84"
  },
  "id": "262",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:02",
  "GeTH_AlleleCount": 1226,
  "GeTH_AlleleFreq": 0.163816141,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;26",
  "hla_adr_exposed_frequency": "48;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.4 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca85"
  },
  "id": "262",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:02",
  "GeTH_AlleleCount": 1226,
  "GeTH_AlleleFreq": 0.163816141,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;26",
  "hla_adr_exposed_frequency": "48;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.4 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca86"
  },
  "id": "262",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:02",
  "GeTH_AlleleCount": 1226,
  "GeTH_AlleleFreq": 0.163816141,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;26",
  "hla_adr_exposed_frequency": "48;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.4 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca87"
  },
  "id": "262",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:02",
  "GeTH_AlleleCount": 1226,
  "GeTH_AlleleFreq": 0.163816141,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;26",
  "hla_adr_exposed_frequency": "48;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.4 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca88"
  },
  "id": "263",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0281,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3 (1.1 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca89"
  },
  "id": "263",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0281,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3 (1.1 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca8a"
  },
  "id": "263",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0281,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3 (1.1 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca8b"
  },
  "id": "263",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*08:01",
  "GeTH_AlleleCount": 757,
  "GeTH_AlleleFreq": 0.101149118,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0281,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;26",
  "hla_adr_exposed_frequency": "17;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3 (1.1 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca8c"
  },
  "id": "264",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*12:02",
  "GeTH_AlleleCount": 256,
  "GeTH_AlleleFreq": 0.034206307,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6433,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.3 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca8d"
  },
  "id": "264",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*12:02",
  "GeTH_AlleleCount": 256,
  "GeTH_AlleleFreq": 0.034206307,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6433,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.3 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca8e"
  },
  "id": "264",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*12:02",
  "GeTH_AlleleCount": 256,
  "GeTH_AlleleFreq": 0.034206307,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6433,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.3 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca8f"
  },
  "id": "264",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*12:02",
  "GeTH_AlleleCount": 256,
  "GeTH_AlleleFreq": 0.034206307,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6433,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.3 - 7.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca90"
  },
  "id": "265",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.063,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.9 (1 - 15.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca91"
  },
  "id": "265",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.063,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.9 (1 - 15.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca92"
  },
  "id": "265",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.063,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.9 (1 - 15.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca93"
  },
  "id": "265",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.063,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "5;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.9 (1 - 15.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca94"
  },
  "id": "266",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4618,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.3 (0 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca95"
  },
  "id": "266",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4618,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.3 (0 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca96"
  },
  "id": "266",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4618,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.3 (0 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca97"
  },
  "id": "266",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4618,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "12;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.3 (0 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca98"
  },
  "id": "267",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca99"
  },
  "id": "267",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca9a"
  },
  "id": "267",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca9b"
  },
  "id": "267",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.1871,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "0;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "9 (0.3 - 277)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca9c"
  },
  "id": "268",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:03",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "11;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.2 - 3.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca9d"
  },
  "id": "268",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:03",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "11;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.2 - 3.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca9e"
  },
  "id": "268",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:03",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "11;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.2 - 3.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73ca9f"
  },
  "id": "268",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:03",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "11;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.8 (0.2 - 3.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa0"
  },
  "id": "269",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5343,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "15;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 4.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa1"
  },
  "id": "269",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5343,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "15;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 4.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa2"
  },
  "id": "269",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5343,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "15;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 4.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa3"
  },
  "id": "269",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5343,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "15;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 4.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa4"
  },
  "id": "270",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:06",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa5"
  },
  "id": "270",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:06",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa6"
  },
  "id": "270",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:06",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa7"
  },
  "id": "270",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:06",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa8"
  },
  "id": "271",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7368,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.1 - 3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caa9"
  },
  "id": "271",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7368,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.1 - 3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caaa"
  },
  "id": "271",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7368,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.1 - 3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caab"
  },
  "id": "271",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7368,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.1 - 3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caac"
  },
  "id": "272",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "33;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.9 (0.3 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caad"
  },
  "id": "272",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "33;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.9 (0.3 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caae"
  },
  "id": "272",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "33;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.9 (0.3 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caaf"
  },
  "id": "272",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "33;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.9 (0.3 - 2.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab0"
  },
  "id": "273",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7864,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.2 (0.4 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab1"
  },
  "id": "273",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7864,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.2 (0.4 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab2"
  },
  "id": "273",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7864,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.2 (0.4 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab3"
  },
  "id": "273",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.7864,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;26",
  "hla_adr_exposed_frequency": "22;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.2 (0.4 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab4"
  },
  "id": "274",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.1 - 6.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab5"
  },
  "id": "274",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.1 - 6.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab6"
  },
  "id": "274",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.1 - 6.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab7"
  },
  "id": "274",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "6;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.1 - 6.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab8"
  },
  "id": "275",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cab9"
  },
  "id": "275",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caba"
  },
  "id": "275",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cabb"
  },
  "id": "275",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cabc"
  },
  "id": "276",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cabd"
  },
  "id": "276",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cabe"
  },
  "id": "276",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cabf"
  },
  "id": "276",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "4;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.1 - 10.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac0"
  },
  "id": "277",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:12",
  "GeTH_AlleleCount": 86,
  "GeTH_AlleleFreq": 0.011491181,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac1"
  },
  "id": "277",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:12",
  "GeTH_AlleleCount": 86,
  "GeTH_AlleleFreq": 0.011491181,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac2"
  },
  "id": "277",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:12",
  "GeTH_AlleleCount": 86,
  "GeTH_AlleleFreq": 0.011491181,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac3"
  },
  "id": "277",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:12",
  "GeTH_AlleleCount": 86,
  "GeTH_AlleleFreq": 0.011491181,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4654,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "2;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.2 (0.2 - 25.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac4"
  },
  "id": "278",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:01",
  "GeTH_AlleleCount": 320,
  "GeTH_AlleleFreq": 0.042757883,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac5"
  },
  "id": "278",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:01",
  "GeTH_AlleleCount": 320,
  "GeTH_AlleleFreq": 0.042757883,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac6"
  },
  "id": "278",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:01",
  "GeTH_AlleleCount": 320,
  "GeTH_AlleleFreq": 0.042757883,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac7"
  },
  "id": "278",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:01",
  "GeTH_AlleleCount": 320,
  "GeTH_AlleleFreq": 0.042757883,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.2 - 4.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac8"
  },
  "id": "279",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:43",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3402,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.5 (0.3 - 74.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cac9"
  },
  "id": "279",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:43",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3402,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.5 (0.3 - 74.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73caca"
  },
  "id": "279",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:43",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3402,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.5 (0.3 - 74.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cacb"
  },
  "id": "279",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:43",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3402,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;26",
  "hla_adr_exposed_frequency": "1;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.5 (0.3 - 74.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cacc"
  },
  "id": "280",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5974,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cacd"
  },
  "id": "280",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5974,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cace"
  },
  "id": "280",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5974,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cacf"
  },
  "id": "280",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.5974,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;26",
  "hla_adr_exposed_frequency": "24;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.7 (0.2 - 2.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad0"
  },
  "id": "281",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2345,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "3;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.1 (0.5 - 19.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad1"
  },
  "id": "281",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2345,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "3;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.1 (0.5 - 19.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad2"
  },
  "id": "281",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2345,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "3;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.1 (0.5 - 19.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad3"
  },
  "id": "281",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:02",
  "GeTH_AlleleCount": 917,
  "GeTH_AlleleFreq": 0.12252806,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2345,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "3;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.1 (0.5 - 19.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad4"
  },
  "id": "282",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0128,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.3 (1.4 - 12.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad5"
  },
  "id": "282",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0128,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.3 (1.4 - 12.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad6"
  },
  "id": "282",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0128,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.3 (1.4 - 12.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad7"
  },
  "id": "282",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0128,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;26",
  "hla_adr_exposed_frequency": "9;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.3 (1.4 - 12.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad8"
  },
  "id": "283",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "6;67",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.62 (1.4 - 42.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cad9"
  },
  "id": "283",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "6;67",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.62 (1.4 - 42.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cada"
  },
  "id": "283",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "6;67",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.62 (1.4 - 42.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cadb"
  },
  "id": "283",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "6;67",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.62 (1.4 - 42.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cadc"
  },
  "id": "283",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "6;67",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.62 (1.4 - 42.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cadd"
  },
  "id": "283",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;6",
  "hla_adr_exposed_frequency": "6;67",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.62 (1.4 - 42.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cade"
  },
  "id": "284",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 2.45e-11,
  "hla_adr_pvalue_population": "2.47E-16",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.8 (18.3 - 521.5)",
  "hla_adr_odds_population": "83 (19 - 361.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cadf"
  },
  "id": "284",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 2.45e-11,
  "hla_adr_pvalue_population": "2.47E-16",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.8 (18.3 - 521.5)",
  "hla_adr_odds_population": "83 (19 - 361.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cae0"
  },
  "id": "284",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 2.45e-11,
  "hla_adr_pvalue_population": "2.47E-16",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.8 (18.3 - 521.5)",
  "hla_adr_odds_population": "83 (19 - 361.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ed8a3f82637a73cae1"
  },
  "id": "284",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 2.45e-11,
  "hla_adr_pvalue_population": "2.47E-16",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.8 (18.3 - 521.5)",
  "hla_adr_odds_population": "83 (19 - 361.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae2"
  },
  "id": "284",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 2.45e-11,
  "hla_adr_pvalue_population": "2.47E-16",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.8 (18.3 - 521.5)",
  "hla_adr_odds_population": "83 (19 - 361.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae3"
  },
  "id": "284",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 2.45e-11,
  "hla_adr_pvalue_population": "2.47E-16",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.8 (18.3 - 521.5)",
  "hla_adr_odds_population": "83 (19 - 361.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae4"
  },
  "id": "284",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 2.45e-11,
  "hla_adr_pvalue_population": "2.47E-16",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "97.8 (18.3 - 521.5)",
  "hla_adr_odds_population": "83 (19 - 361.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae5"
  },
  "id": "285",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 9.39e-11,
  "hla_adr_pvalue_population": "5.58E-12",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "82.1 (15.8 - 426.5)",
  "hla_adr_odds_population": "44.8 (10.4 - 193.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae6"
  },
  "id": "285",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 9.39e-11,
  "hla_adr_pvalue_population": "5.58E-12",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "82.1 (15.8 - 426.5)",
  "hla_adr_odds_population": "44.8 (10.4 - 193.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae7"
  },
  "id": "285",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 9.39e-11,
  "hla_adr_pvalue_population": "5.58E-12",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "82.1 (15.8 - 426.5)",
  "hla_adr_odds_population": "44.8 (10.4 - 193.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae8"
  },
  "id": "285",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 9.39e-11,
  "hla_adr_pvalue_population": "5.58E-12",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "82.1 (15.8 - 426.5)",
  "hla_adr_odds_population": "44.8 (10.4 - 193.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cae9"
  },
  "id": "285",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 9.39e-11,
  "hla_adr_pvalue_population": "5.58E-12",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "82.1 (15.8 - 426.5)",
  "hla_adr_odds_population": "44.8 (10.4 - 193.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caea"
  },
  "id": "285",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 9.39e-11,
  "hla_adr_pvalue_population": "5.58E-12",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "82.1 (15.8 - 426.5)",
  "hla_adr_odds_population": "44.8 (10.4 - 193.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caeb"
  },
  "id": "285",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 9.39e-11,
  "hla_adr_pvalue_population": "5.58E-12",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;25",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "82.1 (15.8 - 426.5)",
  "hla_adr_odds_population": "44.8 (10.4 - 193.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caec"
  },
  "id": "190",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.2 - 1.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caed"
  },
  "id": "190",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.2 - 1.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caee"
  },
  "id": "190",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;51",
  "hla_adr_exposed_frequency": "22;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0.2 - 1.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caef"
  },
  "id": "287",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 1.45e-10,
  "hla_adr_pvalue_population": "2.83E-14",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "161.5 (18.2 - 1430.9)",
  "hla_adr_odds_population": "137.5 (18.1 - 1046.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf0"
  },
  "id": "287",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 1.45e-10,
  "hla_adr_pvalue_population": "2.83E-14",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "161.5 (18.2 - 1430.9)",
  "hla_adr_odds_population": "137.5 (18.1 - 1046.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf1"
  },
  "id": "287",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 1.45e-10,
  "hla_adr_pvalue_population": "2.83E-14",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "161.5 (18.2 - 1430.9)",
  "hla_adr_odds_population": "137.5 (18.1 - 1046.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf2"
  },
  "id": "287",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 1.45e-10,
  "hla_adr_pvalue_population": "2.83E-14",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "161.5 (18.2 - 1430.9)",
  "hla_adr_odds_population": "137.5 (18.1 - 1046.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf3"
  },
  "id": "287",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 1.45e-10,
  "hla_adr_pvalue_population": "2.83E-14",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "161.5 (18.2 - 1430.9)",
  "hla_adr_odds_population": "137.5 (18.1 - 1046.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf4"
  },
  "id": "287",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 1.45e-10,
  "hla_adr_pvalue_population": "2.83E-14",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "161.5 (18.2 - 1430.9)",
  "hla_adr_odds_population": "137.5 (18.1 - 1046.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf5"
  },
  "id": "287",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 1.45e-10,
  "hla_adr_pvalue_population": "2.83E-14",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "161.5 (18.2 - 1430.9)",
  "hla_adr_odds_population": "137.5 (18.1 - 1046.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf6"
  },
  "id": "288",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 5.04e-10,
  "hla_adr_pvalue_population": "1.24E-10",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "135.7 (15.6 - 1177.8)",
  "hla_adr_odds_population": "74.3 (9.8 - 561.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf7"
  },
  "id": "288",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 5.04e-10,
  "hla_adr_pvalue_population": "1.24E-10",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "135.7 (15.6 - 1177.8)",
  "hla_adr_odds_population": "74.3 (9.8 - 561.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf8"
  },
  "id": "288",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 5.04e-10,
  "hla_adr_pvalue_population": "1.24E-10",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "135.7 (15.6 - 1177.8)",
  "hla_adr_odds_population": "74.3 (9.8 - 561.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caf9"
  },
  "id": "288",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 5.04e-10,
  "hla_adr_pvalue_population": "1.24E-10",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "135.7 (15.6 - 1177.8)",
  "hla_adr_odds_population": "74.3 (9.8 - 561.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cafa"
  },
  "id": "288",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 5.04e-10,
  "hla_adr_pvalue_population": "1.24E-10",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "135.7 (15.6 - 1177.8)",
  "hla_adr_odds_population": "74.3 (9.8 - 561.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cafb"
  },
  "id": "288",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 5.04e-10,
  "hla_adr_pvalue_population": "1.24E-10",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "135.7 (15.6 - 1177.8)",
  "hla_adr_odds_population": "74.3 (9.8 - 561.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cafc"
  },
  "id": "288",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 5.04e-10,
  "hla_adr_pvalue_population": "1.24E-10",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;20",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "135.7 (15.6 - 1177.8)",
  "hla_adr_odds_population": "74.3 (9.8 - 561.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cafd"
  },
  "id": "233",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3312,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.6 - 5.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cafe"
  },
  "id": "233",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3312,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.6 - 5.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73caff"
  },
  "id": "233",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3312,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.6 - 5.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb00"
  },
  "id": "233",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.3312,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;26",
  "hla_adr_exposed_frequency": "13;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.6 - 5.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb01"
  },
  "id": "290",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.016,
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "34 (3.2 - 356.1)",
  "hla_adr_odds_population": "28.9 (3.2 - 263.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb02"
  },
  "id": "290",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.016,
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "34 (3.2 - 356.1)",
  "hla_adr_odds_population": "28.9 (3.2 - 263.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb03"
  },
  "id": "290",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.016,
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "34 (3.2 - 356.1)",
  "hla_adr_odds_population": "28.9 (3.2 - 263.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb04"
  },
  "id": "290",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.016,
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "34 (3.2 - 356.1)",
  "hla_adr_odds_population": "28.9 (3.2 - 263.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb05"
  },
  "id": "290",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.016,
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "34 (3.2 - 356.1)",
  "hla_adr_odds_population": "28.9 (3.2 - 263.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb06"
  },
  "id": "290",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.016,
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "34 (3.2 - 356.1)",
  "hla_adr_odds_population": "28.9 (3.2 - 263.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb07"
  },
  "id": "290",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.016,
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "6;57",
  "hla_adr_population_frequency": "59;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "34 (3.2 - 356.1)",
  "hla_adr_odds_population": "28.9 (3.2 - 263.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb08"
  },
  "id": "291",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_pvalue_population": "0.04",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "28.3 (2.8 - 293.6)",
  "hla_adr_odds_population": "15.6 (1.7 - 141.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb09"
  },
  "id": "291",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_pvalue_population": "0.04",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "28.3 (2.8 - 293.6)",
  "hla_adr_odds_population": "15.6 (1.7 - 141.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb0a"
  },
  "id": "291",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_pvalue_population": "0.04",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "28.3 (2.8 - 293.6)",
  "hla_adr_odds_population": "15.6 (1.7 - 141.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb0b"
  },
  "id": "291",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_pvalue_population": "0.04",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "28.3 (2.8 - 293.6)",
  "hla_adr_odds_population": "15.6 (1.7 - 141.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb0c"
  },
  "id": "291",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_pvalue_population": "0.04",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "28.3 (2.8 - 293.6)",
  "hla_adr_odds_population": "15.6 (1.7 - 141.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb0d"
  },
  "id": "291",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_pvalue_population": "0.04",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "28.3 (2.8 - 293.6)",
  "hla_adr_odds_population": "15.6 (1.7 - 141.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb0e"
  },
  "id": "291",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21301380",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_pvalue_population": "0.04",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;5",
  "hla_adr_exposed_frequency": "7;57",
  "hla_adr_population_frequency": "99;485",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Hochberg's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "28.3 (2.8 - 293.6)",
  "hla_adr_odds_population": "15.6 (1.7 - 141.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb0f"
  },
  "id": "403",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.731",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "5;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb10"
  },
  "id": "403",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.731",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "5;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb11"
  },
  "id": "403",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.731",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "5;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb12"
  },
  "id": "403",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.731",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "5;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb13"
  },
  "id": "403",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.731",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "5;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb14"
  },
  "id": "403",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.731",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "5;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb15"
  },
  "id": "293",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19018717",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_population_frequency": "6;986",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "40.83 (10.5 - 158.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb16"
  },
  "id": "293",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19018717",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_population_frequency": "6;986",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "40.83 (10.5 - 158.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb17"
  },
  "id": "293",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19018717",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_population_frequency": "6;986",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "40.83 (10.5 - 158.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb18"
  },
  "id": "293",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19018717",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_population_frequency": "6;986",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "40.83 (10.5 - 158.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb19"
  },
  "id": "293",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19018717",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_population_frequency": "6;986",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "40.83 (10.5 - 158.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb1a"
  },
  "id": "293",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19018717",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_population_frequency": "6;986",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "40.83 (10.5 - 158.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb1b"
  },
  "id": "293",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19018717",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;20",
  "hla_adr_population_frequency": "6;986",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "40.83 (10.5 - 158.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb1c"
  },
  "id": "566",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.57",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_population_frequency": "59;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.17 - 5.77)",
  "hla_adr_odds_population": "0.53 (0.12 - 2.27)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb1d"
  },
  "id": "566",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.57",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_population_frequency": "59;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.17 - 5.77)",
  "hla_adr_odds_population": "0.53 (0.12 - 2.27)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb1e"
  },
  "id": "566",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.57",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "4;64",
  "hla_adr_population_frequency": "59;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.17 - 5.77)",
  "hla_adr_odds_population": "0.53 (0.12 - 2.27)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb1f"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb20"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb21"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb22"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb23"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb24"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb25"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb26"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb27"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb28"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb29"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb2a"
  },
  "id": "295",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb2b"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb2c"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb2d"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb2e"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb2f"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb30"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb31"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb32"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb33"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb34"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb35"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb36"
  },
  "id": "296",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;44",
  "hla_adr_exposed_frequency": "3;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.98 (0.09 - 7.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb37"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb38"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb39"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb3a"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb3b"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb3c"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb3d"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb3e"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb3f"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb40"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb41"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb42"
  },
  "id": "297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*07:18",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb43"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb44"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb45"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb46"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb47"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb48"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb49"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb4a"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb4b"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb4c"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb4d"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb4e"
  },
  "id": "298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;44",
  "hla_adr_exposed_frequency": "0;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "14.59 (0.74 - 289)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb4f"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb50"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb51"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb52"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0234533",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb53"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb54"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0238111",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb55"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb56"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0011570",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb57"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb58"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0751495",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb59"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb5a"
  },
  "id": "299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19668019",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:01",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;44",
  "hla_adr_exposed_frequency": "1;86",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant (after correction for multiple comparisons)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "8.5 (0.79 - 423)",
  "hla_adr_region_id": "North America",
  "c_id": "C0853193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb5b"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb5c"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb5d"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb5e"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb5f"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb60"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb61"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb62"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb63"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb64"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb65"
  },
  "id": "300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "25;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb66"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb67"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb68"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb69"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb6a"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb6b"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb6c"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb6d"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb6e"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb6f"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb70"
  },
  "id": "301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb71"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb72"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb73"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb74"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb75"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb76"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb77"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb78"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb79"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb7a"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb7b"
  },
  "id": "302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb7c"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb7d"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb7e"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb7f"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb80"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb81"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb82"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb83"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb84"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb85"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb86"
  },
  "id": "303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb87"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb88"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb89"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb8a"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb8b"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb8c"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb8d"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb8e"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb8f"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb90"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb91"
  },
  "id": "304",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "38;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb92"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb93"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb94"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb95"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb96"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb97"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb98"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb99"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb9a"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb9b"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb9c"
  },
  "id": "305",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*11:01",
  "GeTH_AlleleCount": 179,
  "GeTH_AlleleFreq": 0.023917691,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "19;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb9d"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb9e"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cb9f"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba0"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba1"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba2"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba3"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba4"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba5"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba6"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba7"
  },
  "id": "306",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:01",
  "GeTH_AlleleCount": 75,
  "GeTH_AlleleFreq": 0.010021379,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba8"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cba9"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbaa"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbab"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbac"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbad"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbae"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbaf"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb0"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb1"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb2"
  },
  "id": "307",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb3"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb4"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb5"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb6"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb7"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb8"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbb9"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbba"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbbb"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbbc"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbbd"
  },
  "id": "308",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*13:02",
  "GeTH_AlleleCount": 118,
  "GeTH_AlleleFreq": 0.01576697,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0005",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "34;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.5",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbbe"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbbf"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc0"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc1"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc2"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc3"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc4"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc5"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc6"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc7"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc8"
  },
  "id": "309",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbc9"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbca"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbcb"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbcc"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbcd"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbce"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbcf"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd0"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd1"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd2"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd3"
  },
  "id": "310",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:01",
  "GeTH_AlleleCount": 872,
  "GeTH_AlleleFreq": 0.116515232,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;188",
  "hla_adr_population_frequency": "30;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd4"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd5"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd6"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd7"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd8"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbd9"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbda"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbdb"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbdc"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbdd"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbde"
  },
  "id": "311",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*05:03",
  "GeTH_AlleleCount": 342,
  "GeTH_AlleleFreq": 0.045697488,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;188",
  "hla_adr_population_frequency": "15;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbdf"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe0"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe1"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe2"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe3"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe4"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe5"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe6"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe7"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe8"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbe9"
  },
  "id": "312",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:01",
  "GeTH_AlleleCount": 595,
  "GeTH_AlleleFreq": 0.07950294,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "34;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbea"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbeb"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbec"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbed"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbee"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbef"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf0"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf1"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf2"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf3"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf4"
  },
  "id": "313",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:04",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;188",
  "hla_adr_population_frequency": "18;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf5"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf6"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf7"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf8"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbf9"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbfa"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbfb"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbfc"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbfd"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbfe"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cbff"
  },
  "id": "314",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:09",
  "GeTH_AlleleCount": 88,
  "GeTH_AlleleFreq": 0.011758418,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0008",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "12;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "3.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc00"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc01"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc02"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc03"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc04"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc05"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc06"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc07"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc08"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc09"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc0a"
  },
  "id": "315",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:01",
  "GeTH_AlleleCount": 1468,
  "GeTH_AlleleFreq": 0.19615179,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "31;188",
  "hla_adr_population_frequency": "56;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc0b"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc0c"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc0d"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc0e"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc0f"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc10"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc11"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc12"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc13"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc14"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc15"
  },
  "id": "316",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:02",
  "GeTH_AlleleCount": 365,
  "GeTH_AlleleFreq": 0.048770711,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "14;188",
  "hla_adr_population_frequency": "44;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc16"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc17"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc18"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc19"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc1a"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc1b"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc1c"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc1d"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc1e"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc1f"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc20"
  },
  "id": "317",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*03:03",
  "GeTH_AlleleCount": 916,
  "GeTH_AlleleFreq": 0.122394441,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "19;188",
  "hla_adr_population_frequency": "45;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc21"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc22"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc23"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc24"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc25"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc26"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc27"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc28"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc29"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc2a"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc2b"
  },
  "id": "318",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*04:01",
  "GeTH_AlleleCount": 261,
  "GeTH_AlleleFreq": 0.034874399,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;188",
  "hla_adr_population_frequency": "28;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc2c"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc2d"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc2e"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc2f"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc30"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc31"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc32"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc33"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc34"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc35"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc36"
  },
  "id": "319",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:01",
  "GeTH_AlleleCount": 837,
  "GeTH_AlleleFreq": 0.111838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "93;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc37"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc38"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc39"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc3a"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc3b"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc3c"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc3d"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc3e"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc3f"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc40"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc41"
  },
  "id": "320",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*02:02",
  "GeTH_AlleleCount": 482,
  "GeTH_AlleleFreq": 0.064404062,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "16;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc42"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc43"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc44"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc45"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc46"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc47"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc48"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc49"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc4a"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc4b"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc4c"
  },
  "id": "321",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;188",
  "hla_adr_population_frequency": "11;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc4d"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc4e"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc4f"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc50"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc51"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc52"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc53"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc54"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc55"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc56"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc57"
  },
  "id": "322",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:01",
  "GeTH_AlleleCount": 886,
  "GeTH_AlleleFreq": 0.11838589,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "26;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc58"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc59"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc5a"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc5b"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc5c"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc5d"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc5e"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc5f"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc60"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc61"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc62"
  },
  "id": "323",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*04:02",
  "GeTH_AlleleCount": 325,
  "GeTH_AlleleFreq": 0.043425975,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "18;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc63"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc64"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc65"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc66"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc67"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc68"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc69"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc6a"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc6b"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc6c"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc6d"
  },
  "id": "324",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*05:01",
  "GeTH_AlleleCount": 1828,
  "GeTH_AlleleFreq": 0.244254409,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.028",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "54;188",
  "hla_adr_population_frequency": "141;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.7",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc6e"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc6f"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc70"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc71"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc72"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc73"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc74"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc75"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc76"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc77"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc78"
  },
  "id": "325",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*09:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;188",
  "hla_adr_population_frequency": "8;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc79"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc7a"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc7b"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc7c"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc7d"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc7e"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc7f"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc80"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc81"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc82"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc83"
  },
  "id": "326",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*13:01",
  "GeTH_AlleleCount": 1245,
  "GeTH_AlleleFreq": 0.16635489,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0324",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "29;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.4",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc84"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc85"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc86"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc87"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc88"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc89"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc8a"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc8b"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc8c"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc8d"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc8e"
  },
  "id": "327",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*14:01",
  "GeTH_AlleleCount": 238,
  "GeTH_AlleleFreq": 0.031801176,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;188",
  "hla_adr_population_frequency": "3;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc8f"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc90"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc91"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc92"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc93"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc94"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc95"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc96"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc97"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc98"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc99"
  },
  "id": "328",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15784113",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*17:01",
  "GeTH_AlleleCount": 109,
  "GeTH_AlleleFreq": 0.014564404,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;188",
  "hla_adr_population_frequency": "5;370",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc9a"
  },
  "id": "587",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "1;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.06 - 16.97)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc9b"
  },
  "id": "587",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "1;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.06 - 16.97)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc9c"
  },
  "id": "587",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:03",
  "GeTH_AlleleCount": 697,
  "GeTH_AlleleFreq": 0.093107133,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "1;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1 (0.06 - 16.97)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc9d"
  },
  "id": "876",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;134",
  "hla_adr_population_frequency": "1;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "3.59",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc9e"
  },
  "id": "988",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;134",
  "hla_adr_population_frequency": "3;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "0.35",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cc9f"
  },
  "id": "1149",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca0"
  },
  "id": "1149",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca1"
  },
  "id": "1149",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca2"
  },
  "id": "333",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.1 - 9.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca3"
  },
  "id": "333",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.1 - 9.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca4"
  },
  "id": "333",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.1 - 9.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca5"
  },
  "id": "334",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "23.3 (0.9 - 634)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca6"
  },
  "id": "334",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "23.3 (0.9 - 634)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca7"
  },
  "id": "334",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;7",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "23.3 (0.9 - 634)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca8"
  },
  "id": "335",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "18 (2.3 - 141.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cca9"
  },
  "id": "335",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "18 (2.3 - 141.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccaa"
  },
  "id": "335",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "18 (2.3 - 141.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccab"
  },
  "id": "336",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3 (0.6 - 15.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccac"
  },
  "id": "336",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3 (0.6 - 15.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccad"
  },
  "id": "336",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3 (0.6 - 15.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccae"
  },
  "id": "337",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.1 (0.4 - 10.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccaf"
  },
  "id": "337",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.1 (0.4 - 10.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb0"
  },
  "id": "337",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.1 (0.4 - 10.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb1"
  },
  "id": "338",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.4 (0.5 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb2"
  },
  "id": "338",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.4 (0.5 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb3"
  },
  "id": "338",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.4 (0.5 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb4"
  },
  "id": "339",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0 - 9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb5"
  },
  "id": "339",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0 - 9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb6"
  },
  "id": "339",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0 - 9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb7"
  },
  "id": "340",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0 - 11)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb8"
  },
  "id": "340",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0 - 11)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccb9"
  },
  "id": "340",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;7",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0 - 11)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccba"
  },
  "id": "341",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.9 (0.7 - 21.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccbb"
  },
  "id": "341",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.9 (0.7 - 21.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccbc"
  },
  "id": "341",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;7",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.9 (0.7 - 21.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccbd"
  },
  "id": "1223",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccbe"
  },
  "id": "1223",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccbf"
  },
  "id": "1223",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc0"
  },
  "id": "1297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc1"
  },
  "id": "1297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc2"
  },
  "id": "1297",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc3"
  },
  "id": "1682",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28278336",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:05",
  "GeTH_AlleleCount": 8,
  "GeTH_AlleleFreq": 0.001068662,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.131",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;39",
  "hla_adr_population_frequency": "3;133",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe occular complicatoins",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Brazil",
  "hla_adr_disease_id": "common cold",
  "hla_adr_region_id": "South America",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc4"
  },
  "id": "155",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.12 (0.45 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc5"
  },
  "id": "155",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.12 (0.45 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc6"
  },
  "id": "155",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;112",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.12 (0.45 - 2.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc7"
  },
  "id": "346",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.9 (0.5 - 7.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc8"
  },
  "id": "346",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.9 (0.5 - 7.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccc9"
  },
  "id": "346",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.9 (0.5 - 7.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccca"
  },
  "id": "347",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;17",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cccb"
  },
  "id": "347",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;17",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cccc"
  },
  "id": "347",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;17",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cccd"
  },
  "id": "348",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;17",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccce"
  },
  "id": "348",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;17",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cccf"
  },
  "id": "348",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;17",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.5 (0 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd0"
  },
  "id": "349",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.2 (0.3 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd1"
  },
  "id": "349",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.2 (0.3 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd2"
  },
  "id": "349",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.2 (0.3 - 4.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd3"
  },
  "id": "350",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.2 - 2.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd4"
  },
  "id": "350",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.2 - 2.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd5"
  },
  "id": "350",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.6 (0.2 - 2.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd6"
  },
  "id": "351",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.3 - 3.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd7"
  },
  "id": "351",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.3 - 3.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd8"
  },
  "id": "351",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.3 - 3.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccd9"
  },
  "id": "352",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.3 (0.6 - 9.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccda"
  },
  "id": "352",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.3 (0.6 - 9.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccdb"
  },
  "id": "352",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.3 (0.6 - 9.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccdc"
  },
  "id": "353",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.8 (0.6 - 11.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccdd"
  },
  "id": "353",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.8 (0.6 - 11.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccde"
  },
  "id": "353",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.8 (0.6 - 11.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccdf"
  },
  "id": "354",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.3 - 4.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce0"
  },
  "id": "354",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.3 - 4.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce1"
  },
  "id": "354",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;17",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.3 - 4.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce2"
  },
  "id": "173",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.28 (0.02 - 4.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce3"
  },
  "id": "173",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.28 (0.02 - 4.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce4"
  },
  "id": "173",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;23",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.28 (0.02 - 4.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce5"
  },
  "id": "191",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.52 (0.1 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce6"
  },
  "id": "191",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.52 (0.1 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce7"
  },
  "id": "191",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24268988",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;51",
  "hla_adr_exposed_frequency": "11;152",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.52 (0.1 - 2.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce8"
  },
  "id": "234",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "8;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.2 - 5.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cce9"
  },
  "id": "234",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "8;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.2 - 5.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccea"
  },
  "id": "234",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "8;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.2 - 5.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cceb"
  },
  "id": "234",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;26",
  "hla_adr_exposed_frequency": "8;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.1 (0.2 - 5.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccec"
  },
  "id": "497",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000246,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;61",
  "hla_adr_exposed_frequency": "68;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cced"
  },
  "id": "497",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000246,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;61",
  "hla_adr_exposed_frequency": "68;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccee"
  },
  "id": "497",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000246,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;61",
  "hla_adr_exposed_frequency": "68;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccef"
  },
  "id": "497",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000246,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;61",
  "hla_adr_exposed_frequency": "68;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf0"
  },
  "id": "497",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000246,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;61",
  "hla_adr_exposed_frequency": "68;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf1"
  },
  "id": "497",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.000246,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "1;61",
  "hla_adr_exposed_frequency": "68;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf2"
  },
  "id": "359",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;24",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 5.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf3"
  },
  "id": "359",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;24",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 5.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf4"
  },
  "id": "359",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;24",
  "hla_adr_exposed_frequency": "7;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 5.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf5"
  },
  "id": "360",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.4 (0.3 - 164.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf6"
  },
  "id": "360",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.4 (0.3 - 164.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf7"
  },
  "id": "360",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;24",
  "hla_adr_exposed_frequency": "0;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.4 (0.3 - 164.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf8"
  },
  "id": "361",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;24",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.4 (0.5 - 22.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccf9"
  },
  "id": "361",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;24",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.4 (0.5 - 22.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccfa"
  },
  "id": "361",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;24",
  "hla_adr_exposed_frequency": "2;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.4 (0.5 - 22.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccfb"
  },
  "id": "362",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccfc"
  },
  "id": "362",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccfd"
  },
  "id": "362",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_exposed_frequency": "10;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.5 - 5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccfe"
  },
  "id": "363",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.4 - 4.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ccff"
  },
  "id": "363",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.4 - 4.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd00"
  },
  "id": "363",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*01:02",
  "GeTH_AlleleCount": 1194,
  "GeTH_AlleleFreq": 0.159540353,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "13;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.4 - 4.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd01"
  },
  "id": "364",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.4 - 3.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd02"
  },
  "id": "364",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.4 - 3.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd03"
  },
  "id": "364",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:03",
  "GeTH_AlleleCount": 182,
  "GeTH_AlleleFreq": 0.024318546,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;24",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.3 (0.4 - 3.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd04"
  },
  "id": "365",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;24",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.4 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd05"
  },
  "id": "365",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;24",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.4 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd06"
  },
  "id": "365",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;24",
  "hla_adr_exposed_frequency": "6;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.5 (0.4 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd07"
  },
  "id": "366",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;24",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.4 - 7.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd08"
  },
  "id": "366",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;24",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.4 - 7.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd09"
  },
  "id": "366",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;24",
  "hla_adr_exposed_frequency": "5;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.4 - 7.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd0a"
  },
  "id": "367",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.5 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd0b"
  },
  "id": "367",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.5 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd0c"
  },
  "id": "367",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21917426",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*14:02",
  "GeTH_AlleleCount": 280,
  "GeTH_AlleleFreq": 0.037413148,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;24",
  "hla_adr_exposed_frequency": "8;50",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.8 (0.5 - 5.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd0d"
  },
  "id": "368",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23153709",
  "hla_adr_drug_id": "antituberculosis drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*04:01",
  "GeTH_AlleleCount": 392,
  "GeTH_AlleleFreq": 0.052378407,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.0204,
  "hla_adr_pvalue_population": "0.0132",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;14",
  "hla_adr_exposed_frequency": "21;166",
  "hla_adr_population_frequency": "62;485",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "tuberculosis",
  "hla_adr_odds_exposed": "6.9 (2.2 - 21.66)",
  "hla_adr_odds_population": "6.82 (2.31 - 20.11)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd0e"
  },
  "id": "369",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21676164",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "32;34",
  "hla_adr_exposed_frequency": "7;40",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "75.4 (13 - 718.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd0f"
  },
  "id": "369",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21676164",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "32;34",
  "hla_adr_exposed_frequency": "7;40",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "75.4 (13 - 718.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd10"
  },
  "id": "369",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21676164",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "32;34",
  "hla_adr_exposed_frequency": "7;40",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "75.4 (13 - 718.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd11"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd12"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd13"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd14"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd15"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd16"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd17"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd18"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd19"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd1a"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd1b"
  },
  "id": "370",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "43;184",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-intolerant asthma (AIA)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.4 (2.6 - 12.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIA"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd1c"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0553662",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd1d"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011065",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd1e"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0029408",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd1f"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021308",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd20"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0021368",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd21"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0024141",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd22"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0027051",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd23"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd24"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd25"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0002965",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd26"
  },
  "id": "371",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19392989",
  "hla_adr_drug_id": "Acetylsalicylic acid",
  "db_id": "DB00945",
  "hla_adr_gene_id": "HLA-DPB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DPB1*03:01",
  "GeTH_AlleleCount": 515,
  "GeTH_AlleleFreq": 0.068813469,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_exposed": 0.00001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "25;364",
  "hla_adr_exposed_frequency": "11;207",
  "hla_adr_adr": "aspirin-induced urticaria (AIU)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-value was reported as < 0.00001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.1 (2.4 - 7.3)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0038013",
  "Type_of_adr": "AIU"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd27"
  },
  "id": "567",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.82",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "3;64",
  "hla_adr_population_frequency": "20;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.36 (0.22 - 8.55)",
  "hla_adr_odds_population": "1.69 (0.38 - 7.59)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd28"
  },
  "id": "567",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.82",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "3;64",
  "hla_adr_population_frequency": "20;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.36 (0.22 - 8.55)",
  "hla_adr_odds_population": "1.69 (0.38 - 7.59)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd29"
  },
  "id": "567",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.82",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_exposed_frequency": "3;64",
  "hla_adr_population_frequency": "20;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.36 (0.22 - 8.55)",
  "hla_adr_odds_population": "1.69 (0.38 - 7.59)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd2a"
  },
  "id": "588",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "1;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.09 (0.18 - 24.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd2b"
  },
  "id": "588",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "1;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.09 (0.18 - 24.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd2c"
  },
  "id": "588",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "1;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.09 (0.18 - 24.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd2d"
  },
  "id": "698",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24399721",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.449,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_exposed_frequency": "7;125",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.873 (0.36 - 9.732)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd2e"
  },
  "id": "698",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24399721",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.449,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_exposed_frequency": "7;125",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.873 (0.36 - 9.732)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd2f"
  },
  "id": "698",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24399721",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.449,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_exposed_frequency": "7;125",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.873 (0.36 - 9.732)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd30"
  },
  "id": "756",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25099678",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_population": "0.938",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;20",
  "hla_adr_population_frequency": "3;55",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "0.91 (0.09 - 9.31)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd31"
  },
  "id": "758",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25099678",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;39",
  "hla_adr_population_frequency": "0;134",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Brazil",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "South America",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd32"
  },
  "id": "760",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25099678",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0362",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "11;31",
  "hla_adr_population_frequency": "14;90",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_population": "3 (1.18 - 7.57)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd33"
  },
  "id": "378",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.545,
  "hla_adr_pvalue_population": "0.694",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;40",
  "hla_adr_exposed_frequency": "16;52",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd34"
  },
  "id": "378",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.545,
  "hla_adr_pvalue_population": "0.694",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;40",
  "hla_adr_exposed_frequency": "16;52",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd35"
  },
  "id": "378",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.545,
  "hla_adr_pvalue_population": "0.694",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;40",
  "hla_adr_exposed_frequency": "16;52",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd36"
  },
  "id": "379",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.795,
  "hla_adr_pvalue_population": "0.479",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;40",
  "hla_adr_exposed_frequency": "8;52",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd37"
  },
  "id": "379",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.795,
  "hla_adr_pvalue_population": "0.479",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;40",
  "hla_adr_exposed_frequency": "8;52",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd38"
  },
  "id": "379",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.795,
  "hla_adr_pvalue_population": "0.479",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;40",
  "hla_adr_exposed_frequency": "8;52",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd39"
  },
  "id": "380",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.877,
  "hla_adr_pvalue_population": "0.356",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "10;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd3a"
  },
  "id": "380",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.877,
  "hla_adr_pvalue_population": "0.356",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "10;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd3b"
  },
  "id": "380",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.877,
  "hla_adr_pvalue_population": "0.356",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "10;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd3c"
  },
  "id": "381",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.087,
  "hla_adr_pvalue_population": "0.528",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd3d"
  },
  "id": "381",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.087,
  "hla_adr_pvalue_population": "0.528",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd3e"
  },
  "id": "381",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.087,
  "hla_adr_pvalue_population": "0.528",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd3f"
  },
  "id": "382",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.748",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd40"
  },
  "id": "382",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.748",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd41"
  },
  "id": "382",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.748",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd42"
  },
  "id": "383",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.47,
  "hla_adr_pvalue_population": "0.775",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "3;52",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd43"
  },
  "id": "383",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.47,
  "hla_adr_pvalue_population": "0.775",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "3;52",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd44"
  },
  "id": "383",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.47,
  "hla_adr_pvalue_population": "0.775",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "3;52",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd45"
  },
  "id": "384",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.729,
  "hla_adr_pvalue_population": "0.461",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "4;52",
  "hla_adr_population_frequency": "4;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd46"
  },
  "id": "384",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.729,
  "hla_adr_pvalue_population": "0.461",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "4;52",
  "hla_adr_population_frequency": "4;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd47"
  },
  "id": "384",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.729,
  "hla_adr_pvalue_population": "0.461",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "4;52",
  "hla_adr_population_frequency": "4;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd48"
  },
  "id": "385",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.037,
  "hla_adr_pvalue_population": "0.189",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;40",
  "hla_adr_exposed_frequency": "13;52",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd49"
  },
  "id": "385",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.037,
  "hla_adr_pvalue_population": "0.189",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;40",
  "hla_adr_exposed_frequency": "13;52",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd4a"
  },
  "id": "385",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.037,
  "hla_adr_pvalue_population": "0.189",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;40",
  "hla_adr_exposed_frequency": "13;52",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd4b"
  },
  "id": "386",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.117,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "9;52",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd4c"
  },
  "id": "386",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.117,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "9;52",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd4d"
  },
  "id": "386",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.117,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "9;52",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd4e"
  },
  "id": "387",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.58,
  "hla_adr_pvalue_population": "0.291",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd4f"
  },
  "id": "387",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.58,
  "hla_adr_pvalue_population": "0.291",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd50"
  },
  "id": "387",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.58,
  "hla_adr_pvalue_population": "0.291",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd51"
  },
  "id": "388",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.127",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "2;52",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd52"
  },
  "id": "388",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.127",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "2;52",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd53"
  },
  "id": "388",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.127",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;40",
  "hla_adr_exposed_frequency": "2;52",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd54"
  },
  "id": "389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.545,
  "hla_adr_pvalue_population": "0.709",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;40",
  "hla_adr_exposed_frequency": "16;52",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd55"
  },
  "id": "389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.545,
  "hla_adr_pvalue_population": "0.709",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;40",
  "hla_adr_exposed_frequency": "16;52",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd56"
  },
  "id": "389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.545,
  "hla_adr_pvalue_population": "0.709",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;40",
  "hla_adr_exposed_frequency": "16;52",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd57"
  },
  "id": "390",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.276,
  "hla_adr_pvalue_population": "0.039",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;40",
  "hla_adr_exposed_frequency": "8;52",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd58"
  },
  "id": "390",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.276,
  "hla_adr_pvalue_population": "0.039",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;40",
  "hla_adr_exposed_frequency": "8;52",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd59"
  },
  "id": "390",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.276,
  "hla_adr_pvalue_population": "0.039",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "10;40",
  "hla_adr_exposed_frequency": "8;52",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd5a"
  },
  "id": "391",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:05",
  "GeTH_AlleleCount": 51,
  "GeTH_AlleleFreq": 0.006814538,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.003,
  "hla_adr_pvalue_population": "0.058",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;40",
  "hla_adr_exposed_frequency": "0;52",
  "hla_adr_population_frequency": "4;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd5b"
  },
  "id": "391",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:05",
  "GeTH_AlleleCount": 51,
  "GeTH_AlleleFreq": 0.006814538,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.003,
  "hla_adr_pvalue_population": "0.058",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;40",
  "hla_adr_exposed_frequency": "0;52",
  "hla_adr_population_frequency": "4;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd5c"
  },
  "id": "391",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:05",
  "GeTH_AlleleCount": 51,
  "GeTH_AlleleFreq": 0.006814538,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.003,
  "hla_adr_pvalue_population": "0.058",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;40",
  "hla_adr_exposed_frequency": "0;52",
  "hla_adr_population_frequency": "4;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd5d"
  },
  "id": "392",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.475,
  "hla_adr_pvalue_population": "0.309",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "11;52",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd5e"
  },
  "id": "392",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.475,
  "hla_adr_pvalue_population": "0.309",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "11;52",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd5f"
  },
  "id": "392",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.475,
  "hla_adr_pvalue_population": "0.309",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "11;52",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd60"
  },
  "id": "393",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.475,
  "hla_adr_pvalue_population": "0.576",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "11;52",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd61"
  },
  "id": "393",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.475,
  "hla_adr_pvalue_population": "0.576",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "11;52",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd62"
  },
  "id": "393",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.475,
  "hla_adr_pvalue_population": "0.576",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;40",
  "hla_adr_exposed_frequency": "11;52",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd63"
  },
  "id": "394",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.169,
  "hla_adr_pvalue_population": "0.056",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd64"
  },
  "id": "394",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.169,
  "hla_adr_pvalue_population": "0.056",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd65"
  },
  "id": "394",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.169,
  "hla_adr_pvalue_population": "0.056",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;40",
  "hla_adr_exposed_frequency": "1;52",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd66"
  },
  "id": "395",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.024,
  "hla_adr_pvalue_population": "0.75",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;40",
  "hla_adr_exposed_frequency": "14;52",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd67"
  },
  "id": "395",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.024,
  "hla_adr_pvalue_population": "0.75",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;40",
  "hla_adr_exposed_frequency": "14;52",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd68"
  },
  "id": "395",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.024,
  "hla_adr_pvalue_population": "0.75",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;40",
  "hla_adr_exposed_frequency": "14;52",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd69"
  },
  "id": "396",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.07,
  "hla_adr_pvalue_population": "0.554",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd6a"
  },
  "id": "396",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.07,
  "hla_adr_pvalue_population": "0.554",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd6b"
  },
  "id": "396",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.07,
  "hla_adr_pvalue_population": "0.554",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;40",
  "hla_adr_exposed_frequency": "5;52",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd6c"
  },
  "id": "762",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25099678",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_population": "0.939",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;40",
  "hla_adr_population_frequency": "3;110",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.91 (0.09 - 9.06)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd6d"
  },
  "id": "764",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25099678",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;78",
  "hla_adr_population_frequency": "0;268",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Brazil",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "South America",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd6e"
  },
  "id": "766",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25099678",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Korean",
  "hla_adr_pvalue_population": "0.0526",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "12;62",
  "hla_adr_population_frequency": "16;180",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "South Korea",
  "hla_adr_disease_id": "other",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.46 (1.09 - 5.54)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd6f"
  },
  "id": "799",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24781922",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 4.75e-15,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "62;131",
  "hla_adr_exposed_frequency": "57;419",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe ocular surface complications",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.71 (3.666 - 8.881)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd70"
  },
  "id": "813",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24781922",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.0056,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;20",
  "hla_adr_exposed_frequency": "30;220",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe ocular surface complications",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "5.18 (1.98 - 13.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd71"
  },
  "id": "851",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25303297",
  "hla_adr_drug_id": "sulfasalazine",
  "db_id": "DB00795",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.352,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "19;283",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.78 (0.31 - 25)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd72"
  },
  "id": "851",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25303297",
  "hla_adr_drug_id": "sulfasalazine",
  "db_id": "DB00795",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.352,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "19;283",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "2.78 (0.31 - 25)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0010346",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd73"
  },
  "id": "877",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;134",
  "hla_adr_population_frequency": "1;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "0.26",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd74"
  },
  "id": "1150",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd75"
  },
  "id": "1150",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd76"
  },
  "id": "1150",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd77"
  },
  "id": "405",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.633,
  "hla_adr_pvalue_population": "0.552",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd78"
  },
  "id": "405",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.633,
  "hla_adr_pvalue_population": "0.552",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd79"
  },
  "id": "405",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.633,
  "hla_adr_pvalue_population": "0.552",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd7a"
  },
  "id": "405",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.633,
  "hla_adr_pvalue_population": "0.552",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd7b"
  },
  "id": "405",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.633,
  "hla_adr_pvalue_population": "0.552",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd7c"
  },
  "id": "405",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.633,
  "hla_adr_pvalue_population": "0.552",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "24;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd7d"
  },
  "id": "406",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.187",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd7e"
  },
  "id": "406",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.187",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd7f"
  },
  "id": "406",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.187",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd80"
  },
  "id": "406",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.187",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd81"
  },
  "id": "406",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.187",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd82"
  },
  "id": "406",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.187",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd83"
  },
  "id": "407",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.608,
  "hla_adr_pvalue_population": "0.238",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd84"
  },
  "id": "407",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.608,
  "hla_adr_pvalue_population": "0.238",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd85"
  },
  "id": "407",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.608,
  "hla_adr_pvalue_population": "0.238",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd86"
  },
  "id": "407",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.608,
  "hla_adr_pvalue_population": "0.238",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd87"
  },
  "id": "407",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.608,
  "hla_adr_pvalue_population": "0.238",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd88"
  },
  "id": "407",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.608,
  "hla_adr_pvalue_population": "0.238",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd89"
  },
  "id": "408",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.013,
  "hla_adr_pvalue_population": "0.082",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd8a"
  },
  "id": "408",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.013,
  "hla_adr_pvalue_population": "0.082",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd8b"
  },
  "id": "408",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.013,
  "hla_adr_pvalue_population": "0.082",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd8c"
  },
  "id": "408",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.013,
  "hla_adr_pvalue_population": "0.082",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd8d"
  },
  "id": "408",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.013,
  "hla_adr_pvalue_population": "0.082",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd8e"
  },
  "id": "408",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.013,
  "hla_adr_pvalue_population": "0.082",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd8f"
  },
  "id": "409",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.275,
  "hla_adr_pvalue_population": "0.751",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd90"
  },
  "id": "409",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.275,
  "hla_adr_pvalue_population": "0.751",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd91"
  },
  "id": "409",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.275,
  "hla_adr_pvalue_population": "0.751",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd92"
  },
  "id": "409",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.275,
  "hla_adr_pvalue_population": "0.751",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd93"
  },
  "id": "409",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.275,
  "hla_adr_pvalue_population": "0.751",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd94"
  },
  "id": "409",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.275,
  "hla_adr_pvalue_population": "0.751",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd95"
  },
  "id": "410",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.288",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd96"
  },
  "id": "410",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.288",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd97"
  },
  "id": "410",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.288",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd98"
  },
  "id": "410",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.288",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd99"
  },
  "id": "410",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.288",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd9a"
  },
  "id": "410",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.288",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "12;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd9b"
  },
  "id": "411",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.482",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd9c"
  },
  "id": "411",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.482",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd9d"
  },
  "id": "411",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.482",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd9e"
  },
  "id": "411",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.482",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cd9f"
  },
  "id": "411",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.482",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda0"
  },
  "id": "411",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.441,
  "hla_adr_pvalue_population": "0.482",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "10;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda1"
  },
  "id": "412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.058,
  "hla_adr_pvalue_population": "0.429",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda2"
  },
  "id": "412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.058,
  "hla_adr_pvalue_population": "0.429",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda3"
  },
  "id": "412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.058,
  "hla_adr_pvalue_population": "0.429",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda4"
  },
  "id": "412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.058,
  "hla_adr_pvalue_population": "0.429",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda5"
  },
  "id": "412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.058,
  "hla_adr_pvalue_population": "0.429",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda6"
  },
  "id": "412",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.058,
  "hla_adr_pvalue_population": "0.429",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda7"
  },
  "id": "413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.682,
  "hla_adr_pvalue_population": "0.713",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda8"
  },
  "id": "413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.682,
  "hla_adr_pvalue_population": "0.713",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cda9"
  },
  "id": "413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.682,
  "hla_adr_pvalue_population": "0.713",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdaa"
  },
  "id": "413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.682,
  "hla_adr_pvalue_population": "0.713",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdab"
  },
  "id": "413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.682,
  "hla_adr_pvalue_population": "0.713",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdac"
  },
  "id": "413",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.682,
  "hla_adr_pvalue_population": "0.713",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "6;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdad"
  },
  "id": "414",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.243,
  "hla_adr_pvalue_population": "0.558",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdae"
  },
  "id": "414",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.243,
  "hla_adr_pvalue_population": "0.558",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdaf"
  },
  "id": "414",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.243,
  "hla_adr_pvalue_population": "0.558",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb0"
  },
  "id": "414",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.243,
  "hla_adr_pvalue_population": "0.558",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb1"
  },
  "id": "414",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.243,
  "hla_adr_pvalue_population": "0.558",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb2"
  },
  "id": "414",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.243,
  "hla_adr_pvalue_population": "0.558",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;43",
  "hla_adr_exposed_frequency": "0;44",
  "hla_adr_population_frequency": "1;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb3"
  },
  "id": "415",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.368,
  "hla_adr_pvalue_population": "0.374",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb4"
  },
  "id": "415",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.368,
  "hla_adr_pvalue_population": "0.374",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb5"
  },
  "id": "415",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.368,
  "hla_adr_pvalue_population": "0.374",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb6"
  },
  "id": "415",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.368,
  "hla_adr_pvalue_population": "0.374",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb7"
  },
  "id": "415",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.368,
  "hla_adr_pvalue_population": "0.374",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb8"
  },
  "id": "415",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.368,
  "hla_adr_pvalue_population": "0.374",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "0;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdb9"
  },
  "id": "416",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_pvalue_population": "0.683",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdba"
  },
  "id": "416",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_pvalue_population": "0.683",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdbb"
  },
  "id": "416",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_pvalue_population": "0.683",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdbc"
  },
  "id": "416",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_pvalue_population": "0.683",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdbd"
  },
  "id": "416",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_pvalue_population": "0.683",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdbe"
  },
  "id": "416",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*09:01",
  "GeTH_AlleleCount": 726,
  "GeTH_AlleleFreq": 0.097006948,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.502,
  "hla_adr_pvalue_population": "0.683",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "20;44",
  "hla_adr_population_frequency": "30;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdbf"
  },
  "id": "417",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.138,
  "hla_adr_pvalue_population": "0.169",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc0"
  },
  "id": "417",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.138,
  "hla_adr_pvalue_population": "0.169",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc1"
  },
  "id": "417",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.138,
  "hla_adr_pvalue_population": "0.169",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc2"
  },
  "id": "417",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.138,
  "hla_adr_pvalue_population": "0.169",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc3"
  },
  "id": "417",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.138,
  "hla_adr_pvalue_population": "0.169",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc4"
  },
  "id": "417",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*04:05",
  "GeTH_AlleleCount": 299,
  "GeTH_AlleleFreq": 0.039951897,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.138,
  "hla_adr_pvalue_population": "0.169",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc5"
  },
  "id": "418",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.555",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc6"
  },
  "id": "418",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.555",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc7"
  },
  "id": "418",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.555",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc8"
  },
  "id": "418",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.555",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdc9"
  },
  "id": "418",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.555",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdca"
  },
  "id": "418",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*12:02",
  "GeTH_AlleleCount": 1204,
  "GeTH_AlleleFreq": 0.160876537,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.547,
  "hla_adr_pvalue_population": "0.555",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;43",
  "hla_adr_exposed_frequency": "6;44",
  "hla_adr_population_frequency": "17;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdcb"
  },
  "id": "419",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.823,
  "hla_adr_pvalue_population": "0.314",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdcc"
  },
  "id": "419",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.823,
  "hla_adr_pvalue_population": "0.314",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdcd"
  },
  "id": "419",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.823,
  "hla_adr_pvalue_population": "0.314",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdce"
  },
  "id": "419",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.823,
  "hla_adr_pvalue_population": "0.314",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdcf"
  },
  "id": "419",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.823,
  "hla_adr_pvalue_population": "0.314",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd0"
  },
  "id": "419",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.823,
  "hla_adr_pvalue_population": "0.314",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "7;43",
  "hla_adr_exposed_frequency": "8;44",
  "hla_adr_population_frequency": "7;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd1"
  },
  "id": "420",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.663",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd2"
  },
  "id": "420",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.663",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd3"
  },
  "id": "420",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.663",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd4"
  },
  "id": "420",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.663",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd5"
  },
  "id": "420",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.663",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd6"
  },
  "id": "420",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.166,
  "hla_adr_pvalue_population": "0.663",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;43",
  "hla_adr_exposed_frequency": "2;44",
  "hla_adr_population_frequency": "8;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd7"
  },
  "id": "421",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.745,
  "hla_adr_pvalue_population": "0.298",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd8"
  },
  "id": "421",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.745,
  "hla_adr_pvalue_population": "0.298",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdd9"
  },
  "id": "421",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.745,
  "hla_adr_pvalue_population": "0.298",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdda"
  },
  "id": "421",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.745,
  "hla_adr_pvalue_population": "0.298",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cddb"
  },
  "id": "421",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.745,
  "hla_adr_pvalue_population": "0.298",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cddc"
  },
  "id": "421",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*08:03",
  "GeTH_AlleleCount": 137,
  "GeTH_AlleleFreq": 0.018305719,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.745,
  "hla_adr_pvalue_population": "0.298",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "4;44",
  "hla_adr_population_frequency": "14;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cddd"
  },
  "id": "422",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_pvalue_population": "0.154",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "12;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdde"
  },
  "id": "422",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_pvalue_population": "0.154",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "12;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cddf"
  },
  "id": "422",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_pvalue_population": "0.154",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "12;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde0"
  },
  "id": "422",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_pvalue_population": "0.154",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "12;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde1"
  },
  "id": "422",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_pvalue_population": "0.154",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "12;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde2"
  },
  "id": "422",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*16:02",
  "GeTH_AlleleCount": 374,
  "GeTH_AlleleFreq": 0.049973276,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_pvalue_population": "0.154",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;43",
  "hla_adr_exposed_frequency": "12;44",
  "hla_adr_population_frequency": "3;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde3"
  },
  "id": "423",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18637831",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;4",
  "hla_adr_exposed_frequency": "0;7",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "18.5 (1.82 - 188.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde4"
  },
  "id": "423",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18637831",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;4",
  "hla_adr_exposed_frequency": "0;7",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "18.5 (1.82 - 188.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde5"
  },
  "id": "423",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18637831",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;4",
  "hla_adr_exposed_frequency": "0;7",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "18.5 (1.82 - 188.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde6"
  },
  "id": "423",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18637831",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;4",
  "hla_adr_exposed_frequency": "0;7",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "18.5 (1.82 - 188.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde7"
  },
  "id": "424",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18637831",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.0005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;6",
  "hla_adr_exposed_frequency": "0;4",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "25.5 (2.68 - 242.61)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde8"
  },
  "id": "424",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18637831",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.0005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;6",
  "hla_adr_exposed_frequency": "0;4",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "25.5 (2.68 - 242.61)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cde9"
  },
  "id": "424",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18637831",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.0005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;6",
  "hla_adr_exposed_frequency": "0;4",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "25.5 (2.68 - 242.61)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdea"
  },
  "id": "425",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.000001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;27",
  "hla_adr_population_frequency": "28;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "80 (34 - 187)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdeb"
  },
  "id": "425",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.000001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;27",
  "hla_adr_population_frequency": "28;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "80 (34 - 187)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdec"
  },
  "id": "425",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.000001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;27",
  "hla_adr_population_frequency": "28;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "80 (34 - 187)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cded"
  },
  "id": "425",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.000001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;27",
  "hla_adr_population_frequency": "28;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "80 (34 - 187)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdee"
  },
  "id": "425",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.000001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;27",
  "hla_adr_population_frequency": "28;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "80 (34 - 187)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdef"
  },
  "id": "425",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.000001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;27",
  "hla_adr_population_frequency": "28;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "80 (34 - 187)",
  "hla_adr_region_id": "Europe",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf0"
  },
  "id": "425",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.000001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;27",
  "hla_adr_population_frequency": "28;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_population": "80 (34 - 187)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf1"
  },
  "id": "426",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.59",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;25",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "4.3 (1.4 - 12.7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0006277",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf2"
  },
  "id": "426",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.59",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;25",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "4.3 (1.4 - 12.7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0033581",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf3"
  },
  "id": "426",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.59",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;25",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "4.3 (1.4 - 12.7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0042029",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf4"
  },
  "id": "426",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.59",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;25",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "4.3 (1.4 - 12.7)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf5"
  },
  "id": "427",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.73",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_population_frequency": "1;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "76 (4.6 - 1250)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0006277",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf6"
  },
  "id": "427",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.73",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_population_frequency": "1;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "76 (4.6 - 1250)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0033581",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf7"
  },
  "id": "427",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.73",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_population_frequency": "1;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "76 (4.6 - 1250)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0042029",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf8"
  },
  "id": "427",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "sulfamethoxazole",
  "db_id": "DB01015",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.73",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;25",
  "hla_adr_population_frequency": "1;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "76 (4.6 - 1250)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0004623",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdf9"
  },
  "id": "428",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "4.7 (1.3 - 16)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdfa"
  },
  "id": "428",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "4.7 (1.3 - 16)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdfb"
  },
  "id": "428",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "4.7 (1.3 - 16)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdfc"
  },
  "id": "428",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "4.7 (1.3 - 16)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdfd"
  },
  "id": "428",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "4.7 (1.3 - 16)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdfe"
  },
  "id": "428",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;17",
  "hla_adr_population_frequency": "78;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_population": "4.7 (1.3 - 16)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cdff"
  },
  "id": "429",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18192896",
  "hla_adr_drug_id": "oxicam NSAIDs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*73:01",
  "GeTH_AlleleCount": 2,
  "GeTH_AlleleFreq": 0.000267237,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.73",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;14",
  "hla_adr_population_frequency": "2;1822",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "France",
  "hla_adr_disease_id": "inflammation",
  "hla_adr_odds_population": "152 (20 - 1167)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce00"
  },
  "id": "430",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "4;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "4.81 (0.25 - 91.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce01"
  },
  "id": "430",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "4;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "4.81 (0.25 - 91.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce02"
  },
  "id": "431",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.86,
  "hla_adr_pvalue_population": "0.62",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "44;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.08 (0.28 - 15.58)",
  "hla_adr_odds_population": "2.08 (0.48 - 9.06)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce03"
  },
  "id": "431",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.86,
  "hla_adr_pvalue_population": "0.62",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "44;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.08 (0.28 - 15.58)",
  "hla_adr_odds_population": "2.08 (0.48 - 9.06)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce04"
  },
  "id": "432",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.46",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "69;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.27 - 5.54)",
  "hla_adr_odds_population": "2.03 (0.6 - 6.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce05"
  },
  "id": "432",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.46",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "69;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.27 - 5.54)",
  "hla_adr_odds_population": "2.03 (0.6 - 6.89)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce06"
  },
  "id": "433",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_pvalue_population": "0.26",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "86;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "4.5 (0.77 - 26.27)",
  "hla_adr_odds_population": "2.23 (0.76 - 6.57)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce07"
  },
  "id": "433",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_pvalue_population": "0.26",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "86;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "4.5 (0.77 - 26.27)",
  "hla_adr_odds_population": "2.23 (0.76 - 6.57)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce08"
  },
  "id": "434",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_pvalue_population": "0.49",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "29;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.38 (0.04 - 3.4)",
  "hla_adr_odds_population": "1.54 (0.2 - 11.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce09"
  },
  "id": "434",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_pvalue_population": "0.49",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "29;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.38 (0.04 - 3.4)",
  "hla_adr_odds_population": "1.54 (0.2 - 11.73)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce0a"
  },
  "id": "435",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.55,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "21;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.38 (0.02 - 8.24)",
  "hla_adr_odds_population": "0.99 (0.06 - 16.78)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce0b"
  },
  "id": "435",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.55,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "21;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.38 (0.02 - 8.24)",
  "hla_adr_odds_population": "0.99 (0.06 - 16.78)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce0c"
  },
  "id": "436",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:13",
  "GeTH_AlleleCount": 55,
  "GeTH_AlleleFreq": 0.007349011,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "1;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "14.45 (0.58 - 362.44)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce0d"
  },
  "id": "436",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:13",
  "GeTH_AlleleCount": 55,
  "GeTH_AlleleFreq": 0.007349011,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "1;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "14.45 (0.58 - 362.44)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce0e"
  },
  "id": "437",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "2;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.85 (2.01 - 259.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce0f"
  },
  "id": "437",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "2;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.85 (2.01 - 259.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce10"
  },
  "id": "438",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:58",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "2;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.85 (2.01 - 259.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce11"
  },
  "id": "438",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:58",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "2;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.85 (2.01 - 259.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce12"
  },
  "id": "439",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:05",
  "GeTH_AlleleCount": 24,
  "GeTH_AlleleFreq": 0.003206841,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "6;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "3.32 (0.18 - 60.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce13"
  },
  "id": "439",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:05",
  "GeTH_AlleleCount": 24,
  "GeTH_AlleleFreq": 0.003206841,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "6;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "3.32 (0.18 - 60.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce14"
  },
  "id": "440",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:08",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "1;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "14.45 (0.58 - 362.44)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce15"
  },
  "id": "440",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:08",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "1;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "14.45 (0.58 - 362.44)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce16"
  },
  "id": "441",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "8;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "2.54 (0.14 - 45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce17"
  },
  "id": "441",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "8;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "2.54 (0.14 - 45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce18"
  },
  "id": "442",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.42,
  "hla_adr_pvalue_population": "0.018",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "23;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "3.24 (0.51 - 20.63)",
  "hla_adr_odds_population": "6.329 (1.783 - 22.46)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce19"
  },
  "id": "442",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.42,
  "hla_adr_pvalue_population": "0.018",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "23;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "3.24 (0.51 - 20.63)",
  "hla_adr_odds_population": "6.329 (1.783 - 22.46)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce1a"
  },
  "id": "443",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "23;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "0.91 (0.05 - 15.29)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce1b"
  },
  "id": "443",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "23;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "0.91 (0.05 - 15.29)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce1c"
  },
  "id": "444",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.89,
  "hla_adr_pvalue_population": "0.88",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "4;28",
  "hla_adr_population_frequency": "100;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.56 (0.32 - 7.51)",
  "hla_adr_odds_population": "1.36 (0.41 - 4.59)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce1d"
  },
  "id": "444",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.89,
  "hla_adr_pvalue_population": "0.88",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "4;28",
  "hla_adr_population_frequency": "100;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.56 (0.32 - 7.51)",
  "hla_adr_odds_population": "1.36 (0.41 - 4.59)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce1e"
  },
  "id": "445",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "39;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "0.53 (0.03 - 8.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce1f"
  },
  "id": "445",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "39;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "0.53 (0.03 - 8.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce20"
  },
  "id": "446",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:02",
  "GeTH_AlleleCount": 10,
  "GeTH_AlleleFreq": 0.001336184,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "11;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "4.13 (0.51 - 33.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce21"
  },
  "id": "446",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:02",
  "GeTH_AlleleCount": 10,
  "GeTH_AlleleFreq": 0.001336184,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "11;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "4.13 (0.51 - 33.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce22"
  },
  "id": "447",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.17",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "32;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.79 (0.14 - 4.32)",
  "hla_adr_odds_population": "2.89 (0.66 - 12.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce23"
  },
  "id": "447",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.17",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "32;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.79 (0.14 - 4.32)",
  "hla_adr_odds_population": "2.89 (0.66 - 12.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce24"
  },
  "id": "448",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.46",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "3;28",
  "hla_adr_population_frequency": "118;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.07 - 6.59)",
  "hla_adr_odds_population": "0.35 (0.05 - 2.61)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce25"
  },
  "id": "448",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.46",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "3;28",
  "hla_adr_population_frequency": "118;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.07 - 6.59)",
  "hla_adr_odds_population": "0.35 (0.05 - 2.61)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce26"
  },
  "id": "449",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.25,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "24;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.16 (0.01 - 3.08)",
  "hla_adr_odds_population": "0.87 (0.05 - 14.63)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce27"
  },
  "id": "449",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.25,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "5;28",
  "hla_adr_population_frequency": "24;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.16 (0.01 - 3.08)",
  "hla_adr_odds_population": "0.87 (0.05 - 14.63)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce28"
  },
  "id": "450",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "66;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.04 (0.12 - 33.83)",
  "hla_adr_odds_population": "0.66 (0.09 - 4.91)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce29"
  },
  "id": "450",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "66;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.04 (0.12 - 33.83)",
  "hla_adr_odds_population": "0.66 (0.09 - 4.91)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce2a"
  },
  "id": "451",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "6;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "3.32 (0.18 - 60.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce2b"
  },
  "id": "451",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "6;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "3.32 (0.18 - 60.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce2c"
  },
  "id": "452",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "21;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "2.14 (0.28 - 16.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce2d"
  },
  "id": "452",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "21;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "2.14 (0.28 - 16.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce2e"
  },
  "id": "453",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "7;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "2.88 (0.16 - 51.58)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce2f"
  },
  "id": "453",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "7;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "2.88 (0.16 - 51.58)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce30"
  },
  "id": "454",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.56",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "35;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.04 (0.12 - 33.83)",
  "hla_adr_odds_population": "1.27 (0.17 - 9.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce31"
  },
  "id": "454",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.56",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "35;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.04 (0.12 - 33.83)",
  "hla_adr_odds_population": "1.27 (0.17 - 9.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce32"
  },
  "id": "455",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "2;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.85 (2.01 - 259.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce33"
  },
  "id": "455",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "2;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.85 (2.01 - 259.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce34"
  },
  "id": "456",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:04",
  "GeTH_AlleleCount": 44,
  "GeTH_AlleleFreq": 0.005879209,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "1;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "14.45 (0.58 - 362.44)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce35"
  },
  "id": "456",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:04",
  "GeTH_AlleleCount": 44,
  "GeTH_AlleleFreq": 0.005879209,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "1;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_odds_population": "14.45 (0.58 - 362.44)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce36"
  },
  "id": "457",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.55,
  "hla_adr_pvalue_population": "0.35",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "3;28",
  "hla_adr_population_frequency": "74;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.27 (0.01 - 5.38)",
  "hla_adr_odds_population": "0.27 (0.02 - 4.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce37"
  },
  "id": "457",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.55,
  "hla_adr_pvalue_population": "0.35",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "3;28",
  "hla_adr_population_frequency": "74;1236",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.27 (0.01 - 5.38)",
  "hla_adr_odds_population": "0.27 (0.02 - 4.53)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce38"
  },
  "id": "458",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:42",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.12",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.96 (0.91 - 577.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce39"
  },
  "id": "458",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:42",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.12",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.96 (0.91 - 577.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce3a"
  },
  "id": "459",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:31",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.55,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.38 (0.02 - 8.24)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce3b"
  },
  "id": "459",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:31",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.55,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "2;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.38 (0.02 - 8.24)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce3c"
  },
  "id": "460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*47:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce3d"
  },
  "id": "460",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*47:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce3e"
  },
  "id": "461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:04",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce3f"
  },
  "id": "461",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:04",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce40"
  },
  "id": "462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*53:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.12",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.96 (0.91 - 577.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce41"
  },
  "id": "462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*53:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.33,
  "hla_adr_pvalue_population": "0.12",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;14",
  "hla_adr_exposed_frequency": "0;28",
  "hla_adr_population_frequency": "0;210",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.16 (0.24 - 156.27)",
  "hla_adr_odds_population": "22.96 (0.91 - 577.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce42"
  },
  "id": "463",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:15",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce43"
  },
  "id": "463",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:15",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce44"
  },
  "id": "464",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce45"
  },
  "id": "464",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23829937",
  "hla_adr_drug_id": "oxcarbazepine",
  "db_id": "DB00776",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;14",
  "hla_adr_exposed_frequency": "1;28",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.65 (0.03 - 16.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce46"
  },
  "id": "465",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11888582",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;18",
  "hla_adr_exposed_frequency": "4;167",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Australia",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "All hypersensitive patients were reported to be Caucasian whilst exposed controls were diverse (mostly Caucasian)",
  "hla_adr_odds_exposed": "117 (29 - 481)",
  "hla_adr_region_id": "Oceania",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce47"
  },
  "id": "466",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/15024131",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "17;18",
  "hla_adr_exposed_frequency": "4;230",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value was reported as < 0.0001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Australia",
  "hla_adr_disease_id": "HIV",
  "hla_adr_notes": "All hypersensitive patients were reported to be Caucasian whilst exposed controls were diverse (mostly Caucasian)",
  "hla_adr_odds_exposed": "960",
  "hla_adr_region_id": "Oceania",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce48"
  },
  "id": "1224",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce49"
  },
  "id": "1224",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce4a"
  },
  "id": "1224",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce4b"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce4c"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce4d"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce4e"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce4f"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce50"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce51"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce52"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce53"
  },
  "id": "468",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:02",
  "GeTH_AlleleCount": 54,
  "GeTH_AlleleFreq": 0.007215393,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Allele designation not as reported in study (as 07020)",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce54"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce55"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce56"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce57"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce58"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce59"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce5a"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce5b"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce5c"
  },
  "id": "469",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce5d"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce5e"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce5f"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce60"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce61"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce62"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce63"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce64"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce65"
  },
  "id": "470",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce66"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce67"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce68"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce69"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce6a"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce6b"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce6c"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce6d"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce6e"
  },
  "id": "471",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce6f"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce70"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce71"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce72"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce73"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce74"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce75"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce76"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce77"
  },
  "id": "472",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:01",
  "GeTH_AlleleCount": 90,
  "GeTH_AlleleFreq": 0.012025655,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.518 (0.053 - 5.074)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce78"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce79"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce7a"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce7b"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce7c"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce7d"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce7e"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce7f"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce80"
  },
  "id": "473",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:07",
  "GeTH_AlleleCount": 19,
  "GeTH_AlleleFreq": 0.002538749,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.313,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "0;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "6.931 (0.266 - 180.436)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce81"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce82"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce83"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce84"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce85"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce86"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce87"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce88"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce89"
  },
  "id": "474",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce8a"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce8b"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce8c"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce8d"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce8e"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce8f"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce90"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce91"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce92"
  },
  "id": "475",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:18",
  "GeTH_AlleleCount": 17,
  "GeTH_AlleleFreq": 0.002271513,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.467 (0.021 - 10.386)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce93"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce94"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce95"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce96"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce97"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce98"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce99"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce9a"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce9b"
  },
  "id": "476",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:04",
  "GeTH_AlleleCount": 114,
  "GeTH_AlleleFreq": 0.015232496,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce9c"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce9d"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce9e"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ce9f"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea0"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea1"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea2"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea3"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea4"
  },
  "id": "477",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.082,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "7;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.114 (0.006 - 2.136)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea5"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea6"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea7"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea8"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cea9"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceaa"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceab"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceac"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cead"
  },
  "id": "478",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*37:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceae"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceaf"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb0"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb1"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb2"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb3"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb4"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb5"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb6"
  },
  "id": "479",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:04",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb7"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb8"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceb9"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceba"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cebb"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cebc"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cebd"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cebe"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cebf"
  },
  "id": "480",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.115 (0.181 - 6.878)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec0"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec1"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec2"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec3"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec4"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec5"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec6"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec7"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec8"
  },
  "id": "481",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:02",
  "GeTH_AlleleCount": 93,
  "GeTH_AlleleFreq": 0.01242651,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.236,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "4;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.636 (0.56 - 12.421)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cec9"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceca"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cecb"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cecc"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cecd"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cece"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cecf"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced0"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced1"
  },
  "id": "482",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:06",
  "GeTH_AlleleCount": 111,
  "GeTH_AlleleFreq": 0.014831641,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced2"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced3"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced4"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced5"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced6"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced7"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced8"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ced9"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceda"
  },
  "id": "483",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.227,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.923 (0.41 - 59.112)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cedb"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cedc"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cedd"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cede"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cedf"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee0"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee1"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee2"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee3"
  },
  "id": "484",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "3;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.714 (0.068 - 7.493)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee4"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee5"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee6"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee7"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee8"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cee9"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceea"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceeb"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceec"
  },
  "id": "485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceed"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceee"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceef"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef0"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef1"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef2"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef3"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef4"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef5"
  },
  "id": "486",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.031,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "4.9 (1.219 - 19.689)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef6"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef7"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef8"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cef9"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cefa"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cefb"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cefc"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cefd"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cefe"
  },
  "id": "487",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*52:01",
  "GeTH_AlleleCount": 204,
  "GeTH_AlleleFreq": 0.027258151,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;15",
  "hla_adr_exposed_frequency": "8;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.781 (0.175 - 3.483)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73ceff"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf00"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf01"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf02"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf03"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf04"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf05"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf06"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf07"
  },
  "id": "488",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "5;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.4 (0.043 - 3.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf08"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf09"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf0a"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf0b"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf0c"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf0d"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf0e"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf0f"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf10"
  },
  "id": "489",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.579,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.385 (0.303 - 18.788)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf11"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf12"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf13"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf14"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf15"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf16"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf17"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf18"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf19"
  },
  "id": "490",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.532,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.286 (0.133 - 39.203)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf1a"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf1b"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf1c"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf1d"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf1e"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf1f"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf20"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf21"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf22"
  },
  "id": "491",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.103 (0.004 - 2.418)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf23"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf24"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf25"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf26"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf27"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf28"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf29"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf2a"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf2b"
  },
  "id": "492",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*59:01",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;15",
  "hla_adr_exposed_frequency": "1;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.699 (0.027 - 18.157)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf2c"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf2d"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf2e"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf2f"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf30"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf31"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf32"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf33"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf34"
  },
  "id": "493",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22211527",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*67:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;15",
  "hla_adr_exposed_frequency": "2;33",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.107 (0.093 - 13.248)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf35"
  },
  "id": "494",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11034591",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0000025,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;20",
  "hla_adr_exposed_frequency": "27;134",
  "hla_adr_adr": "jaundice",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Study reports the use of correction but not declared method, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Scotland",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "9.25",
  "hla_adr_region_id": "Europe",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf36"
  },
  "id": "494",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11034591",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.0000025,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;20",
  "hla_adr_exposed_frequency": "27;134",
  "hla_adr_adr": "jaundice",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "Study reports the use of correction but not declared method, The p-value stated here is the uncorrected value.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Scotland",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "9.25",
  "hla_adr_region_id": "Europe",
  "c_id": "other"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf37"
  },
  "id": "1298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf38"
  },
  "id": "1298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf39"
  },
  "id": "1298",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf3a"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0746693",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf3b"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0155804",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf3c"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0043167",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf3d"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0271429",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf3e"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0031350",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf3f"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0679246",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf40"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0032269",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf41"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030824",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf42"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0035243",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf43"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0427965",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf44"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0037278",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf45"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0004771",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf46"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C1396580",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf47"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0694549",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf48"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0554628",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf49"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0010418",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf4a"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0013295",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf4b"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2367228",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf4c"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014038",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf4d"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0948279",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf4e"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0850666",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf4f"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0348321",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf50"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0455590",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf51"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0019693",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf52"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0020523",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf53"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0023241",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf54"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040425",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf55"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040558",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf56"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C1096746",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf57"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0746690",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf58"
  },
  "id": "1659",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 8.32,
  "hla_adr_pvalue_population": "2.9",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;12",
  "hla_adr_exposed_frequency": "3;34",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "2.07 (0.3 - 14.18)",
  "hla_adr_odds_population": "2.78 (0.57 - 13.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0856695",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf59"
  },
  "id": "1819",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27749688",
  "hla_adr_drug_id": "tetanus antitoxin",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:06",
  "GeTH_AlleleCount": 164,
  "GeTH_AlleleFreq": 0.021907561,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.14",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;15",
  "hla_adr_exposed_frequency": "/ 118",
  "hla_adr_population_frequency": "19;283",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "tetanus",
  "hla_adr_odds_population": "5.05 (1.47 - 17.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf5a"
  },
  "id": "235",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf5b"
  },
  "id": "235",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf5c"
  },
  "id": "235",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf5d"
  },
  "id": "235",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20235791",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.4428,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;26",
  "hla_adr_exposed_frequency": "25;113",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Taiwan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.6 (0.6 - 4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf5e"
  },
  "id": "374",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.596,
  "hla_adr_pvalue_population": "0.206",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;40",
  "hla_adr_exposed_frequency": "14;52",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf5f"
  },
  "id": "374",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.596,
  "hla_adr_pvalue_population": "0.206",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;40",
  "hla_adr_exposed_frequency": "14;52",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf60"
  },
  "id": "374",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.596,
  "hla_adr_pvalue_population": "0.206",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "13;40",
  "hla_adr_exposed_frequency": "14;52",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf61"
  },
  "id": "398",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.943,
  "hla_adr_pvalue_population": "0.079",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "16;44",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf62"
  },
  "id": "398",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.943,
  "hla_adr_pvalue_population": "0.079",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "16;44",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf63"
  },
  "id": "398",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.943,
  "hla_adr_pvalue_population": "0.079",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "16;44",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf64"
  },
  "id": "398",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.943,
  "hla_adr_pvalue_population": "0.079",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "16;44",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf65"
  },
  "id": "398",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.943,
  "hla_adr_pvalue_population": "0.079",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "16;44",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf66"
  },
  "id": "398",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23830818",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.943,
  "hla_adr_pvalue_population": "0.079",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "16;43",
  "hla_adr_exposed_frequency": "16;44",
  "hla_adr_population_frequency": "15;72",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Corrected for chi-square",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf67"
  },
  "id": "498",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;61",
  "hla_adr_exposed_frequency": "23;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf68"
  },
  "id": "498",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;61",
  "hla_adr_exposed_frequency": "23;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf69"
  },
  "id": "498",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;61",
  "hla_adr_exposed_frequency": "23;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf6a"
  },
  "id": "498",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;61",
  "hla_adr_exposed_frequency": "23;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf6b"
  },
  "id": "498",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;61",
  "hla_adr_exposed_frequency": "23;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf6c"
  },
  "id": "498",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;61",
  "hla_adr_exposed_frequency": "23;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf6d"
  },
  "id": "568",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;36",
  "hla_adr_exposed_frequency": "10;64",
  "hla_adr_population_frequency": "42;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.56 (0.14 - 2.19)",
  "hla_adr_odds_population": "1.2 (0.35 - 4.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf6e"
  },
  "id": "568",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;36",
  "hla_adr_exposed_frequency": "10;64",
  "hla_adr_population_frequency": "42;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.56 (0.14 - 2.19)",
  "hla_adr_odds_population": "1.2 (0.35 - 4.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf6f"
  },
  "id": "568",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.6,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;36",
  "hla_adr_exposed_frequency": "10;64",
  "hla_adr_population_frequency": "42;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.56 (0.14 - 2.19)",
  "hla_adr_odds_population": "1.2 (0.35 - 4.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf70"
  },
  "id": "589",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.66,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "4;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.08 - 2.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf71"
  },
  "id": "589",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.66,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "4;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.08 - 2.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf72"
  },
  "id": "589",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.66,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;24",
  "hla_adr_exposed_frequency": "4;24",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.08 - 2.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf73"
  },
  "id": "828",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24856347",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.128,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;10",
  "hla_adr_exposed_frequency": "12;50",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.167 (0.782 - 12.831)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf74"
  },
  "id": "852",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25303297",
  "hla_adr_drug_id": "sulfasalazine",
  "db_id": "DB00795",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "44;283",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "1.09 (0.12 - 9.52)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf75"
  },
  "id": "852",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25303297",
  "hla_adr_drug_id": "sulfasalazine",
  "db_id": "DB00795",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "44;283",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "1.09 (0.12 - 9.52)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0010346",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf76"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0746693",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf77"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0155804",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf78"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0043167",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf79"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0271429",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf7a"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0031350",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf7b"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0679246",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf7c"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0032269",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf7d"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030824",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf7e"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0035243",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf7f"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0427965",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf80"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0037278",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf81"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0004771",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf82"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C1396580",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf83"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0694549",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf84"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0554628",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf85"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0010418",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf86"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0013295",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf87"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2367228",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf88"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014038",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf89"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0948279",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf8a"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0850666",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf8b"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0348321",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf8c"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0455590",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf8d"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0019693",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf8e"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0020523",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf8f"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0023241",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf90"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040425",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf91"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040558",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf92"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C1096746",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf93"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0746690",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf94"
  },
  "id": "1660",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/29575644",
  "hla_adr_drug_id": "clarithromycin",
  "db_id": "DB01211",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0011,
  "hla_adr_pvalue_population": "0.0017",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "7;12",
  "hla_adr_exposed_frequency": "2;34",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "drug-induced skin reaction (DISI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_exposed": "22.4 (3.58 - 139.98)",
  "hla_adr_odds_population": "7.61 (2.31 - 25.04)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0856695",
  "Type_of_adr": "DISI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf95"
  },
  "id": "1820",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27749688",
  "hla_adr_drug_id": "tetanus antitoxin",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:07",
  "GeTH_AlleleCount": 716,
  "GeTH_AlleleFreq": 0.095645204,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.14",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;15",
  "hla_adr_exposed_frequency": "/ 118",
  "hla_adr_population_frequency": "44;283",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "tetanus",
  "hla_adr_odds_population": "3.62 (1.23 - 10.68)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf96"
  },
  "id": "1151",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf97"
  },
  "id": "1151",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf98"
  },
  "id": "1151",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf99"
  },
  "id": "1225",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf9a"
  },
  "id": "1225",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf9b"
  },
  "id": "1225",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf9c"
  },
  "id": "1299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf9d"
  },
  "id": "1299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf9e"
  },
  "id": "1299",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cf9f"
  },
  "id": "499",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa0"
  },
  "id": "499",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa1"
  },
  "id": "499",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa2"
  },
  "id": "499",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa3"
  },
  "id": "499",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa4"
  },
  "id": "499",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa5"
  },
  "id": "1152",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa6"
  },
  "id": "1152",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa7"
  },
  "id": "1152",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa8"
  },
  "id": "1226",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfa9"
  },
  "id": "1226",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfaa"
  },
  "id": "1226",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfab"
  },
  "id": "1300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfac"
  },
  "id": "1300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfad"
  },
  "id": "1300",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:11",
  "GeTH_AlleleCount": 23,
  "GeTH_AlleleFreq": 0.003072402,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "2;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfae"
  },
  "id": "515",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.01,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "3;53",
  "hla_adr_exposed_frequency": "1;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfaf"
  },
  "id": "516",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.042,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;53",
  "hla_adr_exposed_frequency": "20;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb0"
  },
  "id": "517",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:01",
  "GeTH_AlleleCount": 266,
  "GeTH_AlleleFreq": 0.035542491,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.096,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;53",
  "hla_adr_exposed_frequency": "2;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb1"
  },
  "id": "518",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:01",
  "GeTH_AlleleCount": 74,
  "GeTH_AlleleFreq": 0.009887761,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.47,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;53",
  "hla_adr_exposed_frequency": "4;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb2"
  },
  "id": "519",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:05",
  "GeTH_AlleleCount": 173,
  "GeTH_AlleleFreq": 0.023115981,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;53",
  "hla_adr_exposed_frequency": "1;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb3"
  },
  "id": "520",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*41:01",
  "GeTH_AlleleCount": 5,
  "GeTH_AlleleFreq": 0.000668092,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.072,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;53",
  "hla_adr_exposed_frequency": "4;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb4"
  },
  "id": "521",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.018,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "12;53",
  "hla_adr_exposed_frequency": "9;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb5"
  },
  "id": "522",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.057,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;53",
  "hla_adr_exposed_frequency": "25;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb6"
  },
  "id": "523",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*02:10",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0012,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;55",
  "hla_adr_exposed_frequency": "19;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb7"
  },
  "id": "524",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:02",
  "GeTH_AlleleCount": 551,
  "GeTH_AlleleFreq": 0.073623731,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.041,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;55",
  "hla_adr_exposed_frequency": "3;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb8"
  },
  "id": "525",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*03:04",
  "GeTH_AlleleCount": 652,
  "GeTH_AlleleFreq": 0.087119188,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.047,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;55",
  "hla_adr_exposed_frequency": "19;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfb9"
  },
  "id": "526",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*06:02",
  "GeTH_AlleleCount": 330,
  "GeTH_AlleleFreq": 0.044094067,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.042,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "12;55",
  "hla_adr_exposed_frequency": "39;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfba"
  },
  "id": "527",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-C",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-C*12:03",
  "GeTH_AlleleCount": 108,
  "GeTH_AlleleFreq": 0.014430786,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.017,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;55",
  "hla_adr_exposed_frequency": "4;106",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfbb"
  },
  "id": "528",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:01",
  "GeTH_AlleleCount": 31,
  "GeTH_AlleleFreq": 0.00414217,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.14,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;54",
  "hla_adr_exposed_frequency": "3;103",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfbc"
  },
  "id": "529",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*01:02",
  "GeTH_AlleleCount": 3,
  "GeTH_AlleleFreq": 0.000400855,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.022,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "8;54",
  "hla_adr_exposed_frequency": "4;103",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfbd"
  },
  "id": "530",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*03:01",
  "GeTH_AlleleCount": 448,
  "GeTH_AlleleFreq": 0.059861037,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.086,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;54",
  "hla_adr_exposed_frequency": "15;103",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfbe"
  },
  "id": "531",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23328091",
  "hla_adr_drug_id": "nevirapine",
  "db_id": "DB00238",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*14:01",
  "GeTH_AlleleCount": 320,
  "GeTH_AlleleFreq": 0.042757883,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.072,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;54",
  "hla_adr_exposed_frequency": "4;103",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "South Africa",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Africa",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfbf"
  },
  "id": "532",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19195327",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "21;27",
  "hla_adr_exposed_frequency": "17;1728",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "p-value reported as <0.001, Study only reported incidence rate as percentages - therefore the number of patients and controls with the allele has been infered from this.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Switzerland",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Europe",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc0"
  },
  "id": "533",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19195327",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_pvalue_exposed": 0.01,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;27",
  "hla_adr_exposed_frequency": "138;1728",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele reported as ''HLA-DR*0701''. This has been assumed to be HLA-DRB1*07:01 Study only reported incidence rate as percentages - therefore the number of patients and controls with the allele has been infered from this.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Switzerland",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Europe",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc1"
  },
  "id": "534",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/18184080",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.01,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "11;26",
  "hla_adr_exposed_frequency": "1;27",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_association": "p-value reported as <0.01",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "HIV",
  "hla_adr_region_id": "Europe",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc2"
  },
  "id": "535",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.4e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.12 (6.36 - 31.32)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc3"
  },
  "id": "535",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.4e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.12 (6.36 - 31.32)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc4"
  },
  "id": "535",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.4e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.12 (6.36 - 31.32)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc5"
  },
  "id": "535",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.4e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.12 (6.36 - 31.32)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc6"
  },
  "id": "536",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.6e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.08 (6.35 - 31.24)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc7"
  },
  "id": "536",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.6e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.08 (6.35 - 31.24)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc8"
  },
  "id": "536",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.6e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.08 (6.35 - 31.24)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfc9"
  },
  "id": "536",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 2.6e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "29;37",
  "hla_adr_exposed_frequency": "218;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "14.08 (6.35 - 31.24)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfca"
  },
  "id": "537",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 7.9e-10,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;37",
  "hla_adr_exposed_frequency": "170;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "8.64 (4.36 - 17.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfcb"
  },
  "id": "537",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 7.9e-10,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;37",
  "hla_adr_exposed_frequency": "170;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "8.64 (4.36 - 17.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfcc"
  },
  "id": "537",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 7.9e-10,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;37",
  "hla_adr_exposed_frequency": "170;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "8.64 (4.36 - 17.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfcd"
  },
  "id": "537",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24687830",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 7.9e-10,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "23;37",
  "hla_adr_exposed_frequency": "170;1071",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_odds_exposed": "8.64 (4.36 - 17.13)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfce"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfcf"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd0"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd1"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd2"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd3"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd4"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd5"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd6"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd7"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd8"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfd9"
  },
  "id": "538",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*07:05",
  "GeTH_AlleleCount": 186,
  "GeTH_AlleleFreq": 0.02485302,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.23 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfda"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfdb"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfdc"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfdd"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfde"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfdf"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe0"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe1"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe2"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe3"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe4"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe5"
  },
  "id": "539",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "9;22",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.03 - 2.091)",
  "hla_adr_odds_population": "0.65 (0.09 - 4.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe6"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe7"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe8"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfe9"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfea"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfeb"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfec"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfed"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfee"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfef"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff0"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff1"
  },
  "id": "540",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:02",
  "GeTH_AlleleCount": 148,
  "GeTH_AlleleFreq": 0.019775521,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.67,
  "hla_adr_pvalue_population": "0.09",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.7 (0.36 - 20.48)",
  "hla_adr_odds_population": "4.7 (0.98 - 22.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff2"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff3"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff4"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff5"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff6"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff7"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff8"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cff9"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cffa"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cffb"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cffc"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cffd"
  },
  "id": "541",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.62 (0.07 - 5.87)",
  "hla_adr_odds_population": "0.6 (0.08 - 4.56)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cffe"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73cfff"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d000"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d001"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d002"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d003"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d004"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d005"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d006"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d007"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d008"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d009"
  },
  "id": "542",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d00a"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d00b"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d00c"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d00d"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d00e"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d00f"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d010"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d011"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d012"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d013"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d014"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d015"
  },
  "id": "543",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:27",
  "GeTH_AlleleCount": 25,
  "GeTH_AlleleFreq": 0.00334046,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.13",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "2;22",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.8 (0.08 - 8.07)",
  "hla_adr_odds_population": "11.48 (1 - 131.23)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d016"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d017"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d018"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d019"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d01a"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d01b"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d01c"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d01d"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d01e"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d01f"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d020"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d021"
  },
  "id": "544",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.00748263,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.28",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "7;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "3.54 (0.42 - 30.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d022"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d023"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d024"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d025"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d026"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d027"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d028"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d029"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d02a"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d02b"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d02c"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d02d"
  },
  "id": "545",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.54,
  "hla_adr_pvalue_population": "0.18",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;56",
  "hla_adr_exposed_frequency": "10;22",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.73 (0.54 - 5.51)",
  "hla_adr_odds_population": "2.23 (0.85 - 5.88)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d02e"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d02f"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d030"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d031"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d032"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d033"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d034"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d035"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d036"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d037"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d038"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d039"
  },
  "id": "546",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:03",
  "GeTH_AlleleCount": 339,
  "GeTH_AlleleFreq": 0.045296633,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "9;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "2.26 (0.28 - 18.42)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d03a"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d03b"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d03c"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d03d"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d03e"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d03f"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d040"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d041"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d042"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d043"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d044"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d045"
  },
  "id": "547",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.24",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;56",
  "hla_adr_exposed_frequency": "12;22",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.08 (0.33 - 3.52)",
  "hla_adr_odds_population": "2.17 (0.77 - 6.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d046"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d047"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d048"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d049"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d04a"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d04b"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d04c"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d04d"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d04e"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d04f"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d050"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d051"
  },
  "id": "548",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*48:01",
  "GeTH_AlleleCount": 33,
  "GeTH_AlleleFreq": 0.004409407,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "11;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "2.24 (0.28 - 18.15)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d052"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d053"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d054"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d055"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d056"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d057"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d058"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d059"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d05a"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d05b"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d05c"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d05d"
  },
  "id": "549",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.49,
  "hla_adr_pvalue_population": "0.44",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.62 (0.16 - 43.81)",
  "hla_adr_odds_population": "1.89 (0.24 - 15.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d05e"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d05f"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d060"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d061"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d062"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d063"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d064"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d065"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d066"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d067"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d068"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d069"
  },
  "id": "550",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:17",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "/ 528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d06a"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d06b"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d06c"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d06d"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d06e"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d06f"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d070"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d071"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d072"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d073"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d074"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d075"
  },
  "id": "551",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.92,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;56",
  "hla_adr_exposed_frequency": "3;22",
  "hla_adr_population_frequency": "47;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.77 (0.28 - 11.37)",
  "hla_adr_odds_population": "1.02 (0.23 - 4.51)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d076"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d077"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d078"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d079"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d07a"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d07b"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d07c"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d07d"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d07e"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d07f"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d080"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d081"
  },
  "id": "552",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:19",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d082"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d083"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d084"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d085"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d086"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d087"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d088"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d089"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d08a"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d08b"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d08c"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d08d"
  },
  "id": "553",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*44:08",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "1;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "1.22 (0.11 - 14.09)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d08e"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d08f"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d090"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d091"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d092"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d093"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d094"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d095"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d096"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d097"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d098"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d099"
  },
  "id": "554",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:01",
  "GeTH_AlleleCount": 16,
  "GeTH_AlleleFreq": 0.002137894,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.81,
  "hla_adr_pvalue_population": "0.08",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;56",
  "hla_adr_exposed_frequency": "4;22",
  "hla_adr_population_frequency": "0;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.46 (0.05 - 4.17)",
  "hla_adr_odds_population": "24.78 (1.5 - 408.76)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d09a"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d09b"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d09c"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d09d"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d09e"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d09f"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a0"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a1"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a2"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a3"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a4"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a5"
  },
  "id": "555",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.39",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "12;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "2.21 (0.27 - 17.8)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a6"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a7"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a8"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0a9"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0234533",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0aa"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ab"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0238111",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ac"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ad"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0011570",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ae"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0af"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0751495",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b0"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "SJS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b1"
  },
  "id": "556",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21306565",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*81:01",
  "GeTH_AlleleCount": 4,
  "GeTH_AlleleFreq": 0.000534474,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.2,
  "hla_adr_pvalue_population": "0.07",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;56",
  "hla_adr_exposed_frequency": "0;22",
  "hla_adr_population_frequency": "1;569",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "continuity correction",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "5.18 (0.45 - 60.07)",
  "hla_adr_odds_population": "27.05 (1.64 - 447.38)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0853193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b2"
  },
  "id": "557",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.55",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.39 (0.05 - 2.93)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b3"
  },
  "id": "557",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.55",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.39 (0.05 - 2.93)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b4"
  },
  "id": "557",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.55",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_population_frequency": "36;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.39 (0.05 - 2.93)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b5"
  },
  "id": "558",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "9.75E-11",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;36",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "8.96 (4.28 - 18.74)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b6"
  },
  "id": "558",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "9.75E-11",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;36",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "8.96 (4.28 - 18.74)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b7"
  },
  "id": "558",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "9.75E-11",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;36",
  "hla_adr_population_frequency": "39;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "8.96 (4.28 - 18.74)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b8"
  },
  "id": "559",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "31 (2.74 - 350.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0b9"
  },
  "id": "559",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "31 (2.74 - 350.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ba"
  },
  "id": "559",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:11",
  "GeTH_AlleleCount": 22,
  "GeTH_AlleleFreq": 0.002939604,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.01",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_population_frequency": "1;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "31 (2.74 - 350.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0bb"
  },
  "id": "560",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.53",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_population_frequency": "37;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.38 (0.05 - 2.85)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0bc"
  },
  "id": "560",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.53",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_population_frequency": "37;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.38 (0.05 - 2.85)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0bd"
  },
  "id": "560",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.53",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;36",
  "hla_adr_population_frequency": "37;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "0.38 (0.05 - 2.85)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0be"
  },
  "id": "561",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.2",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;36",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "1.7 (0.75 - 3.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0bf"
  },
  "id": "561",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.2",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;36",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "1.7 (0.75 - 3.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c0"
  },
  "id": "561",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.2",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;36",
  "hla_adr_population_frequency": "76;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "1.7 (0.75 - 3.87)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c1"
  },
  "id": "562",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.57",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;36",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "1.48 (0.59 - 3.69)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c2"
  },
  "id": "562",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.57",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;36",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "1.48 (0.59 - 3.69)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c3"
  },
  "id": "562",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.57",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;36",
  "hla_adr_population_frequency": "63;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "1.48 (0.59 - 3.69)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c4"
  },
  "id": "563",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.25",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.33 (0.51 - 10.75)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c5"
  },
  "id": "563",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.25",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.33 (0.51 - 10.75)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c6"
  },
  "id": "563",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*54:01",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_population": "0.25",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;36",
  "hla_adr_population_frequency": "13;528",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_population": "2.33 (0.51 - 10.75)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c7"
  },
  "id": "1153",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c8"
  },
  "id": "1153",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0c9"
  },
  "id": "1153",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;34",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ca"
  },
  "id": "1227",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0cb"
  },
  "id": "1227",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0cc"
  },
  "id": "1227",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0cd"
  },
  "id": "1301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ce"
  },
  "id": "1301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0cf"
  },
  "id": "1301",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:12",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "1;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d0"
  },
  "id": "1154",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;34",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d1"
  },
  "id": "1154",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;34",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d2"
  },
  "id": "1154",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;34",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d3"
  },
  "id": "1228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d4"
  },
  "id": "1228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d5"
  },
  "id": "1228",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d6"
  },
  "id": "1302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d7"
  },
  "id": "1302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d8"
  },
  "id": "1302",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*02:81",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133583,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_population_frequency": "0;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0d9"
  },
  "id": "649",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11266078",
  "hla_adr_drug_id": "clozapine",
  "db_id": "DB00363",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03",
  "GeTH_AlleleCount": 1770,
  "GeTH_AlleleFreq": 0.236441357,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;31",
  "hla_adr_exposed_frequency": "17;77",
  "hla_adr_adr": "agranulocytosis",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "schizophrenia",
  "hla_adr_region_id": "Europe",
  "c_id": "C2063865"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0da"
  },
  "id": "649",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/11266078",
  "hla_adr_drug_id": "clozapine",
  "db_id": "DB00363",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03",
  "GeTH_AlleleCount": 1770,
  "GeTH_AlleleFreq": 0.236441357,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "6;31",
  "hla_adr_exposed_frequency": "17;77",
  "hla_adr_adr": "agranulocytosis",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "schizophrenia",
  "hla_adr_region_id": "Europe",
  "c_id": "C2063865"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0db"
  },
  "id": "500",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0dc"
  },
  "id": "500",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0dd"
  },
  "id": "500",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0de"
  },
  "id": "500",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0df"
  },
  "id": "500",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e0"
  },
  "id": "500",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21149285",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;61",
  "hla_adr_exposed_frequency": "2;376",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Study reports the use of Bonferroni's correction but the corrected values were not reported, The p-value was reported as not significant after correction.",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "unknown",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e1"
  },
  "id": "673",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23057547",
  "hla_adr_drug_id": "EGF receptor inhibitors",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_pvalue_exposed": 0.2811,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;38",
  "hla_adr_exposed_frequency": "21;172",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Germany",
  "hla_adr_disease_id": "cancer",
  "hla_adr_odds_exposed": "0.448 (0.187 - 1.076)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e2"
  },
  "id": "800",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24781922",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_pvalue_exposed": 0.412,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;131",
  "hla_adr_exposed_frequency": "4;419",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe ocular surface complications",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "4.12 (1.089 - 15.564)",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e3"
  },
  "id": "814",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24781922",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Japanese",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;20",
  "hla_adr_exposed_frequency": "19;220",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe ocular surface complications",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Japan",
  "hla_adr_disease_id": "other",
  "hla_adr_region_id": "Asia",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e4"
  },
  "id": "853",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25303297",
  "hla_adr_drug_id": "sulfasalazine",
  "db_id": "DB00795",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.192,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "9;283",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "6.09 (0.64 - 57.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0003873",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e5"
  },
  "id": "853",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/25303297",
  "hla_adr_drug_id": "sulfasalazine",
  "db_id": "DB00795",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.192,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;6",
  "hla_adr_exposed_frequency": "9;283",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "other",
  "hla_adr_odds_exposed": "6.09 (0.64 - 57.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0010346",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e6"
  },
  "id": "878",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "27;134",
  "hla_adr_population_frequency": "24;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "0.98",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e7"
  },
  "id": "577",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "3;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.02 - 2.82)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e8"
  },
  "id": "577",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "3;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.02 - 2.82)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0e9"
  },
  "id": "577",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.32,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "3;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.25 (0.02 - 2.82)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ea"
  },
  "id": "578",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;13",
  "hla_adr_exposed_frequency": "2;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.91 (0.11 - 7.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0eb"
  },
  "id": "578",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;13",
  "hla_adr_exposed_frequency": "2;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.91 (0.11 - 7.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ec"
  },
  "id": "578",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;13",
  "hla_adr_exposed_frequency": "2;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.91 (0.11 - 7.72)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ed"
  },
  "id": "579",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ee"
  },
  "id": "579",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ef"
  },
  "id": "579",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:03",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f0"
  },
  "id": "580",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:25",
  "GeTH_AlleleCount": 160,
  "GeTH_AlleleFreq": 0.021378942,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f1"
  },
  "id": "580",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:25",
  "GeTH_AlleleCount": 160,
  "GeTH_AlleleFreq": 0.021378942,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f2"
  },
  "id": "580",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:25",
  "GeTH_AlleleCount": 160,
  "GeTH_AlleleFreq": 0.021378942,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f3"
  },
  "id": "581",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.16,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.88 (0.67 - 70.82)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f4"
  },
  "id": "581",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.16,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.88 (0.67 - 70.82)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f5"
  },
  "id": "581",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.16,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "5;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "6.88 (0.67 - 70.82)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f6"
  },
  "id": "582",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;13",
  "hla_adr_exposed_frequency": "2;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.22 (0.33 - 15.18)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f7"
  },
  "id": "582",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;13",
  "hla_adr_exposed_frequency": "2;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.22 (0.33 - 15.18)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f8"
  },
  "id": "582",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.65,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;13",
  "hla_adr_exposed_frequency": "2;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "2.22 (0.33 - 15.18)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0f9"
  },
  "id": "583",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0fa"
  },
  "id": "583",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0fb"
  },
  "id": "583",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.48,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.28 (0.01 - 7.67)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0fc"
  },
  "id": "584",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.92 (0.05 - 16.49)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0fd"
  },
  "id": "584",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.92 (0.05 - 16.49)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0fe"
  },
  "id": "584",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/22348435",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:10",
  "GeTH_AlleleCount": 1,
  "GeTH_AlleleFreq": 0.000133618,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;13",
  "hla_adr_exposed_frequency": "1;12",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_association": "Allele count for patients and tolerant controls who are positive for HLA-B*15:02",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_odds_exposed": "0.92 (0.05 - 16.49)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d0ff"
  },
  "id": "989",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21570397",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian (North West)",
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "15;134",
  "hla_adr_population_frequency": "23;107",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United Kingdom",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_odds_population": "1.51",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d100"
  },
  "id": "1155",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;34",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d101"
  },
  "id": "1155",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;34",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d102"
  },
  "id": "1155",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antiepileptic drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;34",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d103"
  },
  "id": "1229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d104"
  },
  "id": "1229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d105"
  },
  "id": "1229",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;24",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d106"
  },
  "id": "1303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d107"
  },
  "id": "1303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d108"
  },
  "id": "1303",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/31089385",
  "hla_adr_drug_id": "antibacterial drugs",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Unknown",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;20",
  "hla_adr_population_frequency": "3;80",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),drug-induced hypersensitivity syndrome (DIHS),acute generalized exanthematous pustulosis (AGEP)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-value was reported as not significant",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Iran",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "AGEP"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d109"
  },
  "id": "1380",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;62",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d10a"
  },
  "id": "1380",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;62",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d10b"
  },
  "id": "1380",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;62",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d10c"
  },
  "id": "1380",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;62",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "maculopapular eruption (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d10d"
  },
  "id": "1383",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d10e"
  },
  "id": "1383",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d10f"
  },
  "id": "1383",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d110"
  },
  "id": "1383",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.08,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;14",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d111"
  },
  "id": "1386",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.11,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;16",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d112"
  },
  "id": "1386",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.11,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;16",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d113"
  },
  "id": "1386",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.11,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;16",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d114"
  },
  "id": "1386",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.11,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;16",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d115"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d116"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014556"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d117"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d118"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014549"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d119"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d11a"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0036572"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d11b"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d11c"
  },
  "id": "1389",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/30826555",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.005,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "4;10",
  "hla_adr_exposed_frequency": "14;200",
  "hla_adr_adr": "fixed drug eruption",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_notes": "patient and control sample sizes represent the number of alleles (not the number of individuals)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0149958"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d11d"
  },
  "id": "1462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "3;10",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.17 (0.05 - 34.03)",
  "hla_adr_odds_population": "2.19 (0.08 - 31.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d11e"
  },
  "id": "1462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "3;10",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.17 (0.05 - 34.03)",
  "hla_adr_odds_population": "2.19 (0.08 - 31.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0234533",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d11f"
  },
  "id": "1462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "3;10",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.17 (0.05 - 34.03)",
  "hla_adr_odds_population": "2.19 (0.08 - 31.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0238111",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d120"
  },
  "id": "1462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "3;10",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.17 (0.05 - 34.03)",
  "hla_adr_odds_population": "2.19 (0.08 - 31.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0011570",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d121"
  },
  "id": "1462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "3;10",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.17 (0.05 - 34.03)",
  "hla_adr_odds_population": "2.19 (0.08 - 31.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0751495",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d122"
  },
  "id": "1462",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "lamotrigine",
  "db_id": "DB00555",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_pvalue_population": "0.93",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;3",
  "hla_adr_exposed_frequency": "3;10",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.17 (0.05 - 34.03)",
  "hla_adr_odds_population": "2.19 (0.08 - 31.72)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0853193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d123"
  },
  "id": "1485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.896,
  "hla_adr_pvalue_population": "0.483",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;5",
  "hla_adr_exposed_frequency": "6;28",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.89 (0.17 - 20.5)",
  "hla_adr_odds_population": "2.92 (0.33 - 22.3)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014556",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d124"
  },
  "id": "1485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.896,
  "hla_adr_pvalue_population": "0.483",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;5",
  "hla_adr_exposed_frequency": "6;28",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.89 (0.17 - 20.5)",
  "hla_adr_odds_population": "2.92 (0.33 - 22.3)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014549",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d125"
  },
  "id": "1485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.896,
  "hla_adr_pvalue_population": "0.483",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;5",
  "hla_adr_exposed_frequency": "6;28",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.89 (0.17 - 20.5)",
  "hla_adr_odds_population": "2.92 (0.33 - 22.3)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0036572",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d126"
  },
  "id": "1485",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "phenytoin",
  "db_id": "DB00252",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.896,
  "hla_adr_pvalue_population": "0.483",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;5",
  "hla_adr_exposed_frequency": "6;28",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.89 (0.17 - 20.5)",
  "hla_adr_odds_population": "2.92 (0.33 - 22.3)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0149958",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d127"
  },
  "id": "1523",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.991,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;4",
  "hla_adr_exposed_frequency": "3;23",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.22 (0.07 - 46.47)",
  "hla_adr_odds_population": "1.46 (0.06 - 16.28)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0030193",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d128"
  },
  "id": "1523",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.991,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;4",
  "hla_adr_exposed_frequency": "3;23",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.22 (0.07 - 46.47)",
  "hla_adr_odds_population": "1.46 (0.06 - 16.28)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0040997",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d129"
  },
  "id": "1523",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/27888155",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_exposed": 0.991,
  "hla_adr_pvalue_population": "1",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;4",
  "hla_adr_exposed_frequency": "3;23",
  "hla_adr_population_frequency": "47;253",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.22 (0.07 - 46.47)",
  "hla_adr_odds_population": "1.46 (0.06 - 16.28)",
  "hla_adr_region_id": "Europe",
  "c_id": "C0014544",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d12a"
  },
  "id": "596",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.00008,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "17;24",
  "hla_adr_exposed_frequency": "33;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "9 (3.2 - 27.4)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d12b"
  },
  "id": "596",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.00008,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "17;24",
  "hla_adr_exposed_frequency": "33;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "9 (3.2 - 27.4)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d12c"
  },
  "id": "596",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.00008,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "17;24",
  "hla_adr_exposed_frequency": "33;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "9 (3.2 - 27.4)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d12d"
  },
  "id": "596",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.00008,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "17;24",
  "hla_adr_exposed_frequency": "33;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "9 (3.2 - 27.4)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d12e"
  },
  "id": "597",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0003,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;24",
  "hla_adr_exposed_frequency": "30;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d12f"
  },
  "id": "597",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0003,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;24",
  "hla_adr_exposed_frequency": "30;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d130"
  },
  "id": "597",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0003,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;24",
  "hla_adr_exposed_frequency": "30;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d131"
  },
  "id": "597",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0003,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "15;24",
  "hla_adr_exposed_frequency": "30;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d132"
  },
  "id": "598",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0004,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "16;24",
  "hla_adr_exposed_frequency": "35;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.9)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d133"
  },
  "id": "598",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0004,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "16;24",
  "hla_adr_exposed_frequency": "35;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.9)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d134"
  },
  "id": "598",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0004,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "16;24",
  "hla_adr_exposed_frequency": "35;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.9)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d135"
  },
  "id": "598",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.0004,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "16;24",
  "hla_adr_exposed_frequency": "35;155",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the confrmatory study",
  "hla_adr_odds_exposed": "6.9 (2.5 - 19.9)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d136"
  },
  "id": "599",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "58;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.6 (1.1 - 5.7)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d137"
  },
  "id": "599",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "58;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.6 (1.1 - 5.7)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d138"
  },
  "id": "599",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "58;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.6 (1.1 - 5.7)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d139"
  },
  "id": "599",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQA1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQA1*02:01",
  "GeTH_AlleleCount": 620,
  "GeTH_AlleleFreq": 0.082843399,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "58;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.6 (1.1 - 5.7)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d13a"
  },
  "id": "600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.007,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;35",
  "hla_adr_exposed_frequency": "47;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.9 (1.3 - 6.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d13b"
  },
  "id": "600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.007,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;35",
  "hla_adr_exposed_frequency": "47;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.9 (1.3 - 6.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d13c"
  },
  "id": "600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.007,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;35",
  "hla_adr_exposed_frequency": "47;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.9 (1.3 - 6.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d13d"
  },
  "id": "600",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*02:02",
  "GeTH_AlleleCount": 0,
  "GeTH_AlleleFreq": 0,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.007,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;35",
  "hla_adr_exposed_frequency": "47;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.9 (1.3 - 6.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d13e"
  },
  "id": "601",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "59;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.5 (1.1 - 5.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C1699634",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d13f"
  },
  "id": "601",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "59;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.5 (1.1 - 5.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C0278488",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d140"
  },
  "id": "601",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "59;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.5 (1.1 - 5.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C1514463",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d141"
  },
  "id": "601",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21245432",
  "hla_adr_drug_id": "lapatinib",
  "db_id": "DB01259",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*07:01",
  "GeTH_AlleleCount": 445,
  "GeTH_AlleleFreq": 0.059460182,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 0.04,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "14;35",
  "hla_adr_exposed_frequency": "59;283",
  "hla_adr_adr": "drug induced liver injury (DILI)",
  "hla_adr_stat_analysis": "unknown",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "breast cancer",
  "hla_adr_notes": "two sub-studies were performed. This data refers to the exploratory study",
  "hla_adr_odds_exposed": "2.5 (1.1 - 5.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C0877373",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d142"
  },
  "id": "602",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/16816555",
  "hla_adr_drug_id": "abacavir",
  "db_id": "DB01048",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*57:01",
  "GeTH_AlleleCount": 112,
  "GeTH_AlleleFreq": 0.014965259,
  "hla_adr_cohort_ethnicity_id": "Caucasian (predominantly)",
  "hla_adr_pvalue_exposed": 0.03,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "2;9",
  "hla_adr_exposed_frequency": "0;41",
  "hla_adr_adr": "drug-induced hypersensitivity syndrome (DIHS)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "United States",
  "hla_adr_disease_id": "HIV",
  "hla_adr_odds_exposed": "6.9 (3.5 - 13.6)",
  "hla_adr_region_id": "North America",
  "c_id": "C2363741",
  "Type_of_adr": "DIHS"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d143"
  },
  "id": "1683",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/28278336",
  "hla_adr_drug_id": "NSAID and 'multi-ingredient cold medication'",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-A",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-A*03:01",
  "GeTH_AlleleCount": 56,
  "GeTH_AlleleFreq": 0.007480631,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_population": "0.193",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;39",
  "hla_adr_population_frequency": "16;133",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN),severe occular complicatoins",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Brazil",
  "hla_adr_disease_id": "common cold",
  "hla_adr_region_id": "South America",
  "c_id": "other",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d144"
  },
  "id": "604",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23874514",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:01",
  "GeTH_AlleleCount": 266,
  "GeTH_AlleleFreq": 0.035542491,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.22",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "11;28",
  "hla_adr_population_frequency": "163;855",
  "hla_adr_adr": "drug induced liver injury (DILI) - hepatocellular type of damage",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "The study reports that amoxicillin-clavulanate is commonly used in Spain and therefore assumed that a large proportion of the population controls were exposed to the drug at some stage of their lives.",
  "hla_adr_odds_population": "2.9 (1.3 - 6.2)",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d145"
  },
  "id": "605",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23874514",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DRB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DRB1*15:01",
  "GeTH_AlleleCount": 599,
  "GeTH_AlleleFreq": 0.080037413,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.06",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "17;47",
  "hla_adr_population_frequency": "158;855",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic/mixed type of damage",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "confidence intervals for the odds ratios were not provided for this association",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "The study reports  that amoxicillin-clavulanate is commonly used in Spain and therefore assumed that a large proportion of the population controls were exposed to the drug at some stage of their lives.",
  "hla_adr_odds_population": "2.6",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d146"
  },
  "id": "606",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/23874514",
  "hla_adr_drug_id": "amoxicillin-clavulanate",
  "db_id": "N/A",
  "hla_adr_gene_id": "HLA-DQB1",
  "hla_adr_gene_class_id": "MHC class II",
  "hla_adr_allele": "HLA-DQB1*06:02",
  "GeTH_AlleleCount": 105,
  "GeTH_AlleleFreq": 0.014029931,
  "hla_adr_cohort_ethnicity_id": "Caucasian",
  "hla_adr_pvalue_population": "0.03",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "17;47",
  "hla_adr_population_frequency": "150;855",
  "hla_adr_adr": "drug induced liver injury (DILI) - cholestatic/mixed type of damage",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_association": "confidence intervals for the odds ratios were not provided for this association",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Spain",
  "hla_adr_disease_id": "bacterial infections",
  "hla_adr_notes": "The study reports  that amoxicillin-clavulanate is commonly used in Spain and therefore assumed that a large proportion of the population controls were exposed to the drug at some stage of their lives.",
  "hla_adr_odds_population": "2.8",
  "hla_adr_region_id": "Europe",
  "c_id": "other",
  "Type_of_adr": "DILI"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d147"
  },
  "id": "607",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1.61e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "27;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "348.3 (19.2 - 6336.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d148"
  },
  "id": "607",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1.61e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "27;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "348.3 (19.2 - 6336.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d149"
  },
  "id": "607",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1.61e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "27;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "348.3 (19.2 - 6336.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d14a"
  },
  "id": "607",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1.61e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "27;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "348.3 (19.2 - 6336.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d14b"
  },
  "id": "607",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1.61e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "27;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "348.3 (19.2 - 6336.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d14c"
  },
  "id": "607",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1.61e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "27;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "348.3 (19.2 - 6336.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d14d"
  },
  "id": "607",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1.61e-13,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "27;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "348.3 (19.2 - 6336.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d14e"
  },
  "id": "608",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.68,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.8 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d14f"
  },
  "id": "608",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.68,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.8 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d150"
  },
  "id": "608",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.68,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.8 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d151"
  },
  "id": "608",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.68,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.8 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d152"
  },
  "id": "608",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.68,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.8 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d153"
  },
  "id": "608",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.68,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.8 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d154"
  },
  "id": "608",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.68,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "4;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.8 (0.2 - 2.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d155"
  },
  "id": "609",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d156"
  },
  "id": "609",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d157"
  },
  "id": "609",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d158"
  },
  "id": "609",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d159"
  },
  "id": "609",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d15a"
  },
  "id": "609",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d15b"
  },
  "id": "609",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.18,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;27",
  "hla_adr_exposed_frequency": "10;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.1 - 1.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d15c"
  },
  "id": "610",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "2;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "3.3 (0.5 - 20.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d15d"
  },
  "id": "610",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "2;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "3.3 (0.5 - 20.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d15e"
  },
  "id": "610",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "2;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "3.3 (0.5 - 20.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d15f"
  },
  "id": "610",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "2;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "3.3 (0.5 - 20.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d160"
  },
  "id": "610",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "2;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "3.3 (0.5 - 20.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d161"
  },
  "id": "610",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "2;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "3.3 (0.5 - 20.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d162"
  },
  "id": "610",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "2;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "3.3 (0.5 - 20.7)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d163"
  },
  "id": "611",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.37,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "5;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.04 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d164"
  },
  "id": "611",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.37,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "5;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.04 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d165"
  },
  "id": "611",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.37,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "5;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.04 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d166"
  },
  "id": "611",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.37,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "5;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.04 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d167"
  },
  "id": "611",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.37,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "5;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.04 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d168"
  },
  "id": "611",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.37,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "5;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.04 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d169"
  },
  "id": "611",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.37,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "5;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.4 (0.04 - 3.4)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d16a"
  },
  "id": "612",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.03 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d16b"
  },
  "id": "612",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.03 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d16c"
  },
  "id": "612",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.03 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d16d"
  },
  "id": "612",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.03 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d16e"
  },
  "id": "612",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.03 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d16f"
  },
  "id": "612",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.03 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d170"
  },
  "id": "612",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.19,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "7;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.03 - 2.2)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d171"
  },
  "id": "613",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.06,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "16;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.08 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d172"
  },
  "id": "613",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.06,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "16;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.08 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d173"
  },
  "id": "613",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.06,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "16;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.08 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d174"
  },
  "id": "613",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.06,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "16;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.08 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d175"
  },
  "id": "613",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.06,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "16;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.08 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d176"
  },
  "id": "613",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.06,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "16;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.08 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d177"
  },
  "id": "613",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.06,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;27",
  "hla_adr_exposed_frequency": "16;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.3 (0.08 - 1.1)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d178"
  },
  "id": "614",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.13,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "8;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.2 (0.03 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0744465",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d179"
  },
  "id": "614",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.13,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "8;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.2 (0.03 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0740394",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d17a"
  },
  "id": "614",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.13,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "8;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.2 (0.03 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0022650",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d17b"
  },
  "id": "614",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.13,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "8;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.2 (0.03 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0277556",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d17c"
  },
  "id": "614",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.13,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "8;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.2 (0.03 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0409908",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d17d"
  },
  "id": "614",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.13,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "8;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.2 (0.03 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C2955673",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d17e"
  },
  "id": "614",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19696695",
  "hla_adr_drug_id": "allopurinol",
  "db_id": "DB00437",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.13,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;27",
  "hla_adr_exposed_frequency": "8;54",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "gout",
  "hla_adr_odds_exposed": "0.2 (0.03 - 1.9)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0018099",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d17f"
  },
  "id": "615",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 2.89e-12,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "37;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "54.76 (14.62 - 205.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d180"
  },
  "id": "615",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 2.89e-12,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "37;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "54.76 (14.62 - 205.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d181"
  },
  "id": "615",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 2.89e-12,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "37;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "54.76 (14.62 - 205.13)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d182"
  },
  "id": "616",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:21",
  "GeTH_AlleleCount": 44,
  "GeTH_AlleleFreq": 0.005879209,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2398,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "0;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.25 (0.24 - 112.66)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d183"
  },
  "id": "616",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:21",
  "GeTH_AlleleCount": 44,
  "GeTH_AlleleFreq": 0.005879209,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2398,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "0;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.25 (0.24 - 112.66)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d184"
  },
  "id": "616",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:21",
  "GeTH_AlleleCount": 44,
  "GeTH_AlleleFreq": 0.005879209,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2398,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "0;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "5.25 (0.24 - 112.66)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d185"
  },
  "id": "617",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:35",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1245,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "0;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.53 (0.38 - 150.47)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d186"
  },
  "id": "617",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:35",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1245,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "0;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.53 (0.38 - 150.47)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d187"
  },
  "id": "617",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:35",
  "GeTH_AlleleCount": 52,
  "GeTH_AlleleFreq": 0.006948156,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1245,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "0;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "7.53 (0.38 - 150.47)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d188"
  },
  "id": "618",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.4572,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.57 (0.13 - 2.55)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d189"
  },
  "id": "618",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.4572,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.57 (0.13 - 2.55)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d18a"
  },
  "id": "618",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*13:01",
  "GeTH_AlleleCount": 468,
  "GeTH_AlleleFreq": 0.062533405,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.4572,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.57 (0.13 - 2.55)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d18b"
  },
  "id": "619",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:01",
  "GeTH_AlleleCount": 266,
  "GeTH_AlleleFreq": 0.035542491,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2363,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.37 (0.07 - 2.02)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d18c"
  },
  "id": "619",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:01",
  "GeTH_AlleleCount": 266,
  "GeTH_AlleleFreq": 0.035542491,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2363,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.37 (0.07 - 2.02)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d18d"
  },
  "id": "619",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:01",
  "GeTH_AlleleCount": 266,
  "GeTH_AlleleFreq": 0.035542491,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2363,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.37 (0.07 - 2.02)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d18e"
  },
  "id": "620",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1665,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;42",
  "hla_adr_exposed_frequency": "4;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0.02 - 2.17)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d18f"
  },
  "id": "620",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1665,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;42",
  "hla_adr_exposed_frequency": "4;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0.02 - 2.17)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d190"
  },
  "id": "620",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*18:02",
  "GeTH_AlleleCount": 155,
  "GeTH_AlleleFreq": 0.02071085,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1665,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;42",
  "hla_adr_exposed_frequency": "4;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.23 (0.02 - 2.17)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d191"
  },
  "id": "621",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:06",
  "GeTH_AlleleCount": 161,
  "GeTH_AlleleFreq": 0.02151256,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.3968,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "4;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.48 (0.08 - 2.75)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d192"
  },
  "id": "621",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:06",
  "GeTH_AlleleCount": 161,
  "GeTH_AlleleFreq": 0.02151256,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.3968,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "4;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.48 (0.08 - 2.75)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d193"
  },
  "id": "621",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*27:06",
  "GeTH_AlleleCount": 161,
  "GeTH_AlleleFreq": 0.02151256,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.3968,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "4;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.48 (0.08 - 2.75)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d194"
  },
  "id": "622",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:05",
  "GeTH_AlleleCount": 173,
  "GeTH_AlleleFreq": 0.023115981,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1245,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "3;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.13 (0.0066 - 2.65)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d195"
  },
  "id": "622",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:05",
  "GeTH_AlleleCount": 173,
  "GeTH_AlleleFreq": 0.023115981,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1245,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "3;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.13 (0.0066 - 2.65)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d196"
  },
  "id": "622",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*35:05",
  "GeTH_AlleleCount": 173,
  "GeTH_AlleleFreq": 0.023115981,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1245,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "3;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.13 (0.0066 - 2.65)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d197"
  },
  "id": "623",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.13 - 7.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d198"
  },
  "id": "623",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.13 - 7.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d199"
  },
  "id": "623",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*38:02",
  "GeTH_AlleleCount": 271,
  "GeTH_AlleleFreq": 0.036210583,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 1,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "2;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1 (0.13 - 7.45)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d19a"
  },
  "id": "624",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:09",
  "GeTH_AlleleCount": 106,
  "GeTH_AlleleFreq": 0.014163549,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6447,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.54 (0.24 - 9.71)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d19b"
  },
  "id": "624",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:09",
  "GeTH_AlleleCount": 106,
  "GeTH_AlleleFreq": 0.014163549,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6447,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.54 (0.24 - 9.71)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d19c"
  },
  "id": "624",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*39:09",
  "GeTH_AlleleCount": 106,
  "GeTH_AlleleFreq": 0.014163549,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6447,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.54 (0.24 - 9.71)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d19d"
  },
  "id": "625",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2899,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "6;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.46 (0.11 - 1.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d19e"
  },
  "id": "625",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2899,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "6;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.46 (0.11 - 1.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d19f"
  },
  "id": "625",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*40:01",
  "GeTH_AlleleCount": 558,
  "GeTH_AlleleFreq": 0.074559059,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2899,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "6;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.46 (0.11 - 1.98)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a0"
  },
  "id": "626",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6084,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;42",
  "hla_adr_exposed_frequency": "11;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.77 (0.28 - 2.11)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a1"
  },
  "id": "626",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6084,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;42",
  "hla_adr_exposed_frequency": "11;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.77 (0.28 - 2.11)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a2"
  },
  "id": "626",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*46:01",
  "GeTH_AlleleCount": 970,
  "GeTH_AlleleFreq": 0.129609834,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6084,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "9;42",
  "hla_adr_exposed_frequency": "11;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.77 (0.28 - 2.11)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a3"
  },
  "id": "627",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.0343,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.08 (0.0043 - 1.4995)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a4"
  },
  "id": "627",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.0343,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.08 (0.0043 - 1.4995)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a5"
  },
  "id": "627",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:01",
  "GeTH_AlleleCount": 305,
  "GeTH_AlleleFreq": 0.040753608,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.0343,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "5;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.08 (0.0043 - 1.4995)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a6"
  },
  "id": "628",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2398,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.19 (0.0089 - 4.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a7"
  },
  "id": "628",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2398,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.19 (0.0089 - 4.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a8"
  },
  "id": "628",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*51:02",
  "GeTH_AlleleCount": 68,
  "GeTH_AlleleFreq": 0.00908605,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.2398,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "0;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.19 (0.0089 - 4.09)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1a9"
  },
  "id": "629",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6086,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.59 (0.07 - 4.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1aa"
  },
  "id": "629",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6086,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.59 (0.07 - 4.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1ab"
  },
  "id": "629",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*55:02",
  "GeTH_AlleleCount": 110,
  "GeTH_AlleleFreq": 0.014698022,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.6086,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "1;42",
  "hla_adr_exposed_frequency": "2;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.59 (0.07 - 4.64)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1ac"
  },
  "id": "630",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.3055,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "1;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.15 (0.31 - 31.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1ad"
  },
  "id": "630",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.3055,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "1;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.15 (0.31 - 31.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1ae"
  },
  "id": "630",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*56:01",
  "GeTH_AlleleCount": 89,
  "GeTH_AlleleFreq": 0.011892036,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.3055,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "1;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "3.15 (0.31 - 31.62)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1af"
  },
  "id": "631",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1058,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "8;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.08 - 1.33)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b0"
  },
  "id": "631",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1058,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "8;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.08 - 1.33)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b1"
  },
  "id": "631",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20345939",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*58:01",
  "GeTH_AlleleCount": 547,
  "GeTH_AlleleFreq": 0.073089257,
  "hla_adr_cohort_ethnicity_id": "Thai",
  "hla_adr_pvalue_exposed": 0.1058,
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;42",
  "hla_adr_exposed_frequency": "8;42",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Bonferroni's correction",
  "hla_adr_country_id": "Thailand",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "0.33 (0.08 - 1.33)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b2"
  },
  "id": "632",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24394201",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 6.9e-8,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "3;26",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Singapore",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "181 (8.7 - 3785)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b3"
  },
  "id": "632",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24394201",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 6.9e-8,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "3;26",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Singapore",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "181 (8.7 - 3785)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b4"
  },
  "id": "632",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/24394201",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Diverse",
  "hla_adr_pvalue_exposed": 6.9e-8,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "13;13",
  "hla_adr_exposed_frequency": "3;26",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "Singapore",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "181 (8.7 - 3785)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b5"
  },
  "id": "633",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21397523",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;9",
  "hla_adr_exposed_frequency": "11;80",
  "hla_adr_population_frequency": "11;62",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "114.826 (6.25 - 2111.03)",
  "hla_adr_odds_population": "85.087 (4.61 - 1569.48)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b6"
  },
  "id": "633",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21397523",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;9",
  "hla_adr_exposed_frequency": "11;80",
  "hla_adr_population_frequency": "11;62",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "114.826 (6.25 - 2111.03)",
  "hla_adr_odds_population": "85.087 (4.61 - 1569.48)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b7"
  },
  "id": "633",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21397523",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.001,
  "hla_adr_pvalue_population": "0.001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "9;9",
  "hla_adr_exposed_frequency": "11;80",
  "hla_adr_population_frequency": "11;62",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "114.826 (6.25 - 2111.03)",
  "hla_adr_odds_population": "85.087 (4.61 - 1569.48)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b8"
  },
  "id": "634",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21397523",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.11,
  "hla_adr_pvalue_population": "0.341",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;39",
  "hla_adr_exposed_frequency": "11;80",
  "hla_adr_population_frequency": "11;62",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.163 (0.828 - 5.649)",
  "hla_adr_odds_population": "1.599 (0.606 - 4.218)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1b9"
  },
  "id": "634",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21397523",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.11,
  "hla_adr_pvalue_population": "0.341",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;39",
  "hla_adr_exposed_frequency": "11;80",
  "hla_adr_population_frequency": "11;62",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.163 (0.828 - 5.649)",
  "hla_adr_odds_population": "1.599 (0.606 - 4.218)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1ba"
  },
  "id": "634",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21397523",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.11,
  "hla_adr_pvalue_population": "0.341",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "10;39",
  "hla_adr_exposed_frequency": "11;80",
  "hla_adr_population_frequency": "11;62",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "2.163 (0.828 - 5.649)",
  "hla_adr_odds_population": "1.599 (0.606 - 4.218)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1bb"
  },
  "id": "635",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20833111",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;8",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-values for this association were not provided, although they were reported as statistically significant, which the study considered <0.05",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Unknown",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "184 (33.2 - 1021)",
  "hla_adr_odds_population": "173.3 (36 - 834.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1bc"
  },
  "id": "635",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20833111",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;8",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-values for this association were not provided, although they were reported as statistically significant, which the study considered <0.05",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Unknown",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "184 (33.2 - 1021)",
  "hla_adr_odds_population": "173.3 (36 - 834.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1bd"
  },
  "id": "635",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20833111",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.05,
  "hla_adr_pvalue_population": "0.05",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "8;8",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_association": "p-values for this association were not provided, although they were reported as statistically significant, which the study considered <0.05",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Unknown",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "184 (33.2 - 1021)",
  "hla_adr_odds_population": "173.3 (36 - 834.5)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1be"
  },
  "id": "636",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20833111",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.697,
  "hla_adr_pvalue_population": "0.724",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;28",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Unknown",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.4 (0.3 - 6.7)",
  "hla_adr_odds_population": "1.3 (0.3 - 5.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1bf"
  },
  "id": "636",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20833111",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.697,
  "hla_adr_pvalue_population": "0.724",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;28",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Unknown",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.4 (0.3 - 6.7)",
  "hla_adr_odds_population": "1.3 (0.3 - 5.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1c0"
  },
  "id": "636",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/20833111",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.697,
  "hla_adr_pvalue_population": "0.724",
  "hla_adr_minP": "FALSE",
  "hla_adr_patient_frequency": "3;28",
  "hla_adr_exposed_frequency": "4;50",
  "hla_adr_population_frequency": "6;71",
  "hla_adr_adr": "maculopapular exanthema (MPE)",
  "hla_adr_stat_analysis": "Fisher's exact test, Chi-squared test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Unknown",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "1.4 (0.3 - 6.7)",
  "hla_adr_odds_population": "1.3 (0.3 - 5.6)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "MPE"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1c1"
  },
  "id": "637",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21424386",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "16;17",
  "hla_adr_exposed_frequency": "2;21",
  "hla_adr_population_frequency": "17;185",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-values reported as <0.0001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "152 (12 - 1835)",
  "hla_adr_odds_population": "158 (19 - 1266)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1c2"
  },
  "id": "637",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21424386",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "16;17",
  "hla_adr_exposed_frequency": "2;21",
  "hla_adr_population_frequency": "17;185",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-values reported as <0.0001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "152 (12 - 1835)",
  "hla_adr_odds_population": "158 (19 - 1266)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1c3"
  },
  "id": "637",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/21424386",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Han Chinese",
  "hla_adr_pvalue_exposed": 0.0001,
  "hla_adr_pvalue_population": "0.0001",
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "16;17",
  "hla_adr_exposed_frequency": "2;21",
  "hla_adr_population_frequency": "17;185",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "Fisher's exact test, chi-squared test",
  "hla_adr_association": "p-values reported as <0.0001",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Null",
  "hla_adr_country_id": "China",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "152 (12 - 1835)",
  "hla_adr_odds_population": "158 (19 - 1266)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1c4"
  },
  "id": "638",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19915237",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.0014,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;8",
  "hla_adr_exposed_frequency": "0;10",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "71.4 (3 - 1698)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0030193",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1c5"
  },
  "id": "638",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19915237",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.0014,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;8",
  "hla_adr_exposed_frequency": "0;10",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "71.4 (3 - 1698)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0040997",
  "Type_of_adr": "SJS/TEN"
},{
  "_id": {
    "$oid": "676543ee8a3f82637a73d1c6"
  },
  "id": "638",
  "hla_adr_pubmed_link": "http://www.ncbi.nlm.nih.gov/pubmed/19915237",
  "hla_adr_drug_id": "carbamazepine",
  "db_id": "DB00564",
  "hla_adr_gene_id": "HLA-B",
  "hla_adr_gene_class_id": "MHC class I",
  "hla_adr_allele": "HLA-B*15:02",
  "GeTH_AlleleCount": 621,
  "GeTH_AlleleFreq": 0.082977018,
  "hla_adr_cohort_ethnicity_id": "Indian",
  "hla_adr_pvalue_exposed": 0.0014,
  "hla_adr_minP": "TRUE",
  "hla_adr_patient_frequency": "6;8",
  "hla_adr_exposed_frequency": "0;10",
  "hla_adr_adr": "Stevens-Johnson syndrome (SJS),toxic epidermal necrolysis (TEN)",
  "hla_adr_stat_analysis": "chi-square test",
  "hla_adr_cal_performed_id": "number of carriers (n)",
  "hla_adr_stat_correction_id": "Yates' continuity correction",
  "hla_adr_country_id": "India",
  "hla_adr_disease_id": "epilepsy",
  "hla_adr_odds_exposed": "71.4 (3 - 1698)",
  "hla_adr_region_id": "Asia",
  "c_id": "C0014544",
  "Type_of_adr": "SJS/TEN"
}]